id	sid	tid	token	lemma	pos
cpe-2361	1	1	evidence	evidence	NOUN
cpe-2361	1	2	of	of	ADP
cpe-2361	1	3	a	a	DET
cpe-2361	1	4	media	media	NOUN
cpe-2361	1	5	-	-	PUNCT
cpe-2361	1	6	induced	induce	VERB
cpe-2361	1	7	nocebo	nocebo	NOUN
cpe-2361	1	8	response	response	NOUN
cpe-2361	1	9	following	follow	VERB
cpe-2361	1	10	a	a	DET
cpe-2361	1	11	nationwide	nationwide	ADJ
cpe-2361	1	12	antidepressant	antidepressant	ADJ
cpe-2361	1	13	drug	drug	NOUN
cpe-2361	1	14	switch	switch	NOUN
cpe-2361	1	15	research	research	NOUN
cpe-2361	1	16	article	article	NOUN
cpe-2361	1	17	evidence	evidence	NOUN
cpe-2361	1	18	of	of	ADP
cpe-2361	1	19	a	a	DET
cpe-2361	1	20	media	media	NOUN
cpe-2361	1	21	-	-	PUNCT
cpe-2361	1	22	induced	induce	VERB
cpe-2361	1	23	nocebo	nocebo	NOUN
cpe-2361	1	24	response	response	NOUN
cpe-2361	1	25	following	follow	VERB
cpe-2361	1	26	a	a	DET
cpe-2361	1	27	nationwide	nationwide	ADJ
cpe-2361	1	28	antidepressant	antidepressant	ADJ
cpe-2361	1	29	drug	drug	NOUN
cpe-2361	1	30	switch	switch	NOUN
cpe-2361	1	31	kate	kate	NOUN
cpe-2361	1	32	mackrill	mackrill	AUX
cpe-2361	1	33	a	a	PROPN
cpe-2361	1	34	,	,	PUNCT
cpe-2361	1	35	greg	greg	PROPN
cpe-2361	1	36	d.	d.	PROPN
cpe-2361	1	37	gamble	gamble	PROPN
cpe-2361	1	38	b	b	PROPN
cpe-2361	1	39	,	,	PUNCT
cpe-2361	1	40	debbie	debbie	PROPN
cpe-2361	1	41	j.	j.	PROPN
cpe-2361	1	42	bean	bean	PROPN
cpe-2361	1	43	a	a	PROPN
cpe-2361	1	44	,	,	PUNCT
cpe-2361	1	45	tim	tim	PROPN
cpe-2361	1	46	cundy	cundy	PROPN
cpe-2361	1	47	b	b	PROPN
cpe-2361	1	48	,	,	PUNCT
cpe-2361	1	49	keith	keith	PROPN
cpe-2361	1	50	j.	j.	PROPN
cpe-2361	1	51	petrie	petrie	VERB
cpe-2361	1	52	a	a	DET
cpe-2361	1	53	[	[	X
cpe-2361	1	54	a	a	X
cpe-2361	1	55	]	]	X
cpe-2361	1	56	department	department	NOUN
cpe-2361	1	57	of	of	ADP
cpe-2361	1	58	psychological	psychological	ADJ
cpe-2361	1	59	medicine	medicine	NOUN
cpe-2361	1	60	,	,	PUNCT
cpe-2361	1	61	university	university	NOUN
cpe-2361	1	62	of	of	ADP
cpe-2361	1	63	auckland	auckland	PROPN
cpe-2361	1	64	,	,	PUNCT
cpe-2361	1	65	auckland	auckland	PROPN
cpe-2361	1	66	,	,	PUNCT
cpe-2361	1	67	new	new	PROPN
cpe-2361	1	68	zealand	zealand	PROPN
cpe-2361	1	69	.	.	PUNCT
cpe-2361	2	1	[	[	X
cpe-2361	2	2	b	b	X
cpe-2361	2	3	]	]	X
cpe-2361	2	4	department	department	NOUN
cpe-2361	2	5	of	of	ADP
cpe-2361	2	6	medicine	medicine	NOUN
cpe-2361	2	7	,	,	PUNCT
cpe-2361	2	8	university	university	NOUN
cpe-2361	2	9	of	of	ADP
cpe-2361	2	10	auckland	auckland	PROPN
cpe-2361	2	11	,	,	PUNCT
cpe-2361	2	12	auckland	auckland	PROPN
cpe-2361	2	13	,	,	PUNCT
cpe-2361	2	14	new	new	PROPN
cpe-2361	2	15	zealand	zealand	PROPN
cpe-2361	2	16	.	.	PUNCT
cpe-2361	3	1	clinical	clinical	ADJ
cpe-2361	3	2	psychology	psychology	NOUN
cpe-2361	3	3	in	in	ADP
cpe-2361	3	4	europe	europe	PROPN
cpe-2361	3	5	,	,	PUNCT
cpe-2361	3	6	2019	2019	NUM
cpe-2361	3	7	,	,	PUNCT
cpe-2361	3	8	vol	vol	NOUN
cpe-2361	3	9	.	.	NOUN
cpe-2361	3	10	1(1	1(1	NUM
cpe-2361	3	11	)	)	PUNCT
cpe-2361	3	12	,	,	PUNCT
cpe-2361	3	13	article	article	NOUN
cpe-2361	3	14	e29642	e29642	PROPN
cpe-2361	3	15	,	,	PUNCT
cpe-2361	3	16	https://doi.org/10.32872/cpe.v1i1.29642	https://doi.org/10.32872/cpe.v1i1.29642	PROPN
cpe-2361	3	17	received	receive	VERB
cpe-2361	3	18	:	:	PUNCT
cpe-2361	3	19	2018	2018	NUM
cpe-2361	3	20	-	-	SYM
cpe-2361	3	21	09	09	NUM
cpe-2361	3	22	-	-	SYM
cpe-2361	3	23	10	10	NUM
cpe-2361	3	24	•	•	NUM
cpe-2361	3	25	accepted	accept	VERB
cpe-2361	3	26	:	:	PUNCT
cpe-2361	3	27	2018	2018	NUM
cpe-2361	3	28	-	-	SYM
cpe-2361	3	29	12	12	NUM
cpe-2361	3	30	-	-	SYM
cpe-2361	3	31	05	05	NUM
cpe-2361	3	32	•	•	NOUN
cpe-2361	3	33	published	publish	VERB
cpe-2361	3	34	(	(	PUNCT
cpe-2361	3	35	vor	vor	NOUN
cpe-2361	3	36	):	):	PUNCT
cpe-2361	3	37	2019	2019	NUM
cpe-2361	3	38	-	-	SYM
cpe-2361	3	39	03	03	NUM
cpe-2361	3	40	-	-	SYM
cpe-2361	3	41	29	29	NUM
cpe-2361	3	42	handling	handling	NOUN
cpe-2361	3	43	editor	editor	NOUN
cpe-2361	3	44	:	:	PUNCT
cpe-2361	3	45	winfried	winfrie	VERB
cpe-2361	3	46	rief	rief	NOUN
cpe-2361	3	47	,	,	PUNCT
cpe-2361	3	48	division	division	NOUN
cpe-2361	3	49	of	of	ADP
cpe-2361	3	50	clinical	clinical	ADJ
cpe-2361	3	51	psychology	psychology	NOUN
cpe-2361	3	52	and	and	CCONJ
cpe-2361	3	53	psychotherapy	psychotherapy	NOUN
cpe-2361	3	54	,	,	PUNCT
cpe-2361	3	55	department	department	NOUN
cpe-2361	3	56	of	of	ADP
cpe-2361	3	57	psychology	psychology	NOUN
cpe-2361	3	58	,	,	PUNCT
cpe-2361	3	59	philipps	philipps	NOUN
cpe-2361	3	60	-	-	PUNCT
cpe-2361	3	61	university	university	PROPN
cpe-2361	3	62	of	of	ADP
cpe-2361	3	63	marburg	marburg	PROPN
cpe-2361	3	64	,	,	PUNCT
cpe-2361	3	65	marburg	marburg	PROPN
cpe-2361	3	66	,	,	PUNCT
cpe-2361	3	67	germany	germany	PROPN
cpe-2361	3	68	corresponding	corresponding	ADJ
cpe-2361	3	69	author	author	NOUN
cpe-2361	3	70	:	:	PUNCT
cpe-2361	3	71	keith	keith	PROPN
cpe-2361	3	72	j.	j.	PROPN
cpe-2361	3	73	petrie	petrie	PROPN
cpe-2361	3	74	,	,	PUNCT
cpe-2361	3	75	psychological	psychological	ADJ
cpe-2361	3	76	medicine	medicine	NOUN
cpe-2361	3	77	,	,	PUNCT
cpe-2361	3	78	faculty	faculty	NOUN
cpe-2361	3	79	of	of	ADP
cpe-2361	3	80	medical	medical	ADJ
cpe-2361	3	81	and	and	CCONJ
cpe-2361	3	82	health	health	NOUN
cpe-2361	3	83	sciences	sciences	PROPN
cpe-2361	3	84	,	,	PUNCT
cpe-2361	3	85	university	university	NOUN
cpe-2361	3	86	of	of	ADP
cpe-2361	3	87	auckland	auckland	PROPN
cpe-2361	3	88	,	,	PUNCT
cpe-2361	3	89	private	private	ADJ
cpe-2361	3	90	bag	bag	NOUN
cpe-2361	3	91	92019	92019	NUM
cpe-2361	3	92	,	,	PUNCT
cpe-2361	3	93	auckland	auckland	PROPN
cpe-2361	3	94	,	,	PUNCT
cpe-2361	3	95	new	new	PROPN
cpe-2361	3	96	zealand	zealand	PROPN
cpe-2361	3	97	.	.	PUNCT
cpe-2361	4	1	e	e	X
cpe-2361	4	2	-	-	NOUN
cpe-2361	4	3	mail	mail	NOUN
cpe-2361	4	4	:	:	PUNCT
cpe-2361	4	5	kj.petrie@auckland.ac.nz	kj.petrie@auckland.ac.nz	PROPN
cpe-2361	4	6	abstract	abstract	ADJ
cpe-2361	4	7	background	background	NOUN
cpe-2361	4	8	:	:	PUNCT
cpe-2361	4	9	in	in	ADP
cpe-2361	4	10	2017	2017	NUM
cpe-2361	4	11	,	,	PUNCT
cpe-2361	4	12	patients	patient	NOUN
cpe-2361	4	13	on	on	ADP
cpe-2361	4	14	a	a	DET
cpe-2361	4	15	generic	generic	ADJ
cpe-2361	4	16	or	or	CCONJ
cpe-2361	4	17	branded	brand	VERB
cpe-2361	4	18	antidepressant	antidepressant	ADJ
cpe-2361	4	19	venlafaxine	venlafaxine	NOUN
cpe-2361	4	20	were	be	AUX
cpe-2361	4	21	switched	switch	VERB
cpe-2361	4	22	to	to	ADP
cpe-2361	4	23	a	a	DET
cpe-2361	4	24	new	new	ADJ
cpe-2361	4	25	generic	generic	ADJ
cpe-2361	4	26	formulation	formulation	NOUN
cpe-2361	4	27	(	(	PUNCT
cpe-2361	4	28	enlafax	enlafax	ADJ
cpe-2361	4	29	)	)	PUNCT
cpe-2361	4	30	.	.	PUNCT
cpe-2361	5	1	in	in	ADP
cpe-2361	5	2	february	february	PROPN
cpe-2361	5	3	and	and	CCONJ
cpe-2361	5	4	april	april	PROPN
cpe-2361	5	5	2018	2018	NUM
cpe-2361	5	6	,	,	PUNCT
cpe-2361	5	7	two	two	NUM
cpe-2361	5	8	major	major	ADJ
cpe-2361	5	9	nz	nz	ADJ
cpe-2361	5	10	media	medium	NOUN
cpe-2361	5	11	outlets	outlet	NOUN
cpe-2361	5	12	ran	run	VERB
cpe-2361	5	13	stories	story	NOUN
cpe-2361	5	14	about	about	ADP
cpe-2361	5	15	the	the	DET
cpe-2361	5	16	new	new	ADJ
cpe-2361	5	17	generic	generic	ADJ
cpe-2361	5	18	being	be	AUX
cpe-2361	5	19	less	less	ADV
cpe-2361	5	20	effective	effective	ADJ
cpe-2361	5	21	and	and	CCONJ
cpe-2361	5	22	causing	cause	VERB
cpe-2361	5	23	specific	specific	ADJ
cpe-2361	5	24	side	side	NOUN
cpe-2361	5	25	effects	effect	NOUN
cpe-2361	5	26	.	.	PUNCT
cpe-2361	6	1	this	this	DET
cpe-2361	6	2	study	study	NOUN
cpe-2361	6	3	aimed	aim	VERB
cpe-2361	6	4	to	to	PART
cpe-2361	6	5	examine	examine	VERB
cpe-2361	6	6	the	the	DET
cpe-2361	6	7	effect	effect	NOUN
cpe-2361	6	8	of	of	ADP
cpe-2361	6	9	the	the	DET
cpe-2361	6	10	media	medium	NOUN
cpe-2361	6	11	coverage	coverage	NOUN
cpe-2361	6	12	on	on	ADP
cpe-2361	6	13	drug	drug	NOUN
cpe-2361	6	14	side	side	NOUN
cpe-2361	6	15	effects	effect	NOUN
cpe-2361	6	16	reported	report	VERB
cpe-2361	6	17	to	to	ADP
cpe-2361	6	18	the	the	DET
cpe-2361	6	19	national	national	ADJ
cpe-2361	6	20	centre	centre	NOUN
cpe-2361	6	21	for	for	ADP
cpe-2361	6	22	adverse	adverse	ADJ
cpe-2361	6	23	reactions	reaction	NOUN
cpe-2361	6	24	monitoring	monitor	VERB
cpe-2361	6	25	(	(	PUNCT
cpe-2361	6	26	carm	carm	PROPN
cpe-2361	6	27	)	)	PUNCT
cpe-2361	6	28	and	and	CCONJ
cpe-2361	6	29	whether	whether	SCONJ
cpe-2361	6	30	the	the	DET
cpe-2361	6	31	specific	specific	ADJ
cpe-2361	6	32	symptoms	symptom	NOUN
cpe-2361	6	33	reported	report	VERB
cpe-2361	6	34	in	in	ADP
cpe-2361	6	35	the	the	DET
cpe-2361	6	36	media	medium	NOUN
cpe-2361	6	37	increased	increase	VERB
cpe-2361	6	38	compared	compare	VERB
cpe-2361	6	39	to	to	ADP
cpe-2361	6	40	side	side	ADJ
cpe-2361	6	41	effects	effect	NOUN
cpe-2361	6	42	not	not	PART
cpe-2361	6	43	reported	report	VERB
cpe-2361	6	44	in	in	ADP
cpe-2361	6	45	the	the	DET
cpe-2361	6	46	media	medium	NOUN
cpe-2361	6	47	.	.	PUNCT
cpe-2361	7	1	method	method	NOUN
cpe-2361	7	2	:	:	PUNCT
cpe-2361	7	3	we	we	PRON
cpe-2361	7	4	analysed	analyse	VERB
cpe-2361	7	5	monthly	monthly	ADJ
cpe-2361	7	6	adverse	adverse	ADJ
cpe-2361	7	7	reaction	reaction	NOUN
cpe-2361	7	8	reports	report	NOUN
cpe-2361	7	9	for	for	SCONJ
cpe-2361	7	10	enlafax	enlafax	ADJ
cpe-2361	7	11	to	to	PART
cpe-2361	7	12	carm	carm	VERB
cpe-2361	7	13	from	from	ADP
cpe-2361	7	14	october	october	PROPN
cpe-2361	7	15	2017	2017	NUM
cpe-2361	7	16	to	to	ADP
cpe-2361	7	17	june	june	PROPN
cpe-2361	7	18	2018	2018	NUM
cpe-2361	7	19	and	and	CCONJ
cpe-2361	7	20	compared	compare	VERB
cpe-2361	7	21	adverse	adverse	ADJ
cpe-2361	7	22	reports	report	NOUN
cpe-2361	7	23	,	,	PUNCT
cpe-2361	7	24	complaints	complaint	NOUN
cpe-2361	7	25	of	of	ADP
cpe-2361	7	26	decreased	decrease	VERB
cpe-2361	7	27	therapeutic	therapeutic	ADJ
cpe-2361	7	28	effect	effect	NOUN
cpe-2361	7	29	and	and	CCONJ
cpe-2361	7	30	specific	specific	ADJ
cpe-2361	7	31	symptom	symptom	NOUN
cpe-2361	7	32	reports	report	NOUN
cpe-2361	7	33	before	before	ADV
cpe-2361	7	34	and	and	CCONJ
cpe-2361	7	35	after	after	ADP
cpe-2361	7	36	the	the	DET
cpe-2361	7	37	media	media	NOUN
cpe-2361	7	38	coverage	coverage	NOUN
cpe-2361	7	39	using	use	VERB
cpe-2361	7	40	an	an	DET
cpe-2361	7	41	interrupted	interrupted	ADJ
cpe-2361	7	42	time	time	NOUN
cpe-2361	7	43	series	series	PROPN
cpe-2361	7	44	analysis	analysis	NOUN
cpe-2361	7	45	.	.	PUNCT
cpe-2361	8	1	results	result	NOUN
cpe-2361	8	2	:	:	PUNCT
cpe-2361	8	3	we	we	PRON
cpe-2361	8	4	found	find	VERB
cpe-2361	8	5	the	the	DET
cpe-2361	8	6	number	number	NOUN
cpe-2361	8	7	of	of	ADP
cpe-2361	8	8	side	side	NOUN
cpe-2361	8	9	effects	effect	NOUN
cpe-2361	8	10	and	and	CCONJ
cpe-2361	8	11	complaints	complaint	NOUN
cpe-2361	8	12	of	of	ADP
cpe-2361	8	13	reduced	reduce	VERB
cpe-2361	8	14	therapeutic	therapeutic	ADJ
cpe-2361	8	15	effect	effect	NOUN
cpe-2361	8	16	increased	increase	VERB
cpe-2361	8	17	significantly	significantly	ADV
cpe-2361	8	18	following	follow	VERB
cpe-2361	8	19	the	the	DET
cpe-2361	8	20	media	medium	NOUN
cpe-2361	8	21	stories	story	NOUN
cpe-2361	8	22	(	(	PUNCT
cpe-2361	8	23	interruption	interruption	NOUN
cpe-2361	8	24	effect	effect	NOUN
cpe-2361	8	25	=	=	PROPN
cpe-2361	8	26	41.83	41.83	NUM
cpe-2361	8	27	,	,	PUNCT
cpe-2361	8	28	95	95	NUM
cpe-2361	8	29	%	%	NOUN
cpe-2361	8	30	ci	ci	NOUN
cpe-2361	9	1	[	[	X
cpe-2361	9	2	25.25	25.25	NUM
cpe-2361	9	3	,	,	PUNCT
cpe-2361	9	4	58.41	58.41	NUM
cpe-2361	9	5	]	]	PUNCT
cpe-2361	9	6	,	,	PUNCT
cpe-2361	9	7	p	p	X
cpe-2361	9	8	=	=	NOUN
cpe-2361	9	9	.003	.003	NUM
cpe-2361	9	10	;	;	PUNCT
cpe-2361	9	11	interruption	interruption	NOUN
cpe-2361	9	12	effect	effect	NOUN
cpe-2361	9	13	=	=	PUNCT
cpe-2361	9	14	15.49	15.49	NUM
cpe-2361	9	15	,	,	PUNCT
cpe-2361	9	16	95	95	NUM
cpe-2361	9	17	%	%	NOUN
cpe-2361	9	18	ci	ci	NOUN
cpe-2361	10	1	[	[	X
cpe-2361	10	2	7.01	7.01	NUM
cpe-2361	10	3	,	,	PUNCT
cpe-2361	10	4	23.98	23.98	NUM
cpe-2361	10	5	]	]	PUNCT
cpe-2361	10	6	,	,	PUNCT
cpe-2361	10	7	p	p	X
cpe-2361	10	8	=	=	PROPN
cpe-2361	10	9	.012	.012	NUM
cpe-2361	10	10	,	,	PUNCT
cpe-2361	10	11	respectively	respectively	ADV
cpe-2361	10	12	)	)	PUNCT
cpe-2361	10	13	.	.	PUNCT
cpe-2361	11	1	the	the	DET
cpe-2361	11	2	specific	specific	ADJ
cpe-2361	11	3	side	side	NOUN
cpe-2361	11	4	effects	effect	NOUN
cpe-2361	11	5	mentioned	mention	VERB
cpe-2361	11	6	in	in	ADP
cpe-2361	11	7	the	the	DET
cpe-2361	11	8	media	medium	NOUN
cpe-2361	11	9	coverage	coverage	NOUN
cpe-2361	11	10	,	,	PUNCT
cpe-2361	11	11	including	include	VERB
cpe-2361	11	12	suicidal	suicidal	ADJ
cpe-2361	11	13	thoughts	thought	NOUN
cpe-2361	11	14	,	,	PUNCT
cpe-2361	11	15	also	also	ADV
cpe-2361	11	16	increased	increase	VERB
cpe-2361	11	17	significantly	significantly	ADV
cpe-2361	11	18	compared	compare	VERB
cpe-2361	11	19	to	to	ADP
cpe-2361	11	20	other	other	ADJ
cpe-2361	11	21	side	side	NOUN
cpe-2361	11	22	effects	effect	NOUN
cpe-2361	11	23	not	not	PART
cpe-2361	11	24	mentioned	mention	VERB
cpe-2361	11	25	in	in	ADP
cpe-2361	11	26	the	the	DET
cpe-2361	11	27	media	medium	NOUN
cpe-2361	11	28	.	.	PUNCT
cpe-2361	12	1	conclusions	conclusion	NOUN
cpe-2361	12	2	:	:	PUNCT
cpe-2361	12	3	in	in	ADP
cpe-2361	12	4	the	the	DET
cpe-2361	12	5	context	context	NOUN
cpe-2361	12	6	of	of	ADP
cpe-2361	12	7	a	a	DET
cpe-2361	12	8	drug	drug	NOUN
cpe-2361	12	9	switch	switch	NOUN
cpe-2361	12	10	,	,	PUNCT
cpe-2361	12	11	media	medium	NOUN
cpe-2361	12	12	reports	report	NOUN
cpe-2361	12	13	of	of	ADP
cpe-2361	12	14	side	side	NOUN
cpe-2361	12	15	effects	effect	NOUN
cpe-2361	12	16	appear	appear	VERB
cpe-2361	12	17	to	to	PART
cpe-2361	12	18	cause	cause	VERB
cpe-2361	12	19	a	a	DET
cpe-2361	12	20	strong	strong	ADJ
cpe-2361	12	21	nocebo	nocebo	NOUN
cpe-2361	12	22	response	response	NOUN
cpe-2361	12	23	by	by	ADP
cpe-2361	12	24	increasing	increase	VERB
cpe-2361	12	25	both	both	CCONJ
cpe-2361	12	26	the	the	DET
cpe-2361	12	27	overall	overall	ADJ
cpe-2361	12	28	rate	rate	NOUN
cpe-2361	12	29	of	of	ADP
cpe-2361	12	30	side	side	ADJ
cpe-2361	12	31	effect	effect	NOUN
cpe-2361	12	32	reporting	reporting	NOUN
cpe-2361	12	33	and	and	CCONJ
cpe-2361	12	34	an	an	DET
cpe-2361	12	35	increase	increase	NOUN
cpe-2361	12	36	in	in	ADP
cpe-2361	12	37	the	the	DET
cpe-2361	12	38	specific	specific	ADJ
cpe-2361	12	39	side	side	NOUN
cpe-2361	12	40	effects	effect	NOUN
cpe-2361	12	41	mentioned	mention	VERB
cpe-2361	12	42	in	in	ADP
cpe-2361	12	43	the	the	DET
cpe-2361	12	44	media	medium	NOUN
cpe-2361	12	45	coverage	coverage	NOUN
cpe-2361	12	46	,	,	PUNCT
cpe-2361	12	47	including	include	VERB
cpe-2361	12	48	reduced	reduce	VERB
cpe-2361	12	49	drug	drug	NOUN
cpe-2361	12	50	efficacy	efficacy	NOUN
cpe-2361	12	51	and	and	CCONJ
cpe-2361	12	52	heightened	heighten	VERB
cpe-2361	12	53	suicidal	suicidal	ADJ
cpe-2361	12	54	thoughts	thought	NOUN
cpe-2361	12	55	.	.	PUNCT
cpe-2361	13	1	keywords	keyword	VERB
cpe-2361	13	2	media	medium	NOUN
cpe-2361	13	3	,	,	PUNCT
cpe-2361	13	4	nocebo	nocebo	NOUN
cpe-2361	13	5	effect	effect	NOUN
cpe-2361	13	6	,	,	PUNCT
cpe-2361	13	7	venlafaxine	venlafaxine	NOUN
cpe-2361	13	8	,	,	PUNCT
cpe-2361	13	9	side	side	NOUN
cpe-2361	13	10	effects	effect	NOUN
cpe-2361	13	11	,	,	PUNCT
cpe-2361	13	12	generic	generic	ADJ
cpe-2361	13	13	medicines	medicine	NOUN
cpe-2361	13	14	this	this	PRON
cpe-2361	13	15	is	be	AUX
cpe-2361	13	16	an	an	DET
cpe-2361	13	17	open	open	ADJ
cpe-2361	13	18	access	access	NOUN
cpe-2361	13	19	article	article	NOUN
cpe-2361	13	20	distributed	distribute	VERB
cpe-2361	13	21	under	under	ADP
cpe-2361	13	22	the	the	DET
cpe-2361	13	23	terms	term	NOUN
cpe-2361	13	24	of	of	ADP
cpe-2361	13	25	the	the	DET
cpe-2361	13	26	creative	creative	ADJ
cpe-2361	13	27	commons	common	NOUN
cpe-2361	13	28	attribution	attribution	NOUN
cpe-2361	13	29	4.0	4.0	NUM
cpe-2361	13	30	international	international	ADJ
cpe-2361	13	31	license	license	NOUN
cpe-2361	13	32	,	,	PUNCT
cpe-2361	13	33	cc	cc	VERB
cpe-2361	13	34	by	by	ADP
cpe-2361	13	35	4.0	4.0	NUM
cpe-2361	13	36	,	,	PUNCT
cpe-2361	13	37	which	which	PRON
cpe-2361	13	38	permits	permit	VERB
cpe-2361	13	39	unrestricted	unrestricted	ADJ
cpe-2361	13	40	use	use	NOUN
cpe-2361	13	41	,	,	PUNCT
cpe-2361	13	42	distribution	distribution	NOUN
cpe-2361	13	43	,	,	PUNCT
cpe-2361	13	44	and	and	CCONJ
cpe-2361	13	45	reproduction	reproduction	NOUN
cpe-2361	13	46	,	,	PUNCT
cpe-2361	13	47	provided	provide	VERB
cpe-2361	13	48	the	the	DET
cpe-2361	13	49	original	original	ADJ
cpe-2361	13	50	work	work	NOUN
cpe-2361	13	51	is	be	AUX
cpe-2361	13	52	properly	properly	ADV
cpe-2361	13	53	cited	cite	VERB
cpe-2361	13	54	.	.	PUNCT
cpe-2361	14	1	https://crossmark.crossref.org/dialog/?doi=10.32872/cpe.v1i1.29642&domain=pdf&date_stamp=2019-03-29	https://crossmark.crossref.org/dialog/?doi=10.32872/cpe.v1i1.29642&domain=pdf&date_stamp=2019-03-29	PUNCT
cpe-2361	14	2	https://cpe.psychopen.eu/	https://cpe.psychopen.eu/	PROPN
cpe-2361	14	3	https://www.psychopen.eu/	https://www.psychopen.eu/	PROPN
cpe-2361	14	4	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
cpe-2361	14	5	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
cpe-2361	14	6	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
cpe-2361	14	7	highlights	highlight	VERB
cpe-2361	14	8	•	•	ADP
cpe-2361	14	9	the	the	DET
cpe-2361	14	10	study	study	NOUN
cpe-2361	14	11	provides	provide	VERB
cpe-2361	14	12	further	further	ADJ
cpe-2361	14	13	evidence	evidence	NOUN
cpe-2361	14	14	that	that	SCONJ
cpe-2361	14	15	media	medium	NOUN
cpe-2361	14	16	coverage	coverage	NOUN
cpe-2361	14	17	of	of	ADP
cpe-2361	14	18	side	side	NOUN
cpe-2361	14	19	effects	effect	NOUN
cpe-2361	14	20	can	can	AUX
cpe-2361	14	21	induce	induce	VERB
cpe-2361	14	22	a	a	DET
cpe-2361	14	23	nocebo	nocebo	NOUN
cpe-2361	14	24	effect	effect	NOUN
cpe-2361	14	25	.	.	PUNCT
cpe-2361	15	1	•	•	NOUN
cpe-2361	15	2	this	this	PRON
cpe-2361	15	3	is	be	AUX
cpe-2361	15	4	the	the	DET
cpe-2361	15	5	first	first	ADJ
cpe-2361	15	6	study	study	NOUN
cpe-2361	15	7	to	to	PART
cpe-2361	15	8	look	look	VERB
cpe-2361	15	9	at	at	ADP
cpe-2361	15	10	media	medium	NOUN
cpe-2361	15	11	coverage	coverage	NOUN
cpe-2361	15	12	of	of	ADP
cpe-2361	15	13	an	an	DET
cpe-2361	15	14	antidepressant	antidepressant	ADJ
cpe-2361	15	15	brand	brand	NOUN
cpe-2361	15	16	switch	switch	NOUN
cpe-2361	15	17	.	.	PUNCT
cpe-2361	16	1	•	•	NUM
cpe-2361	16	2	the	the	DET
cpe-2361	16	3	increase	increase	NOUN
cpe-2361	16	4	in	in	ADP
cpe-2361	16	5	reported	report	VERB
cpe-2361	16	6	adverse	adverse	ADJ
cpe-2361	16	7	events	event	NOUN
cpe-2361	16	8	was	be	AUX
cpe-2361	16	9	higher	high	ADJ
cpe-2361	16	10	for	for	ADP
cpe-2361	16	11	those	those	DET
cpe-2361	16	12	symptoms	symptom	NOUN
cpe-2361	16	13	mentioned	mention	VERB
cpe-2361	16	14	in	in	ADP
cpe-2361	16	15	the	the	DET
cpe-2361	16	16	media	medium	NOUN
cpe-2361	16	17	reports	report	NOUN
cpe-2361	16	18	.	.	PUNCT
cpe-2361	17	1	switches	switch	NOUN
cpe-2361	17	2	from	from	ADP
cpe-2361	17	3	branded	brand	VERB
cpe-2361	17	4	to	to	ADP
cpe-2361	17	5	generic	generic	ADJ
cpe-2361	17	6	medicine	medicine	NOUN
cpe-2361	17	7	formulations	formulation	NOUN
cpe-2361	17	8	have	have	AUX
cpe-2361	17	9	become	become	VERB
cpe-2361	17	10	more	more	ADV
cpe-2361	17	11	frequent	frequent	ADJ
cpe-2361	17	12	in	in	ADP
cpe-2361	17	13	recent	recent	ADJ
cpe-2361	17	14	times	time	NOUN
cpe-2361	17	15	as	as	SCONJ
cpe-2361	17	16	health	health	NOUN
cpe-2361	17	17	funders	funder	NOUN
cpe-2361	17	18	seek	seek	VERB
cpe-2361	17	19	to	to	PART
cpe-2361	17	20	reduce	reduce	VERB
cpe-2361	17	21	costs	cost	NOUN
cpe-2361	17	22	.	.	PUNCT
cpe-2361	18	1	these	these	DET
cpe-2361	18	2	switches	switch	NOUN
cpe-2361	18	3	to	to	ADP
cpe-2361	18	4	generic	generic	ADJ
cpe-2361	18	5	medical	medical	ADJ
cpe-2361	18	6	and	and	CCONJ
cpe-2361	18	7	psychotropic	psychotropic	ADJ
cpe-2361	18	8	medications	medication	NOUN
cpe-2361	18	9	have	have	AUX
cpe-2361	18	10	from	from	ADP
cpe-2361	18	11	time	time	NOUN
cpe-2361	18	12	to	to	ADP
cpe-2361	18	13	time	time	NOUN
cpe-2361	18	14	caused	cause	VERB
cpe-2361	18	15	an	an	DET
cpe-2361	18	16	increase	increase	NOUN
cpe-2361	18	17	in	in	SCONJ
cpe-2361	18	18	reported	report	VERB
cpe-2361	19	1	ad‐	ad‐	ADJ
cpe-2361	19	2	verse	verse	NOUN
cpe-2361	19	3	events	event	NOUN
cpe-2361	19	4	(	(	PUNCT
cpe-2361	19	5	desmarais	desmarais	PROPN
cpe-2361	19	6	,	,	PUNCT
cpe-2361	19	7	beauclair	beauclair	NOUN
cpe-2361	19	8	,	,	PUNCT
cpe-2361	19	9	&	&	CCONJ
cpe-2361	19	10	margolese	margolese	PROPN
cpe-2361	19	11	,	,	PUNCT
cpe-2361	19	12	2011	2011	NUM
cpe-2361	19	13	;	;	PUNCT
cpe-2361	19	14	leclerc	leclerc	PROPN
cpe-2361	19	15	et	et	PROPN
cpe-2361	19	16	al	al	PROPN
cpe-2361	19	17	.	.	PROPN
cpe-2361	19	18	,	,	PUNCT
cpe-2361	19	19	2017	2017	NUM
cpe-2361	19	20	)	)	PUNCT
cpe-2361	19	21	,	,	PUNCT
cpe-2361	19	22	and	and	CCONJ
cpe-2361	19	23	this	this	PRON
cpe-2361	19	24	is	be	AUX
cpe-2361	19	25	likely	likely	ADJ
cpe-2361	19	26	to	to	PART
cpe-2361	19	27	be	be	AUX
cpe-2361	19	28	due	due	ADJ
cpe-2361	19	29	to	to	ADP
cpe-2361	19	30	negative	negative	ADJ
cpe-2361	19	31	attitudes	attitude	NOUN
cpe-2361	19	32	towards	towards	ADP
cpe-2361	19	33	generic	generic	ADJ
cpe-2361	19	34	medicines	medicine	NOUN
cpe-2361	19	35	rather	rather	ADV
cpe-2361	19	36	than	than	ADP
cpe-2361	19	37	pharmaco‐	pharmaco‐	X
cpe-2361	19	38	logical	logical	ADJ
cpe-2361	19	39	differences	difference	NOUN
cpe-2361	19	40	between	between	ADP
cpe-2361	19	41	the	the	DET
cpe-2361	19	42	branded	brand	VERB
cpe-2361	19	43	and	and	CCONJ
cpe-2361	19	44	generic	generic	ADJ
cpe-2361	19	45	versions	version	NOUN
cpe-2361	19	46	of	of	ADP
cpe-2361	19	47	the	the	DET
cpe-2361	19	48	medication	medication	NOUN
cpe-2361	19	49	(	(	PUNCT
cpe-2361	19	50	colgan	colgan	PROPN
cpe-2361	19	51	et	et	PROPN
cpe-2361	19	52	al	al	PROPN
cpe-2361	19	53	.	.	PROPN
cpe-2361	19	54	,	,	PUNCT
cpe-2361	19	55	2015	2015	NUM
cpe-2361	19	56	)	)	PUNCT
cpe-2361	19	57	.	.	PUNCT
cpe-2361	20	1	this	this	DET
cpe-2361	20	2	phenomenon	phenomenon	NOUN
cpe-2361	20	3	is	be	AUX
cpe-2361	20	4	known	know	VERB
cpe-2361	20	5	as	as	ADP
cpe-2361	20	6	the	the	DET
cpe-2361	20	7	nocebo	nocebo	NOUN
cpe-2361	20	8	effect	effect	NOUN
cpe-2361	20	9	and	and	CCONJ
cpe-2361	20	10	research	research	NOUN
cpe-2361	20	11	using	use	VERB
cpe-2361	20	12	inert	inert	ADJ
cpe-2361	20	13	medicines	medicine	NOUN
cpe-2361	20	14	has	have	AUX
cpe-2361	20	15	shown	show	VERB
cpe-2361	20	16	that	that	SCONJ
cpe-2361	20	17	people	people	NOUN
cpe-2361	20	18	report	report	VERB
cpe-2361	20	19	a	a	DET
cpe-2361	20	20	reduced	reduced	ADJ
cpe-2361	20	21	therapeutic	therapeutic	ADJ
cpe-2361	20	22	effect	effect	NOUN
cpe-2361	20	23	and	and	CCONJ
cpe-2361	20	24	more	more	ADJ
cpe-2361	20	25	side	side	ADJ
cpe-2361	20	26	effects	effect	NOUN
cpe-2361	20	27	from	from	ADP
cpe-2361	20	28	a	a	DET
cpe-2361	20	29	generic	generic	ADJ
cpe-2361	20	30	-	-	PUNCT
cpe-2361	20	31	labelled	label	VERB
cpe-2361	20	32	placebo	placebo	NOUN
cpe-2361	20	33	compared	compare	VERB
cpe-2361	20	34	to	to	ADP
cpe-2361	20	35	a	a	DET
cpe-2361	20	36	branded	brand	VERB
cpe-2361	20	37	placebo	placebo	NOUN
cpe-2361	20	38	(	(	PUNCT
cpe-2361	20	39	faasse	faasse	ADJ
cpe-2361	20	40	,	,	PUNCT
cpe-2361	20	41	martin	martin	PROPN
cpe-2361	20	42	,	,	PUNCT
cpe-2361	20	43	grey	grey	ADJ
cpe-2361	20	44	,	,	PUNCT
cpe-2361	20	45	gamble	gamble	NOUN
cpe-2361	20	46	,	,	PUNCT
cpe-2361	20	47	&	&	CCONJ
cpe-2361	20	48	petrie	petrie	NOUN
cpe-2361	20	49	,	,	PUNCT
cpe-2361	20	50	2016	2016	NUM
cpe-2361	20	51	)	)	PUNCT
cpe-2361	20	52	.	.	PUNCT
cpe-2361	21	1	similarly	similarly	ADV
cpe-2361	21	2	,	,	PUNCT
cpe-2361	21	3	the	the	DET
cpe-2361	21	4	process	process	NOUN
cpe-2361	21	5	of	of	ADP
cpe-2361	21	6	switching	switch	VERB
cpe-2361	21	7	from	from	ADP
cpe-2361	21	8	one	one	NUM
cpe-2361	21	9	placebo	placebo	NOUN
cpe-2361	21	10	tablet	tablet	NOUN
cpe-2361	21	11	to	to	ADP
cpe-2361	21	12	another	another	PRON
cpe-2361	21	13	is	be	AUX
cpe-2361	21	14	as‐	as‐	VERB
cpe-2361	21	15	sociated	sociate	VERB
cpe-2361	21	16	with	with	ADP
cpe-2361	21	17	reports	report	NOUN
cpe-2361	21	18	of	of	ADP
cpe-2361	21	19	side	side	NOUN
cpe-2361	21	20	effects	effect	NOUN
cpe-2361	21	21	and	and	CCONJ
cpe-2361	21	22	reduced	reduced	ADJ
cpe-2361	21	23	drug	drug	NOUN
cpe-2361	21	24	efficacy	efficacy	NOUN
cpe-2361	21	25	(	(	PUNCT
cpe-2361	21	26	faasse	faasse	ADJ
cpe-2361	21	27	,	,	PUNCT
cpe-2361	21	28	cundy	cundy	NOUN
cpe-2361	21	29	,	,	PUNCT
cpe-2361	21	30	gamble	gamble	NOUN
cpe-2361	21	31	,	,	PUNCT
cpe-2361	21	32	&	&	CCONJ
cpe-2361	21	33	petrie	petrie	NOUN
cpe-2361	21	34	,	,	PUNCT
cpe-2361	21	35	2013	2013	NUM
cpe-2361	21	36	)	)	PUNCT
cpe-2361	21	37	.	.	PUNCT
cpe-2361	22	1	the	the	DET
cpe-2361	22	2	nocebo	nocebo	NOUN
cpe-2361	22	3	effect	effect	NOUN
cpe-2361	22	4	can	can	AUX
cpe-2361	22	5	also	also	ADV
cpe-2361	22	6	occur	occur	VERB
cpe-2361	22	7	in	in	ADP
cpe-2361	22	8	active	active	ADJ
cpe-2361	22	9	medications	medication	NOUN
cpe-2361	22	10	and	and	CCONJ
cpe-2361	22	11	there	there	PRON
cpe-2361	22	12	is	be	VERB
cpe-2361	22	13	recent	recent	ADJ
cpe-2361	22	14	evidence	evidence	NOUN
cpe-2361	22	15	that	that	SCONJ
cpe-2361	22	16	media	medium	NOUN
cpe-2361	22	17	coverage	coverage	NOUN
cpe-2361	22	18	about	about	ADP
cpe-2361	22	19	drug	drug	NOUN
cpe-2361	22	20	side	side	NOUN
cpe-2361	22	21	effects	effect	NOUN
cpe-2361	22	22	can	can	AUX
cpe-2361	22	23	create	create	VERB
cpe-2361	22	24	a	a	DET
cpe-2361	22	25	nocebo	nocebo	NOUN
cpe-2361	22	26	response	response	NOUN
cpe-2361	22	27	by	by	ADP
cpe-2361	22	28	highlighting	highlight	VERB
cpe-2361	22	29	negative	negative	ADJ
cpe-2361	22	30	reactions	reaction	NOUN
cpe-2361	22	31	to	to	ADP
cpe-2361	22	32	a	a	DET
cpe-2361	22	33	particular	particular	ADJ
cpe-2361	22	34	medication	medication	NOUN
cpe-2361	22	35	and	and	CCONJ
cpe-2361	22	36	prompting	prompt	VERB
cpe-2361	22	37	an	an	DET
cpe-2361	22	38	increase	increase	NOUN
cpe-2361	22	39	in	in	ADP
cpe-2361	22	40	symptom	symptom	NOUN
cpe-2361	22	41	complaints	complaint	NOUN
cpe-2361	22	42	and	and	CCONJ
cpe-2361	22	43	drug	drug	NOUN
cpe-2361	22	44	discontinuation	discontinuation	NOUN
cpe-2361	22	45	(	(	PUNCT
cpe-2361	22	46	faasse	faasse	NOUN
cpe-2361	22	47	&	&	CCONJ
cpe-2361	22	48	petrie	petrie	NOUN
cpe-2361	22	49	,	,	PUNCT
cpe-2361	22	50	2013	2013	NUM
cpe-2361	22	51	)	)	PUNCT
cpe-2361	22	52	.	.	PUNCT
cpe-2361	23	1	in	in	ADP
cpe-2361	23	2	2017	2017	NUM
cpe-2361	23	3	,	,	PUNCT
cpe-2361	23	4	45,000	45,000	NUM
cpe-2361	23	5	new	new	PROPN
cpe-2361	23	6	zealand	zealand	PROPN
cpe-2361	23	7	patients	patient	NOUN
cpe-2361	23	8	prescribed	prescribe	VERB
cpe-2361	23	9	the	the	DET
cpe-2361	23	10	antidepressant	antidepressant	ADJ
cpe-2361	23	11	venlafaxine	venlafaxine	NOUN
cpe-2361	23	12	were	be	AUX
cpe-2361	23	13	switched	switch	VERB
cpe-2361	23	14	to	to	ADP
cpe-2361	23	15	a	a	DET
cpe-2361	23	16	new	new	ADJ
cpe-2361	23	17	funded	fund	VERB
cpe-2361	23	18	generic	generic	ADJ
cpe-2361	23	19	(	(	PUNCT
cpe-2361	23	20	enlafax	enlafax	PROPN
cpe-2361	23	21	xr	xr	PROPN
cpe-2361	23	22	)	)	PUNCT
cpe-2361	23	23	from	from	ADP
cpe-2361	23	24	either	either	CCONJ
cpe-2361	23	25	the	the	DET
cpe-2361	23	26	branded	brand	VERB
cpe-2361	23	27	originator	originator	NOUN
cpe-2361	23	28	or	or	CCONJ
cpe-2361	23	29	a	a	DET
cpe-2361	23	30	different	different	ADJ
cpe-2361	23	31	generic	generic	ADJ
cpe-2361	23	32	version	version	NOUN
cpe-2361	23	33	.	.	PUNCT
cpe-2361	24	1	in	in	ADP
cpe-2361	24	2	february	february	PROPN
cpe-2361	24	3	2018	2018	NUM
cpe-2361	24	4	,	,	PUNCT
cpe-2361	24	5	two	two	NUM
cpe-2361	24	6	major	major	ADJ
cpe-2361	24	7	print	print	NOUN
cpe-2361	24	8	and	and	CCONJ
cpe-2361	24	9	online	online	ADJ
cpe-2361	24	10	media	medium	NOUN
cpe-2361	24	11	outlets	outlet	NOUN
cpe-2361	24	12	in	in	ADP
cpe-2361	24	13	new	new	PROPN
cpe-2361	24	14	zealand	zealand	PROPN
cpe-2361	24	15	ran	run	VERB
cpe-2361	24	16	stories	story	NOUN
cpe-2361	24	17	on	on	ADP
cpe-2361	24	18	patients	patient	NOUN
cpe-2361	24	19	’	'	PUNCT
cpe-2361	24	20	complaints	complaint	NOUN
cpe-2361	24	21	that	that	SCONJ
cpe-2361	24	22	the	the	DET
cpe-2361	24	23	new	new	ADJ
cpe-2361	24	24	generic	generic	NOUN
cpe-2361	24	25	was	be	AUX
cpe-2361	24	26	less	less	ADV
cpe-2361	24	27	effective	effective	ADJ
cpe-2361	24	28	and	and	CCONJ
cpe-2361	24	29	causing	cause	VERB
cpe-2361	24	30	an	an	DET
cpe-2361	24	31	increase	increase	NOUN
cpe-2361	24	32	in	in	ADP
cpe-2361	24	33	various	various	ADJ
cpe-2361	24	34	symptoms	symptom	NOUN
cpe-2361	24	35	,	,	PUNCT
cpe-2361	24	36	including	include	VERB
cpe-2361	24	37	heightened	heighten	VERB
cpe-2361	24	38	suicidal	suicidal	ADJ
cpe-2361	24	39	thoughts	thought	NOUN
cpe-2361	24	40	.	.	PUNCT
cpe-2361	25	1	a	a	DET
cpe-2361	25	2	few	few	ADJ
cpe-2361	25	3	months	month	NOUN
cpe-2361	25	4	later	later	ADV
cpe-2361	25	5	,	,	PUNCT
cpe-2361	25	6	another	another	DET
cpe-2361	25	7	media	medium	NOUN
cpe-2361	25	8	report	report	NOUN
cpe-2361	25	9	was	be	AUX
cpe-2361	25	10	released	release	VERB
cpe-2361	25	11	,	,	PUNCT
cpe-2361	25	12	again	again	ADV
cpe-2361	25	13	discussing	discuss	VERB
cpe-2361	25	14	patients	patient	NOUN
cpe-2361	25	15	’	'	PUNCT
cpe-2361	25	16	reports	report	NOUN
cpe-2361	25	17	of	of	ADP
cpe-2361	25	18	ineffectiveness	ineffectiveness	NOUN
cpe-2361	25	19	and	and	CCONJ
cpe-2361	25	20	side	side	NOUN
cpe-2361	25	21	effects	effect	NOUN
cpe-2361	25	22	from	from	ADP
cpe-2361	25	23	enlafax	enlafax	PROPN
cpe-2361	25	24	.	.	PUNCT
cpe-2361	26	1	based	base	VERB
cpe-2361	26	2	on	on	ADP
cpe-2361	26	3	previous	previous	ADJ
cpe-2361	26	4	research	research	NOUN
cpe-2361	26	5	,	,	PUNCT
cpe-2361	26	6	we	we	PRON
cpe-2361	26	7	tested	test	VERB
cpe-2361	26	8	two	two	NUM
cpe-2361	26	9	hypotheses	hypothesis	NOUN
cpe-2361	26	10	:	:	PUNCT
cpe-2361	26	11	firstly	firstly	ADV
cpe-2361	26	12	,	,	PUNCT
cpe-2361	26	13	that	that	SCONJ
cpe-2361	26	14	media	medium	NOUN
cpe-2361	26	15	coverage	coverage	NOUN
cpe-2361	26	16	of	of	ADP
cpe-2361	26	17	the	the	DET
cpe-2361	26	18	complaints	complaint	NOUN
cpe-2361	26	19	following	follow	VERB
cpe-2361	26	20	the	the	DET
cpe-2361	26	21	venlafaxine	venlafaxine	ADJ
cpe-2361	26	22	switch	switch	NOUN
cpe-2361	26	23	would	would	AUX
cpe-2361	26	24	be	be	AUX
cpe-2361	26	25	associated	associate	VERB
cpe-2361	26	26	with	with	ADP
cpe-2361	26	27	an	an	DET
cpe-2361	26	28	increase	increase	NOUN
cpe-2361	26	29	in	in	ADP
cpe-2361	26	30	adverse	adverse	ADJ
cpe-2361	26	31	drug	drug	NOUN
cpe-2361	26	32	reactions	reaction	NOUN
cpe-2361	26	33	reported	report	VERB
cpe-2361	26	34	to	to	ADP
cpe-2361	26	35	the	the	DET
cpe-2361	26	36	new	new	PROPN
cpe-2361	26	37	zealand	zealand	PROPN
cpe-2361	26	38	centre	centre	PROPN
cpe-2361	26	39	for	for	ADP
cpe-2361	26	40	adverse	adverse	ADJ
cpe-2361	26	41	reactions	reaction	NOUN
cpe-2361	26	42	monitoring	monitor	VERB
cpe-2361	26	43	(	(	PUNCT
cpe-2361	26	44	carm	carm	PROPN
cpe-2361	26	45	)	)	PUNCT
cpe-2361	26	46	;	;	PUNCT
cpe-2361	26	47	and	and	CCONJ
cpe-2361	26	48	secondly	secondly	ADV
cpe-2361	26	49	,	,	PUNCT
cpe-2361	26	50	that	that	SCONJ
cpe-2361	26	51	the	the	DET
cpe-2361	26	52	specific	specific	ADJ
cpe-2361	26	53	side	side	NOUN
cpe-2361	26	54	effects	effect	NOUN
cpe-2361	26	55	reported	report	VERB
cpe-2361	26	56	in	in	ADP
cpe-2361	26	57	the	the	DET
cpe-2361	26	58	media	medium	NOUN
cpe-2361	26	59	would	would	AUX
cpe-2361	26	60	increase	increase	VERB
cpe-2361	26	61	compared	compare	VERB
cpe-2361	26	62	to	to	ADP
cpe-2361	26	63	other	other	ADJ
cpe-2361	26	64	side	side	NOUN
cpe-2361	26	65	effects	effect	NOUN
cpe-2361	26	66	not	not	PART
cpe-2361	26	67	reported	report	VERB
cpe-2361	26	68	in	in	ADP
cpe-2361	26	69	the	the	DET
cpe-2361	26	70	coverage	coverage	NOUN
cpe-2361	26	71	.	.	PUNCT
cpe-2361	27	1	media	medium	NOUN
cpe-2361	27	2	-	-	PUNCT
cpe-2361	27	3	induced	induce	VERB
cpe-2361	27	4	nocebo	nocebo	NOUN
cpe-2361	27	5	response	response	NOUN
cpe-2361	27	6	2	2	NUM
cpe-2361	27	7	clinical	clinical	ADJ
cpe-2361	27	8	psychology	psychology	NOUN
cpe-2361	27	9	in	in	ADP
cpe-2361	27	10	europe	europe	PROPN
cpe-2361	27	11	2019	2019	NUM
cpe-2361	27	12	,	,	PUNCT
cpe-2361	27	13	vol.1(1	vol.1(1	NOUN
cpe-2361	27	14	)	)	PUNCT
cpe-2361	27	15	,	,	PUNCT
cpe-2361	27	16	article	article	NOUN
cpe-2361	27	17	e29642	e29642	VERB
cpe-2361	27	18	https://doi.org/10.32872/cpe.v1i1.29642	https://doi.org/10.32872/cpe.v1i1.29642	PROPN
cpe-2361	27	19	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
cpe-2361	27	20	method	method	NOUN
cpe-2361	27	21	newspaper	newspaper	NOUN
cpe-2361	27	22	articles	article	NOUN
cpe-2361	27	23	on	on	ADP
cpe-2361	27	24	february	february	PROPN
cpe-2361	27	25	28	28	NUM
cpe-2361	27	26	2018	2018	NUM
cpe-2361	27	27	,	,	PUNCT
cpe-2361	27	28	two	two	NUM
cpe-2361	27	29	leading	lead	VERB
cpe-2361	27	30	new	new	ADJ
cpe-2361	27	31	zealand	zealand	PROPN
cpe-2361	27	32	media	medium	NOUN
cpe-2361	27	33	outlets	outlet	NOUN
cpe-2361	27	34	,	,	PUNCT
cpe-2361	27	35	the	the	DET
cpe-2361	27	36	new	new	PROPN
cpe-2361	27	37	zealand	zealand	PROPN
cpe-2361	27	38	herald	herald	PROPN
cpe-2361	27	39	(	(	PUNCT
cpe-2361	27	40	nzme	nzme	PROPN
cpe-2361	27	41	)	)	PUNCT
cpe-2361	27	42	and	and	CCONJ
cpe-2361	27	43	stuff	stuff	NOUN
cpe-2361	27	44	(	(	PUNCT
cpe-2361	27	45	fairfax	fairfax	NOUN
cpe-2361	27	46	media	medium	NOUN
cpe-2361	27	47	)	)	PUNCT
cpe-2361	27	48	,	,	PUNCT
cpe-2361	27	49	published	publish	VERB
cpe-2361	27	50	newspaper	newspaper	NOUN
cpe-2361	27	51	and	and	CCONJ
cpe-2361	27	52	online	online	ADJ
cpe-2361	27	53	articles	article	NOUN
cpe-2361	27	54	on	on	ADP
cpe-2361	27	55	the	the	DET
cpe-2361	27	56	venla‐	venla‐	PROPN
cpe-2361	27	57	faxine	faxine	PROPN
cpe-2361	27	58	brand	brand	PROPN
cpe-2361	27	59	switch	switch	VERB
cpe-2361	27	60	.	.	PUNCT
cpe-2361	28	1	the	the	DET
cpe-2361	28	2	new	new	PROPN
cpe-2361	28	3	zealand	zealand	PROPN
cpe-2361	28	4	herald	herald	PROPN
cpe-2361	28	5	ran	run	VERB
cpe-2361	28	6	a	a	DET
cpe-2361	28	7	story	story	NOUN
cpe-2361	28	8	titled	title	VERB
cpe-2361	28	9	“	"	PUNCT
cpe-2361	28	10	patients	patient	NOUN
cpe-2361	28	11	say	say	VERB
cpe-2361	28	12	generic	generic	ADJ
cpe-2361	28	13	pharmac	pharmac	NOUN
cpe-2361	28	14	-	-	PUNCT
cpe-2361	28	15	funded	fund	VERB
cpe-2361	28	16	version	version	NOUN
cpe-2361	28	17	of	of	ADP
cpe-2361	28	18	antidepressant	antidepressant	ADJ
cpe-2361	28	19	venlafaxine	venlafaxine	NOUN
cpe-2361	28	20	left	leave	VERB
cpe-2361	28	21	them	they	PRON
cpe-2361	28	22	depressed	depressed	ADJ
cpe-2361	28	23	,	,	PUNCT
cpe-2361	28	24	anxious	anxious	ADJ
cpe-2361	28	25	”	"	PUNCT
cpe-2361	28	26	(	(	PUNCT
cpe-2361	28	27	henry	henry	PROPN
cpe-2361	28	28	,	,	PUNCT
cpe-2361	28	29	2018	2018	NUM
cpe-2361	28	30	)	)	PUNCT
cpe-2361	28	31	,	,	PUNCT
cpe-2361	28	32	while	while	SCONJ
cpe-2361	28	33	stuff	stuff	NOUN
cpe-2361	28	34	’s	’s	PART
cpe-2361	28	35	article	article	NOUN
cpe-2361	28	36	was	be	AUX
cpe-2361	28	37	titled	title	VERB
cpe-2361	28	38	“	"	PUNCT
cpe-2361	28	39	anti	anti	ADJ
cpe-2361	28	40	-	-	ADJ
cpe-2361	28	41	depressant	depressant	ADJ
cpe-2361	28	42	swap	swap	NOUN
cpe-2361	28	43	:	:	PUNCT
cpe-2361	28	44	sufferers	sufferer	NOUN
cpe-2361	28	45	claim	claim	VERB
cpe-2361	28	46	ge‐	ge‐	ADJ
cpe-2361	28	47	neric	neric	ADJ
cpe-2361	28	48	drug	drug	NOUN
cpe-2361	28	49	is	be	AUX
cpe-2361	28	50	harming	harm	VERB
cpe-2361	28	51	their	their	PRON
cpe-2361	28	52	condition	condition	NOUN
cpe-2361	28	53	”	"	PUNCT
cpe-2361	28	54	(	(	PUNCT
cpe-2361	28	55	maude	maude	NOUN
cpe-2361	28	56	,	,	PUNCT
cpe-2361	28	57	2018	2018	NUM
cpe-2361	28	58	)	)	PUNCT
cpe-2361	28	59	.	.	PUNCT
cpe-2361	29	1	these	these	DET
cpe-2361	29	2	articles	article	NOUN
cpe-2361	29	3	described	describe	VERB
cpe-2361	29	4	the	the	DET
cpe-2361	29	5	per‐	per‐	PUNCT
cpe-2361	29	6	sonal	sonal	ADJ
cpe-2361	29	7	experience	experience	NOUN
cpe-2361	29	8	of	of	ADP
cpe-2361	29	9	two	two	NUM
cpe-2361	29	10	patients	patient	NOUN
cpe-2361	29	11	when	when	SCONJ
cpe-2361	29	12	they	they	PRON
cpe-2361	29	13	switched	switch	VERB
cpe-2361	29	14	from	from	ADP
cpe-2361	29	15	their	their	PRON
cpe-2361	29	16	original	original	ADJ
cpe-2361	29	17	brand	brand	NOUN
cpe-2361	29	18	efexor	efexor	PROPN
cpe-2361	29	19	to	to	ADP
cpe-2361	29	20	enlafax	enlafax	PROPN
cpe-2361	29	21	.	.	PUNCT
cpe-2361	30	1	the	the	DET
cpe-2361	30	2	reports	report	NOUN
cpe-2361	30	3	stated	state	VERB
cpe-2361	30	4	that	that	SCONJ
cpe-2361	30	5	the	the	DET
cpe-2361	30	6	new	new	ADJ
cpe-2361	30	7	,	,	PUNCT
cpe-2361	30	8	cheaper	cheap	ADJ
cpe-2361	30	9	generic	generic	ADJ
cpe-2361	30	10	version	version	NOUN
cpe-2361	30	11	was	be	AUX
cpe-2361	30	12	not	not	PART
cpe-2361	30	13	as	as	ADV
cpe-2361	30	14	efficacious	efficacious	ADJ
cpe-2361	30	15	in	in	ADP
cpe-2361	30	16	managing	manage	VERB
cpe-2361	30	17	the	the	DET
cpe-2361	30	18	patients	patient	NOUN
cpe-2361	30	19	’	’	PART
cpe-2361	30	20	depression	depression	NOUN
cpe-2361	30	21	and	and	CCONJ
cpe-2361	30	22	they	they	PRON
cpe-2361	30	23	were	be	AUX
cpe-2361	30	24	also	also	ADV
cpe-2361	30	25	experiencing	experience	VERB
cpe-2361	30	26	side	side	NOUN
cpe-2361	30	27	effects	effect	NOUN
cpe-2361	30	28	.	.	PUNCT
cpe-2361	31	1	the	the	DET
cpe-2361	31	2	new	new	PROPN
cpe-2361	31	3	zealand	zealand	PROPN
cpe-2361	31	4	herald	herald	PROPN
cpe-2361	31	5	article	article	PROPN
cpe-2361	31	6	specifically	specifically	ADV
cpe-2361	31	7	mentioned	mention	VERB
cpe-2361	31	8	that	that	SCONJ
cpe-2361	31	9	patients	patient	NOUN
cpe-2361	31	10	were	be	AUX
cpe-2361	31	11	reporting	report	VERB
cpe-2361	31	12	suicidal	suicidal	ADJ
cpe-2361	31	13	thoughts	thought	NOUN
cpe-2361	31	14	,	,	PUNCT
cpe-2361	31	15	nausea	nausea	NOUN
cpe-2361	31	16	,	,	PUNCT
cpe-2361	31	17	fatigue	fatigue	NOUN
cpe-2361	31	18	,	,	PUNCT
cpe-2361	31	19	headaches	headache	NOUN
cpe-2361	31	20	and	and	CCONJ
cpe-2361	31	21	anxiety	anxiety	NOUN
cpe-2361	31	22	.	.	PUNCT
cpe-2361	32	1	in	in	ADP
cpe-2361	32	2	april	april	PROPN
cpe-2361	32	3	,	,	PUNCT
cpe-2361	32	4	stuff	stuff	NOUN
cpe-2361	32	5	released	release	VERB
cpe-2361	32	6	another	another	DET
cpe-2361	32	7	online	online	ADJ
cpe-2361	32	8	article	article	NOUN
cpe-2361	32	9	,	,	PUNCT
cpe-2361	32	10	which	which	PRON
cpe-2361	32	11	continued	continue	VERB
cpe-2361	32	12	on	on	ADP
cpe-2361	32	13	the	the	DET
cpe-2361	32	14	subject	subject	NOUN
cpe-2361	32	15	of	of	ADP
cpe-2361	32	16	the	the	DET
cpe-2361	32	17	previous	previous	ADJ
cpe-2361	32	18	media	medium	NOUN
cpe-2361	32	19	coverage	coverage	NOUN
cpe-2361	32	20	.	.	PUNCT
cpe-2361	33	1	this	this	DET
cpe-2361	33	2	media	medium	NOUN
cpe-2361	33	3	report	report	NOUN
cpe-2361	33	4	,	,	PUNCT
cpe-2361	33	5	“	"	PUNCT
cpe-2361	33	6	fight	fight	VERB
cpe-2361	33	7	over	over	ADP
cpe-2361	33	8	pharmac	pharmac	NOUN
cpe-2361	33	9	’s	’s	PART
cpe-2361	33	10	switch	switch	NOUN
cpe-2361	33	11	to	to	ADP
cpe-2361	33	12	generic	generic	ADJ
cpe-2361	33	13	an‐	an‐	CCONJ
cpe-2361	33	14	ti	ti	NOUN
cpe-2361	33	15	-	-	ADJ
cpe-2361	33	16	depressant	depressant	ADJ
cpe-2361	33	17	brand	brand	NOUN
cpe-2361	33	18	continues	continue	VERB
cpe-2361	33	19	”	"	PUNCT
cpe-2361	33	20	(	(	PUNCT
cpe-2361	33	21	steele	steele	PROPN
cpe-2361	33	22	,	,	PUNCT
cpe-2361	33	23	2018	2018	NUM
cpe-2361	33	24	)	)	PUNCT
cpe-2361	33	25	,	,	PUNCT
cpe-2361	33	26	again	again	ADV
cpe-2361	33	27	stated	state	VERB
cpe-2361	33	28	that	that	SCONJ
cpe-2361	33	29	the	the	DET
cpe-2361	33	30	new	new	ADJ
cpe-2361	33	31	generic	generic	NOUN
cpe-2361	33	32	was	be	AUX
cpe-2361	33	33	not	not	PART
cpe-2361	33	34	as	as	ADV
cpe-2361	33	35	effective	effective	ADJ
cpe-2361	33	36	and	and	CCONJ
cpe-2361	33	37	noted	note	VERB
cpe-2361	33	38	that	that	SCONJ
cpe-2361	33	39	various	various	ADJ
cpe-2361	33	40	adverse	adverse	ADJ
cpe-2361	33	41	events	event	NOUN
cpe-2361	33	42	had	have	AUX
cpe-2361	33	43	been	be	AUX
cpe-2361	33	44	reported	report	VERB
cpe-2361	33	45	specifically	specifically	ADV
cpe-2361	33	46	head‐	head‐	NOUN
cpe-2361	33	47	aches	ache	NOUN
cpe-2361	33	48	,	,	PUNCT
cpe-2361	33	49	anxiety	anxiety	NOUN
cpe-2361	33	50	and	and	CCONJ
cpe-2361	33	51	suicidal	suicidal	ADJ
cpe-2361	33	52	thoughts	thought	NOUN
cpe-2361	33	53	.	.	PUNCT
cpe-2361	34	1	of	of	ADP
cpe-2361	34	2	the	the	DET
cpe-2361	34	3	two	two	NUM
cpe-2361	34	4	websites	website	NOUN
cpe-2361	34	5	,	,	PUNCT
cpe-2361	34	6	stuff	stuff	NOUN
cpe-2361	34	7	is	be	AUX
cpe-2361	34	8	the	the	DET
cpe-2361	34	9	most	most	ADV
cpe-2361	34	10	viewed	view	VERB
cpe-2361	34	11	with	with	ADP
cpe-2361	34	12	approximately	approximately	ADV
cpe-2361	34	13	161,600	161,600	NUM
cpe-2361	34	14	unique	unique	ADJ
cpe-2361	34	15	views	view	NOUN
cpe-2361	34	16	per	per	ADP
cpe-2361	34	17	day	day	NOUN
cpe-2361	34	18	,	,	PUNCT
cpe-2361	34	19	while	while	SCONJ
cpe-2361	34	20	the	the	DET
cpe-2361	34	21	new	new	PROPN
cpe-2361	34	22	zealand	zealand	PROPN
cpe-2361	34	23	herald	herald	PROPN
cpe-2361	34	24	has	have	VERB
cpe-2361	34	25	94,800	94,800	NUM
cpe-2361	34	26	views	view	NOUN
cpe-2361	34	27	(	(	PUNCT
cpe-2361	34	28	https://www.siteprice.org	https://www.siteprice.org	NUM
cpe-2361	34	29	)	)	PUNCT
cpe-2361	34	30	.	.	PUNCT
cpe-2361	35	1	neither	neither	PRON
cpe-2361	35	2	of	of	ADP
cpe-2361	35	3	these	these	DET
cpe-2361	35	4	stories	story	NOUN
cpe-2361	35	5	suggested	suggest	VERB
cpe-2361	35	6	patients	patient	NOUN
cpe-2361	35	7	report	report	VERB
cpe-2361	35	8	side	side	ADJ
cpe-2361	35	9	effects	effect	NOUN
cpe-2361	35	10	to	to	ADP
cpe-2361	35	11	their	their	PRON
cpe-2361	35	12	doctor	doctor	NOUN
cpe-2361	35	13	or	or	CCONJ
cpe-2361	35	14	to	to	PART
cpe-2361	35	15	carm	carm	VERB
cpe-2361	35	16	.	.	PUNCT
cpe-2361	36	1	adverse	adverse	ADJ
cpe-2361	36	2	drug	drug	NOUN
cpe-2361	36	3	reactions	reaction	NOUN
cpe-2361	36	4	a	a	DET
cpe-2361	36	5	report	report	NOUN
cpe-2361	36	6	of	of	ADP
cpe-2361	36	7	all	all	DET
cpe-2361	36	8	adverse	adverse	ADJ
cpe-2361	36	9	reactions	reaction	NOUN
cpe-2361	36	10	to	to	ADP
cpe-2361	36	11	venlafaxine	venlafaxine	NOUN
cpe-2361	36	12	was	be	AUX
cpe-2361	36	13	obtained	obtain	VERB
cpe-2361	36	14	from	from	ADP
cpe-2361	36	15	carm	carm	PROPN
cpe-2361	36	16	through	through	ADP
cpe-2361	36	17	med‐	med‐	PROPN
cpe-2361	36	18	safe	safe	ADJ
cpe-2361	36	19	,	,	PUNCT
cpe-2361	36	20	new	new	PROPN
cpe-2361	36	21	zealand	zealand	PROPN
cpe-2361	36	22	’s	’s	PART
cpe-2361	36	23	medicines	medicine	NOUN
cpe-2361	36	24	monitoring	monitor	VERB
cpe-2361	36	25	agency	agency	NOUN
cpe-2361	36	26	.	.	PUNCT
cpe-2361	37	1	the	the	DET
cpe-2361	37	2	carm	carm	PROPN
cpe-2361	37	3	database	database	NOUN
cpe-2361	37	4	collects	collect	VERB
cpe-2361	37	5	adverse	adverse	ADJ
cpe-2361	37	6	reactions	reaction	NOUN
cpe-2361	37	7	to	to	ADP
cpe-2361	37	8	medicines	medicine	NOUN
cpe-2361	37	9	and	and	CCONJ
cpe-2361	37	10	vaccines	vaccine	NOUN
cpe-2361	37	11	,	,	PUNCT
cpe-2361	37	12	the	the	DET
cpe-2361	37	13	majority	majority	NOUN
cpe-2361	37	14	of	of	ADP
cpe-2361	37	15	which	which	PRON
cpe-2361	37	16	are	be	AUX
cpe-2361	37	17	submitted	submit	VERB
cpe-2361	37	18	by	by	ADP
cpe-2361	37	19	healthcare	healthcare	NOUN
cpe-2361	37	20	professionals	professional	NOUN
cpe-2361	37	21	.	.	PUNCT
cpe-2361	38	1	reporting	reporting	NOUN
cpe-2361	38	2	is	be	AUX
cpe-2361	38	3	usually	usually	ADV
cpe-2361	38	4	made	make	VERB
cpe-2361	38	5	online	online	ADJ
cpe-2361	38	6	and	and	CCONJ
cpe-2361	38	7	carm	carm	VERB
cpe-2361	38	8	reporting	reporting	NOUN
cpe-2361	38	9	forms	form	NOUN
cpe-2361	38	10	can	can	AUX
cpe-2361	38	11	be	be	AUX
cpe-2361	38	12	ac‐	ac‐	NOUN
cpe-2361	38	13	cessed	cesse	VERB
cpe-2361	38	14	on	on	ADP
cpe-2361	38	15	the	the	DET
cpe-2361	38	16	website	website	NOUN
cpe-2361	38	17	https://nzphvc.otago.ac.nz	https://nzphvc.otago.ac.nz	PROPN
cpe-2361	38	18	.	.	PUNCT
cpe-2361	39	1	reports	report	NOUN
cpe-2361	39	2	were	be	AUX
cpe-2361	39	3	obtained	obtain	VERB
cpe-2361	39	4	from	from	ADP
cpe-2361	39	5	october	october	PROPN
cpe-2361	39	6	2017	2017	NUM
cpe-2361	39	7	to	to	ADP
cpe-2361	39	8	july	july	PROPN
cpe-2361	39	9	2018	2018	NUM
cpe-2361	39	10	and	and	CCONJ
cpe-2361	39	11	included	include	VERB
cpe-2361	39	12	the	the	DET
cpe-2361	39	13	month	month	NOUN
cpe-2361	39	14	the	the	DET
cpe-2361	39	15	report	report	NOUN
cpe-2361	39	16	was	be	AUX
cpe-2361	39	17	received	receive	VERB
cpe-2361	39	18	,	,	PUNCT
cpe-2361	39	19	the	the	DET
cpe-2361	39	20	patients	patient	NOUN
cpe-2361	39	21	’	’	PART
cpe-2361	39	22	age	age	NOUN
cpe-2361	39	23	and	and	CCONJ
cpe-2361	39	24	gender	gender	NOUN
cpe-2361	39	25	,	,	PUNCT
cpe-2361	39	26	and	and	CCONJ
cpe-2361	39	27	up	up	ADP
cpe-2361	39	28	to	to	PART
cpe-2361	39	29	five	five	NUM
cpe-2361	39	30	symptoms	symptom	NOUN
cpe-2361	39	31	attributed	attribute	VERB
cpe-2361	39	32	to	to	ADP
cpe-2361	39	33	the	the	DET
cpe-2361	39	34	medicine	medicine	NOUN
cpe-2361	39	35	.	.	PUNCT
cpe-2361	40	1	as	as	SCONJ
cpe-2361	40	2	the	the	DET
cpe-2361	40	3	data	data	NOUN
cpe-2361	40	4	was	be	AUX
cpe-2361	40	5	anonymous	anonymous	ADJ
cpe-2361	40	6	and	and	CCONJ
cpe-2361	40	7	publicly	publicly	ADV
cpe-2361	40	8	available	available	ADJ
cpe-2361	40	9	,	,	PUNCT
cpe-2361	40	10	the	the	DET
cpe-2361	40	11	study	study	NOUN
cpe-2361	40	12	did	do	AUX
cpe-2361	40	13	not	not	PART
cpe-2361	40	14	require	require	VERB
cpe-2361	40	15	ethical	ethical	ADJ
cpe-2361	40	16	approval	approval	NOUN
cpe-2361	40	17	.	.	PUNCT
cpe-2361	41	1	measures	measure	NOUN
cpe-2361	41	2	the	the	DET
cpe-2361	41	3	number	number	NOUN
cpe-2361	41	4	of	of	ADP
cpe-2361	41	5	reports	report	NOUN
cpe-2361	41	6	of	of	ADP
cpe-2361	41	7	decreased	decrease	VERB
cpe-2361	41	8	therapeutic	therapeutic	ADJ
cpe-2361	41	9	response	response	NOUN
cpe-2361	41	10	was	be	AUX
cpe-2361	41	11	calculated	calculate	VERB
cpe-2361	41	12	for	for	ADP
cpe-2361	41	13	each	each	DET
cpe-2361	41	14	month	month	NOUN
cpe-2361	41	15	.	.	PUNCT
cpe-2361	42	1	decreased	decrease	VERB
cpe-2361	42	2	therapeutic	therapeutic	ADJ
cpe-2361	42	3	response	response	NOUN
cpe-2361	42	4	is	be	AUX
cpe-2361	42	5	an	an	DET
cpe-2361	42	6	adverse	adverse	ADJ
cpe-2361	42	7	reaction	reaction	NOUN
cpe-2361	42	8	category	category	NOUN
cpe-2361	42	9	on	on	ADP
cpe-2361	42	10	the	the	DET
cpe-2361	42	11	carm	carm	PROPN
cpe-2361	42	12	database	database	NOUN
cpe-2361	42	13	equivalent	equivalent	ADJ
cpe-2361	42	14	to	to	ADP
cpe-2361	42	15	a	a	DET
cpe-2361	42	16	reduced	reduce	VERB
cpe-2361	42	17	efficacy	efficacy	NOUN
cpe-2361	42	18	of	of	ADP
cpe-2361	42	19	the	the	DET
cpe-2361	42	20	medicine	medicine	NOUN
cpe-2361	42	21	.	.	PUNCT
cpe-2361	43	1	mackrill	mackrill	NOUN
cpe-2361	43	2	,	,	PUNCT
cpe-2361	43	3	gamble	gamble	ADJ
cpe-2361	43	4	,	,	PUNCT
cpe-2361	43	5	bean	bean	NOUN
cpe-2361	43	6	et	et	PROPN
cpe-2361	43	7	al	al	PROPN
cpe-2361	43	8	.	.	PROPN
cpe-2361	43	9	3	3	NUM
cpe-2361	43	10	clinical	clinical	ADJ
cpe-2361	43	11	psychology	psychology	NOUN
cpe-2361	43	12	in	in	ADP
cpe-2361	43	13	europe	europe	PROPN
cpe-2361	43	14	2019	2019	NUM
cpe-2361	43	15	,	,	PUNCT
cpe-2361	43	16	vol.1(1	vol.1(1	NOUN
cpe-2361	43	17	)	)	PUNCT
cpe-2361	43	18	,	,	PUNCT
cpe-2361	43	19	article	article	NOUN
cpe-2361	43	20	e29642	e29642	VERB
cpe-2361	43	21	https://doi.org/10.32872/cpe.v1i1.29642	https://doi.org/10.32872/cpe.v1i1.29642	PROPN
cpe-2361	43	22	https://www.siteprice.org	https://www.siteprice.org	PROPN
cpe-2361	43	23	https://nzphvc.otago.ac.nz	https://nzphvc.otago.ac.nz	NOUN
cpe-2361	43	24	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
cpe-2361	43	25	the	the	DET
cpe-2361	43	26	total	total	ADJ
cpe-2361	43	27	number	number	NOUN
cpe-2361	43	28	of	of	ADP
cpe-2361	43	29	side	side	NOUN
cpe-2361	43	30	effects	effect	NOUN
cpe-2361	43	31	reported	report	VERB
cpe-2361	43	32	each	each	DET
cpe-2361	43	33	month	month	NOUN
cpe-2361	43	34	was	be	AUX
cpe-2361	43	35	also	also	ADV
cpe-2361	43	36	calculated	calculate	VERB
cpe-2361	43	37	as	as	SCONJ
cpe-2361	43	38	was	be	AUX
cpe-2361	43	39	the	the	DET
cpe-2361	43	40	number	number	NOUN
cpe-2361	43	41	of	of	ADP
cpe-2361	43	42	times	time	NOUN
cpe-2361	43	43	the	the	DET
cpe-2361	43	44	five	five	NUM
cpe-2361	43	45	specific	specific	ADJ
cpe-2361	43	46	side	side	NOUN
cpe-2361	43	47	effects	effect	NOUN
cpe-2361	43	48	mentioned	mention	VERB
cpe-2361	43	49	in	in	ADP
cpe-2361	43	50	the	the	DET
cpe-2361	43	51	new	new	PROPN
cpe-2361	43	52	zealand	zealand	PROPN
cpe-2361	43	53	herald	herald	PROPN
cpe-2361	43	54	arti‐	arti‐	PROPN
cpe-2361	43	55	cle	cle	PROPN
cpe-2361	43	56	were	be	AUX
cpe-2361	43	57	reported	report	VERB
cpe-2361	43	58	.	.	PUNCT
cpe-2361	44	1	the	the	DET
cpe-2361	44	2	side	side	NOUN
cpe-2361	44	3	effects	effect	NOUN
cpe-2361	44	4	were	be	AUX
cpe-2361	44	5	matched	match	VERB
cpe-2361	44	6	to	to	ADP
cpe-2361	44	7	the	the	DET
cpe-2361	44	8	corresponding	corresponding	ADJ
cpe-2361	44	9	adverse	adverse	ADJ
cpe-2361	44	10	reactions	reaction	NOUN
cpe-2361	44	11	in	in	ADP
cpe-2361	44	12	the	the	DET
cpe-2361	44	13	carm	carm	NOUN
cpe-2361	44	14	database	database	NOUN
cpe-2361	44	15	with	with	ADP
cpe-2361	44	16	headaches	headache	NOUN
cpe-2361	44	17	,	,	PUNCT
cpe-2361	44	18	nausea	nausea	NOUN
cpe-2361	44	19	and	and	CCONJ
cpe-2361	44	20	anxiety	anxiety	NOUN
cpe-2361	44	21	being	be	AUX
cpe-2361	44	22	matched	match	VERB
cpe-2361	44	23	exactly	exactly	ADV
cpe-2361	44	24	.	.	PUNCT
cpe-2361	45	1	two	two	NUM
cpe-2361	45	2	of	of	ADP
cpe-2361	45	3	the	the	DET
cpe-2361	45	4	media	medium	NOUN
cpe-2361	45	5	-	-	PUNCT
cpe-2361	45	6	mentioned	mention	VERB
cpe-2361	45	7	side	side	NOUN
cpe-2361	45	8	effects	effect	NOUN
cpe-2361	45	9	were	be	AUX
cpe-2361	45	10	considered	consider	VERB
cpe-2361	45	11	broad	broad	ADJ
cpe-2361	45	12	enough	enough	ADV
cpe-2361	45	13	to	to	PART
cpe-2361	45	14	cover	cover	VERB
cpe-2361	45	15	a	a	DET
cpe-2361	45	16	range	range	NOUN
cpe-2361	45	17	of	of	ADP
cpe-2361	45	18	carm	carm	PROPN
cpe-2361	45	19	adverse	adverse	ADJ
cpe-2361	45	20	reactions	reaction	NOUN
cpe-2361	45	21	.	.	PUNCT
cpe-2361	46	1	as	as	ADP
cpe-2361	46	2	such	such	ADJ
cpe-2361	46	3	,	,	PUNCT
cpe-2361	46	4	reports	report	NOUN
cpe-2361	46	5	of	of	ADP
cpe-2361	46	6	fatigue	fatigue	NOUN
cpe-2361	46	7	,	,	PUNCT
cpe-2361	46	8	lethargy	lethargy	NOUN
cpe-2361	46	9	and	and	CCONJ
cpe-2361	46	10	tiredness	tiredness	NOUN
cpe-2361	46	11	were	be	AUX
cpe-2361	46	12	grou‐	grou‐	AUX
cpe-2361	46	13	ped	pe	VERB
cpe-2361	46	14	under	under	ADP
cpe-2361	46	15	the	the	DET
cpe-2361	46	16	broader	broad	ADJ
cpe-2361	46	17	side	side	NOUN
cpe-2361	46	18	effect	effect	NOUN
cpe-2361	46	19	of	of	ADP
cpe-2361	46	20	fatigue	fatigue	NOUN
cpe-2361	46	21	,	,	PUNCT
cpe-2361	46	22	while	while	SCONJ
cpe-2361	46	23	suicidal	suicidal	ADJ
cpe-2361	46	24	thoughts	thought	NOUN
cpe-2361	46	25	were	be	AUX
cpe-2361	46	26	matched	match	VERB
cpe-2361	46	27	with	with	ADP
cpe-2361	46	28	reports	report	NOUN
cpe-2361	46	29	of	of	ADP
cpe-2361	46	30	suicidal	suicidal	ADJ
cpe-2361	46	31	tendencies	tendency	NOUN
cpe-2361	46	32	,	,	PUNCT
cpe-2361	46	33	suicidal	suicidal	ADJ
cpe-2361	46	34	ideation	ideation	NOUN
cpe-2361	46	35	and	and	CCONJ
cpe-2361	46	36	impulses	impulse	NOUN
cpe-2361	46	37	to	to	ADP
cpe-2361	46	38	self	self	NOUN
cpe-2361	46	39	-	-	PUNCT
cpe-2361	46	40	harm	harm	NOUN
cpe-2361	46	41	.	.	PUNCT
cpe-2361	47	1	the	the	DET
cpe-2361	47	2	five	five	NUM
cpe-2361	47	3	most	most	ADV
cpe-2361	47	4	common	common	ADJ
cpe-2361	47	5	adverse	adverse	ADJ
cpe-2361	47	6	reactions	reaction	NOUN
cpe-2361	47	7	not	not	PART
cpe-2361	47	8	mentioned	mention	VERB
cpe-2361	47	9	in	in	ADP
cpe-2361	47	10	the	the	DET
cpe-2361	47	11	media	medium	NOUN
cpe-2361	47	12	reports	report	NOUN
cpe-2361	47	13	were	be	AUX
cpe-2361	47	14	identified	identify	VERB
cpe-2361	47	15	from	from	ADP
cpe-2361	47	16	the	the	DET
cpe-2361	47	17	carm	carm	NOUN
cpe-2361	47	18	database	database	NOUN
cpe-2361	47	19	and	and	CCONJ
cpe-2361	47	20	used	use	VERB
cpe-2361	47	21	as	as	ADP
cpe-2361	47	22	control	control	NOUN
cpe-2361	47	23	symptoms	symptom	NOUN
cpe-2361	47	24	.	.	PUNCT
cpe-2361	48	1	these	these	PRON
cpe-2361	48	2	were	be	AUX
cpe-2361	48	3	dizziness	dizziness	NOUN
cpe-2361	48	4	,	,	PUNCT
cpe-2361	48	5	drug	drug	NOUN
cpe-2361	48	6	withdrawal	withdrawal	NOUN
cpe-2361	48	7	syndrome	syndrome	NOUN
cpe-2361	48	8	,	,	PUNCT
cpe-2361	48	9	irritability	irritability	NOUN
cpe-2361	48	10	,	,	PUNCT
cpe-2361	48	11	sleep	sleep	VERB
cpe-2361	48	12	disturbance	disturbance	NOUN
cpe-2361	48	13	and	and	CCONJ
cpe-2361	48	14	a	a	DET
cpe-2361	48	15	fuzzy	fuzzy	ADJ
cpe-2361	48	16	head	head	NOUN
cpe-2361	48	17	.	.	PUNCT
cpe-2361	49	1	statistical	statistical	ADJ
cpe-2361	49	2	analyses	analysis	NOUN
cpe-2361	49	3	interrupted	interrupt	VERB
cpe-2361	49	4	time	time	NOUN
cpe-2361	49	5	series	series	PROPN
cpe-2361	49	6	analyses	analysis	NOUN
cpe-2361	49	7	were	be	AUX
cpe-2361	49	8	conducted	conduct	VERB
cpe-2361	49	9	to	to	PART
cpe-2361	49	10	investigate	investigate	VERB
cpe-2361	49	11	whether	whether	SCONJ
cpe-2361	49	12	the	the	DET
cpe-2361	49	13	february	february	PROPN
cpe-2361	49	14	and	and	CCONJ
cpe-2361	49	15	april	april	PROPN
cpe-2361	49	16	media	medium	NOUN
cpe-2361	49	17	reports	report	NOUN
cpe-2361	49	18	on	on	ADP
cpe-2361	49	19	the	the	DET
cpe-2361	49	20	venlafaxine	venlafaxine	ADJ
cpe-2361	49	21	brand	brand	NOUN
cpe-2361	49	22	switch	switch	NOUN
cpe-2361	49	23	were	be	AUX
cpe-2361	49	24	associated	associate	VERB
cpe-2361	49	25	with	with	ADP
cpe-2361	49	26	an	an	DET
cpe-2361	49	27	increase	increase	NOUN
cpe-2361	49	28	in	in	ADP
cpe-2361	49	29	the	the	DET
cpe-2361	49	30	carm	carm	NOUN
cpe-2361	49	31	reporting	reporting	NOUN
cpe-2361	49	32	of	of	ADP
cpe-2361	49	33	decreased	decrease	VERB
cpe-2361	49	34	therapeutic	therapeutic	ADJ
cpe-2361	49	35	response	response	NOUN
cpe-2361	49	36	,	,	PUNCT
cpe-2361	49	37	total	total	ADJ
cpe-2361	49	38	number	number	NOUN
cpe-2361	49	39	of	of	ADP
cpe-2361	49	40	side	side	NOUN
cpe-2361	49	41	effects	effect	NOUN
cpe-2361	49	42	and	and	CCONJ
cpe-2361	49	43	the	the	DET
cpe-2361	49	44	specifically	specifically	ADV
cpe-2361	49	45	mentioned	mention	VERB
cpe-2361	49	46	side	side	NOUN
cpe-2361	49	47	effects	effect	NOUN
cpe-2361	49	48	in	in	ADP
cpe-2361	49	49	the	the	DET
cpe-2361	49	50	months	month	NOUN
cpe-2361	49	51	directly	directly	ADV
cpe-2361	49	52	after	after	SCONJ
cpe-2361	49	53	the	the	DET
cpe-2361	49	54	media	media	NOUN
cpe-2361	49	55	reports	report	NOUN
cpe-2361	49	56	compared	compare	VERB
cpe-2361	49	57	to	to	ADP
cpe-2361	49	58	the	the	DET
cpe-2361	49	59	five	five	NUM
cpe-2361	49	60	months	month	NOUN
cpe-2361	49	61	before	before	ADV
cpe-2361	49	62	.	.	PUNCT
cpe-2361	50	1	an	an	DET
cpe-2361	50	2	autoregressive	autoregressive	ADJ
cpe-2361	50	3	integrated	integrated	ADJ
cpe-2361	50	4	moving	move	VERB
cpe-2361	50	5	average	average	NOUN
cpe-2361	50	6	(	(	PUNCT
cpe-2361	50	7	ari‐	ari‐	PROPN
cpe-2361	50	8	ma	ma	PROPN
cpe-2361	50	9	)	)	PUNCT
cpe-2361	50	10	model	model	NOUN
cpe-2361	50	11	with	with	ADP
cpe-2361	50	12	an	an	DET
cpe-2361	50	13	autoregression	autoregression	NOUN
cpe-2361	50	14	term	term	NOUN
cpe-2361	50	15	of	of	ADP
cpe-2361	50	16	1	1	NUM
cpe-2361	50	17	and	and	CCONJ
cpe-2361	50	18	moving	move	VERB
cpe-2361	50	19	average	average	ADJ
cpe-2361	50	20	term	term	NOUN
cpe-2361	50	21	of	of	ADP
cpe-2361	50	22	1	1	NUM
cpe-2361	50	23	was	be	AUX
cpe-2361	50	24	used	use	VERB
cpe-2361	50	25	for	for	ADP
cpe-2361	50	26	all	all	DET
cpe-2361	50	27	analyses	analysis	NOUN
cpe-2361	50	28	.	.	PUNCT
cpe-2361	51	1	as	as	SCONJ
cpe-2361	51	2	the	the	DET
cpe-2361	51	3	three	three	NUM
cpe-2361	51	4	media	medium	NOUN
cpe-2361	51	5	reports	report	NOUN
cpe-2361	51	6	were	be	AUX
cpe-2361	51	7	a	a	DET
cpe-2361	51	8	one	one	NUM
cpe-2361	51	9	-	-	PUNCT
cpe-2361	51	10	off	off	ADP
cpe-2361	51	11	interruption	interruption	NOUN
cpe-2361	51	12	to	to	ADP
cpe-2361	51	13	the	the	DET
cpe-2361	51	14	normal	normal	ADJ
cpe-2361	51	15	time	time	NOUN
cpe-2361	51	16	series	series	PROPN
cpe-2361	51	17	,	,	PUNCT
cpe-2361	51	18	a	a	DET
cpe-2361	51	19	binary	binary	ADJ
cpe-2361	51	20	independent	independent	ADJ
cpe-2361	51	21	variable	variable	NOUN
cpe-2361	51	22	was	be	AUX
cpe-2361	51	23	created	create	VERB
cpe-2361	51	24	to	to	PART
cpe-2361	51	25	indicate	indicate	VERB
cpe-2361	51	26	their	their	PRON
cpe-2361	51	27	presence	presence	NOUN
cpe-2361	51	28	by	by	ADP
cpe-2361	51	29	month	month	NOUN
cpe-2361	51	30	.	.	PUNCT
cpe-2361	52	1	march	march	PROPN
cpe-2361	52	2	and	and	CCONJ
cpe-2361	52	3	may	may	AUX
cpe-2361	52	4	were	be	AUX
cpe-2361	52	5	given	give	VERB
cpe-2361	52	6	the	the	DET
cpe-2361	52	7	value	value	NOUN
cpe-2361	52	8	of	of	ADP
cpe-2361	52	9	1	1	NUM
cpe-2361	52	10	as	as	SCONJ
cpe-2361	52	11	these	these	PRON
cpe-2361	52	12	were	be	AUX
cpe-2361	52	13	the	the	DET
cpe-2361	52	14	periods	period	NOUN
cpe-2361	52	15	directly	directly	ADV
cpe-2361	52	16	after	after	SCONJ
cpe-2361	52	17	the	the	DET
cpe-2361	52	18	feb‐	feb‐	NUM
cpe-2361	52	19	ruary	ruary	ADJ
cpe-2361	52	20	and	and	CCONJ
cpe-2361	52	21	april	april	PROPN
cpe-2361	52	22	media	medium	NOUN
cpe-2361	52	23	reports	report	NOUN
cpe-2361	52	24	and	and	CCONJ
cpe-2361	52	25	all	all	DET
cpe-2361	52	26	other	other	ADJ
cpe-2361	52	27	months	month	NOUN
cpe-2361	52	28	were	be	AUX
cpe-2361	52	29	coded	code	VERB
cpe-2361	52	30	0	0	NUM
cpe-2361	52	31	.	.	PUNCT
cpe-2361	53	1	the	the	DET
cpe-2361	53	2	analysis	analysis	NOUN
cpe-2361	53	3	produces	produce	VERB
cpe-2361	53	4	an	an	DET
cpe-2361	53	5	estimated	estimate	VERB
cpe-2361	53	6	interruption	interruption	NOUN
cpe-2361	53	7	effect	effect	NOUN
cpe-2361	53	8	,	,	PUNCT
cpe-2361	53	9	which	which	PRON
cpe-2361	53	10	is	be	AUX
cpe-2361	53	11	the	the	DET
cpe-2361	53	12	change	change	NOUN
cpe-2361	53	13	in	in	ADP
cpe-2361	53	14	the	the	DET
cpe-2361	53	15	rate	rate	NOUN
cpe-2361	53	16	of	of	ADP
cpe-2361	53	17	adverse	adverse	ADJ
cpe-2361	53	18	event	event	NOUN
cpe-2361	53	19	report‐	report‐	VERB
cpe-2361	53	20	ing	ing	NOUN
cpe-2361	53	21	from	from	ADP
cpe-2361	53	22	the	the	DET
cpe-2361	53	23	months	month	NOUN
cpe-2361	53	24	coded	code	VERB
cpe-2361	53	25	0	0	NUM
cpe-2361	53	26	and	and	CCONJ
cpe-2361	53	27	1	1	NUM
cpe-2361	53	28	,	,	PUNCT
cpe-2361	53	29	and	and	CCONJ
cpe-2361	53	30	indicates	indicate	VERB
cpe-2361	53	31	whether	whether	SCONJ
cpe-2361	53	32	this	this	DET
cpe-2361	53	33	change	change	NOUN
cpe-2361	53	34	is	be	AUX
cpe-2361	53	35	significantly	significantly	ADV
cpe-2361	53	36	different	different	ADJ
cpe-2361	53	37	.	.	PUNCT
cpe-2361	54	1	this	this	PRON
cpe-2361	54	2	is	be	AUX
cpe-2361	54	3	a	a	DET
cpe-2361	54	4	more	more	ADV
cpe-2361	54	5	conservative	conservative	ADJ
cpe-2361	54	6	analysis	analysis	NOUN
cpe-2361	54	7	as	as	SCONJ
cpe-2361	54	8	the	the	DET
cpe-2361	54	9	adverse	adverse	ADJ
cpe-2361	54	10	event	event	NOUN
cpe-2361	54	11	reports	report	VERB
cpe-2361	54	12	in	in	ADP
cpe-2361	54	13	march	march	PROPN
cpe-2361	54	14	and	and	CCONJ
cpe-2361	54	15	may	may	AUX
cpe-2361	54	16	are	be	AUX
cpe-2361	54	17	averaged	average	VERB
cpe-2361	54	18	together	together	ADV
cpe-2361	54	19	to	to	PART
cpe-2361	54	20	calculate	calculate	VERB
cpe-2361	54	21	the	the	DET
cpe-2361	54	22	general	general	ADJ
cpe-2361	54	23	effect	effect	NOUN
cpe-2361	54	24	of	of	ADP
cpe-2361	54	25	the	the	DET
cpe-2361	54	26	three	three	NUM
cpe-2361	54	27	media	medium	NOUN
cpe-2361	54	28	stories	story	NOUN
cpe-2361	54	29	rather	rather	ADV
cpe-2361	54	30	than	than	ADP
cpe-2361	54	31	both	both	DET
cpe-2361	54	32	months	month	NOUN
cpe-2361	54	33	being	be	AUX
cpe-2361	54	34	compared	compare	VERB
cpe-2361	54	35	separately	separately	ADV
cpe-2361	54	36	to	to	ADP
cpe-2361	54	37	the	the	DET
cpe-2361	54	38	pre	pre	ADJ
cpe-2361	54	39	-	-	ADJ
cpe-2361	54	40	media	media	ADJ
cpe-2361	54	41	rate	rate	NOUN
cpe-2361	54	42	.	.	PUNCT
cpe-2361	55	1	analyses	analysis	NOUN
cpe-2361	55	2	were	be	AUX
cpe-2361	55	3	con‐	con‐	VERB
cpe-2361	55	4	ducted	ducte	VERB
cpe-2361	55	5	in	in	ADP
cpe-2361	55	6	sas	sas	PROPN
cpe-2361	55	7	(	(	PUNCT
cpe-2361	55	8	v9.4	v9.4	PROPN
cpe-2361	55	9	sas	sas	PROPN
cpe-2361	55	10	institute	institute	PROPN
cpe-2361	55	11	inc	inc	PROPN
cpe-2361	55	12	.	.	PROPN
cpe-2361	55	13	,	,	PUNCT
cpe-2361	55	14	cary	cary	PROPN
cpe-2361	55	15	,	,	PUNCT
cpe-2361	55	16	nc	nc	PROPN
cpe-2361	55	17	)	)	PUNCT
cpe-2361	55	18	using	use	VERB
cpe-2361	55	19	the	the	DET
cpe-2361	55	20	sas	sas	PROPN
cpe-2361	55	21	proc	proc	NOUN
cpe-2361	55	22	arima	arima	PROPN
cpe-2361	55	23	procedure	procedure	NOUN
cpe-2361	55	24	.	.	PUNCT
cpe-2361	56	1	an	an	DET
cpe-2361	56	2	alpha	alpha	ADJ
cpe-2361	56	3	level	level	NOUN
cpe-2361	56	4	of	of	ADP
cpe-2361	56	5	.05	.05	NUM
cpe-2361	56	6	was	be	AUX
cpe-2361	56	7	considered	consider	VERB
cpe-2361	56	8	significant	significant	ADJ
cpe-2361	56	9	.	.	PUNCT
cpe-2361	57	1	results	result	NOUN
cpe-2361	57	2	in	in	ADP
cpe-2361	57	3	total	total	NOUN
cpe-2361	57	4	,	,	PUNCT
cpe-2361	57	5	there	there	PRON
cpe-2361	57	6	were	be	VERB
cpe-2361	57	7	100	100	NUM
cpe-2361	57	8	adverse	adverse	ADJ
cpe-2361	57	9	event	event	NOUN
cpe-2361	57	10	reports	report	NOUN
cpe-2361	57	11	from	from	ADP
cpe-2361	57	12	october	october	PROPN
cpe-2361	57	13	2017	2017	NUM
cpe-2361	57	14	to	to	ADP
cpe-2361	57	15	july	july	PROPN
cpe-2361	57	16	2018	2018	NUM
cpe-2361	57	17	.	.	PUNCT
cpe-2361	58	1	the	the	DET
cpe-2361	58	2	aver‐	aver‐	ADV
cpe-2361	58	3	age	age	NOUN
cpe-2361	58	4	age	age	NOUN
cpe-2361	58	5	of	of	ADP
cpe-2361	58	6	reporters	reporter	NOUN
cpe-2361	58	7	was	be	AUX
cpe-2361	58	8	43.7	43.7	NUM
cpe-2361	58	9	years	year	NOUN
cpe-2361	58	10	old	old	ADJ
cpe-2361	58	11	and	and	CCONJ
cpe-2361	58	12	70.0	70.0	NUM
cpe-2361	58	13	%	%	NOUN
cpe-2361	58	14	were	be	AUX
cpe-2361	58	15	female	female	ADJ
cpe-2361	58	16	.	.	PUNCT
cpe-2361	59	1	in	in	ADP
cpe-2361	59	2	the	the	DET
cpe-2361	59	3	five	five	NUM
cpe-2361	59	4	months	month	NOUN
cpe-2361	59	5	prior	prior	ADV
cpe-2361	59	6	to	to	ADP
cpe-2361	59	7	the	the	DET
cpe-2361	59	8	first	first	ADJ
cpe-2361	59	9	newspaper	newspaper	NOUN
cpe-2361	59	10	articles	article	NOUN
cpe-2361	59	11	,	,	PUNCT
cpe-2361	59	12	the	the	DET
cpe-2361	59	13	average	average	ADJ
cpe-2361	59	14	number	number	NOUN
cpe-2361	59	15	of	of	ADP
cpe-2361	59	16	adverse	adverse	ADJ
cpe-2361	59	17	event	event	NOUN
cpe-2361	59	18	reports	report	VERB
cpe-2361	59	19	to	to	ADP
cpe-2361	59	20	carm	carm	PROPN
cpe-2361	59	21	was	be	AUX
cpe-2361	59	22	6.00	6.00	NUM
cpe-2361	59	23	(	(	PUNCT
cpe-2361	59	24	sd	sd	NOUN
cpe-2361	59	25	=	=	SYM
cpe-2361	59	26	1.23	1.23	NUM
cpe-2361	59	27	)	)	PUNCT
cpe-2361	59	28	per	per	ADP
cpe-2361	59	29	month	month	NOUN
cpe-2361	59	30	.	.	PUNCT
cpe-2361	60	1	in	in	ADP
cpe-2361	60	2	march	march	PROPN
cpe-2361	60	3	and	and	CCONJ
cpe-2361	60	4	may	may	AUX
cpe-2361	60	5	,	,	PUNCT
cpe-2361	60	6	the	the	DET
cpe-2361	60	7	two	two	NUM
cpe-2361	60	8	months	month	NOUN
cpe-2361	60	9	directly	directly	ADV
cpe-2361	60	10	after	after	ADP
cpe-2361	60	11	the	the	DET
cpe-2361	60	12	release	release	NOUN
cpe-2361	60	13	of	of	ADP
cpe-2361	60	14	the	the	DET
cpe-2361	60	15	articles	article	NOUN
cpe-2361	60	16	,	,	PUNCT
cpe-2361	60	17	the	the	DET
cpe-2361	60	18	average	average	ADJ
cpe-2361	60	19	number	number	NOUN
cpe-2361	60	20	of	of	ADP
cpe-2361	60	21	carm	carm	PROPN
cpe-2361	60	22	reports	report	NOUN
cpe-2361	60	23	significantly	significantly	ADV
cpe-2361	60	24	increased	increase	VERB
cpe-2361	60	25	to	to	ADP
cpe-2361	60	26	25.50	25.50	NUM
cpe-2361	60	27	media	medium	NOUN
cpe-2361	60	28	-	-	PUNCT
cpe-2361	60	29	induced	induce	VERB
cpe-2361	60	30	nocebo	nocebo	NOUN
cpe-2361	60	31	response	response	NOUN
cpe-2361	60	32	4	4	NUM
cpe-2361	60	33	clinical	clinical	ADJ
cpe-2361	60	34	psychology	psychology	NOUN
cpe-2361	60	35	in	in	ADP
cpe-2361	60	36	europe	europe	PROPN
cpe-2361	60	37	2019	2019	NUM
cpe-2361	60	38	,	,	PUNCT
cpe-2361	60	39	vol.1(1	vol.1(1	NOUN
cpe-2361	60	40	)	)	PUNCT
cpe-2361	60	41	,	,	PUNCT
cpe-2361	60	42	article	article	NOUN
cpe-2361	60	43	e29642	e29642	VERB
cpe-2361	60	44	https://doi.org/10.32872/cpe.v1i1.29642	https://doi.org/10.32872/cpe.v1i1.29642	PROPN
cpe-2361	60	45	https://www.psychopen.eu/	https://www.psychopen.eu/	PROPN
cpe-2361	60	46	(	(	PUNCT
cpe-2361	60	47	sd	sd	ADP
cpe-2361	60	48	=	=	SYM
cpe-2361	60	49	12.02	12.02	NUM
cpe-2361	60	50	;	;	PUNCT
cpe-2361	60	51	interruption	interruption	NOUN
cpe-2361	60	52	effect	effect	NOUN
cpe-2361	60	53	i.e.	i.e.	X
cpe-2361	60	54	difference	difference	NOUN
cpe-2361	60	55	between	between	ADP
cpe-2361	60	56	the	the	DET
cpe-2361	60	57	pre	pre	ADJ
cpe-2361	60	58	-	-	ADJ
cpe-2361	60	59	media	media	ADJ
cpe-2361	60	60	average	average	NOUN
cpe-2361	60	61	and	and	CCONJ
cpe-2361	60	62	march	march	PROPN
cpe-2361	60	63	+	+	CCONJ
cpe-2361	60	64	may	may	AUX
cpe-2361	60	65	average	average	VERB
cpe-2361	60	66	=	=	PROPN
cpe-2361	60	67	19.45	19.45	NUM
cpe-2361	60	68	,	,	PUNCT
cpe-2361	60	69	95	95	NUM
cpe-2361	60	70	%	%	NOUN
cpe-2361	60	71	confidence	confidence	NOUN
cpe-2361	60	72	interval	interval	NOUN
cpe-2361	60	73	(	(	PUNCT
cpe-2361	60	74	ci	ci	NOUN
cpe-2361	60	75	)	)	PUNCT
cpe-2361	61	1	[	[	X
cpe-2361	61	2	10.77	10.77	NUM
cpe-2361	61	3	,	,	PUNCT
cpe-2361	61	4	28.13	28.13	NUM
cpe-2361	61	5	]	]	PUNCT
cpe-2361	61	6	,	,	PUNCT
cpe-2361	61	7	p	p	X
cpe-2361	61	8	=	=	NOUN
cpe-2361	61	9	.005	.005	NUM
cpe-2361	61	10	)	)	PUNCT
cpe-2361	61	11	.	.	PUNCT
cpe-2361	62	1	the	the	DET
cpe-2361	62	2	newspaper	newspaper	NOUN
cpe-2361	62	3	articles	article	NOUN
cpe-2361	62	4	also	also	ADV
cpe-2361	62	5	had	have	VERB
cpe-2361	62	6	a	a	DET
cpe-2361	62	7	significant	significant	ADJ
cpe-2361	62	8	effect	effect	NOUN
cpe-2361	62	9	on	on	ADP
cpe-2361	62	10	side	side	ADJ
cpe-2361	62	11	effect	effect	NOUN
cpe-2361	62	12	reporting	report	VERB
cpe-2361	62	13	with	with	ADP
cpe-2361	62	14	the	the	DET
cpe-2361	62	15	pre	pre	ADJ
cpe-2361	62	16	-	-	ADJ
cpe-2361	62	17	media	media	ADJ
cpe-2361	62	18	average	average	NOUN
cpe-2361	62	19	of	of	ADP
cpe-2361	62	20	7.00	7.00	NUM
cpe-2361	62	21	reports	report	NOUN
cpe-2361	62	22	(	(	PUNCT
cpe-2361	62	23	sd	sd	NOUN
cpe-2361	62	24	=	=	SYM
cpe-2361	62	25	4.18	4.18	NUM
cpe-2361	62	26	)	)	PUNCT
cpe-2361	62	27	a	a	DET
cpe-2361	62	28	month	month	NOUN
cpe-2361	62	29	increasing	increase	VERB
cpe-2361	62	30	to	to	ADP
cpe-2361	62	31	49.00	49.00	NUM
cpe-2361	62	32	(	(	PUNCT
cpe-2361	62	33	sd	sd	X
cpe-2361	62	34	=	=	SYM
cpe-2361	62	35	26.63	26.63	NUM
cpe-2361	62	36	)	)	PUNCT
cpe-2361	62	37	in	in	ADP
cpe-2361	62	38	march	march	PROPN
cpe-2361	62	39	and	and	CCONJ
cpe-2361	62	40	may	may	AUX
cpe-2361	62	41	,	,	PUNCT
cpe-2361	62	42	see	see	VERB
cpe-2361	62	43	figure	figure	NOUN
cpe-2361	62	44	1	1	NUM
cpe-2361	62	45	.	.	PUNCT
cpe-2361	62	46	similarly	similarly	ADV
cpe-2361	62	47	,	,	PUNCT
cpe-2361	62	48	the	the	DET
cpe-2361	62	49	rate	rate	NOUN
cpe-2361	62	50	of	of	ADP
cpe-2361	62	51	decreased	decrease	VERB
cpe-2361	62	52	therapeutic	therapeutic	ADJ
cpe-2361	62	53	response	response	NOUN
cpe-2361	62	54	re‐	re‐	ADP
cpe-2361	62	55	porting	port	VERB
cpe-2361	62	56	significantly	significantly	ADV
cpe-2361	62	57	increased	increase	VERB
cpe-2361	62	58	from	from	ADP
cpe-2361	62	59	4.00	4.00	NUM
cpe-2361	62	60	(	(	PUNCT
cpe-2361	62	61	sd	sd	NOUN
cpe-2361	62	62	=	=	SYM
cpe-2361	62	63	2.12	2.12	NUM
cpe-2361	62	64	)	)	PUNCT
cpe-2361	62	65	during	during	ADP
cpe-2361	62	66	the	the	DET
cpe-2361	62	67	previous	previous	ADJ
cpe-2361	62	68	months	month	NOUN
cpe-2361	62	69	to	to	ADP
cpe-2361	62	70	an	an	DET
cpe-2361	62	71	average	average	NOUN
cpe-2361	62	72	of	of	ADP
cpe-2361	62	73	17.00	17.00	NUM
cpe-2361	62	74	(	(	PUNCT
cpe-2361	62	75	sd	sd	NOUN
cpe-2361	62	76	=	=	SYM
cpe-2361	62	77	9.90	9.90	NUM
cpe-2361	62	78	)	)	PUNCT
cpe-2361	62	79	over	over	ADP
cpe-2361	62	80	march	march	PROPN
cpe-2361	62	81	and	and	CCONJ
cpe-2361	62	82	may	may	AUX
cpe-2361	62	83	.	.	PUNCT
cpe-2361	63	1	the	the	DET
cpe-2361	63	2	interruption	interruption	NOUN
cpe-2361	63	3	effect	effect	NOUN
cpe-2361	63	4	of	of	ADP
cpe-2361	63	5	the	the	DET
cpe-2361	63	6	media	medium	NOUN
cpe-2361	63	7	on	on	ADP
cpe-2361	63	8	side	side	ADJ
cpe-2361	63	9	effect	effect	NOUN
cpe-2361	63	10	reporting	report	VERB
cpe-2361	63	11	=	=	PROPN
cpe-2361	63	12	41.83	41.83	NUM
cpe-2361	63	13	,	,	PUNCT
cpe-2361	63	14	95	95	NUM
cpe-2361	63	15	%	%	NOUN
cpe-2361	63	16	ci	ci	NOUN
cpe-2361	64	1	[	[	X
cpe-2361	64	2	25.25	25.25	NUM
cpe-2361	64	3	,	,	PUNCT
cpe-2361	64	4	58.41	58.41	NUM
cpe-2361	64	5	]	]	PUNCT
cpe-2361	64	6	,	,	PUNCT
cpe-2361	64	7	p	p	X
cpe-2361	64	8	=	=	NOUN
cpe-2361	64	9	.003	.003	NUM
cpe-2361	64	10	.	.	PUNCT
cpe-2361	65	1	interruption	interruption	NOUN
cpe-2361	65	2	effect	effect	NOUN
cpe-2361	65	3	for	for	ADP
cpe-2361	65	4	de‐	de‐	NOUN
cpe-2361	65	5	creased	crease	VERB
cpe-2361	65	6	therapeutic	therapeutic	ADJ
cpe-2361	65	7	response	response	NOUN
cpe-2361	65	8	reports	report	VERB
cpe-2361	65	9	=	=	NOUN
cpe-2361	65	10	15.49	15.49	NUM
cpe-2361	65	11	,	,	PUNCT
cpe-2361	65	12	95	95	NUM
cpe-2361	65	13	%	%	NOUN
cpe-2361	65	14	ci	ci	NOUN
cpe-2361	66	1	[	[	X
cpe-2361	66	2	7.01	7.01	NUM
cpe-2361	66	3	,	,	PUNCT
cpe-2361	66	4	23.98	23.98	NUM
cpe-2361	66	5	]	]	PUNCT
cpe-2361	66	6	,	,	PUNCT
cpe-2361	66	7	p	p	PROPN
cpe-2361	66	8	=	=	SYM
cpe-2361	66	9	.012	.012	PROPN
cpe-2361	66	10	.	.	PUNCT
cpe-2361	67	1	figure	figure	NOUN
cpe-2361	67	2	1	1	NUM
cpe-2361	67	3	.	.	PUNCT
cpe-2361	67	4	number	number	NOUN
cpe-2361	67	5	of	of	ADP
cpe-2361	67	6	reports	report	NOUN
cpe-2361	67	7	of	of	ADP
cpe-2361	67	8	side	side	NOUN
cpe-2361	67	9	effects	effect	NOUN
cpe-2361	67	10	and	and	CCONJ
cpe-2361	67	11	decreased	decrease	VERB
cpe-2361	67	12	therapeutic	therapeutic	ADJ
cpe-2361	67	13	response	response	NOUN
cpe-2361	67	14	before	before	ADP
cpe-2361	67	15	and	and	CCONJ
cpe-2361	67	16	after	after	ADP
cpe-2361	67	17	the	the	DET
cpe-2361	67	18	media	media	NOUN
cpe-2361	67	19	reports	report	VERB
cpe-2361	67	20	.	.	PUNCT
cpe-2361	68	1	mackrill	mackrill	NOUN
cpe-2361	68	2	,	,	PUNCT
cpe-2361	68	3	gamble	gamble	ADJ
cpe-2361	68	4	,	,	PUNCT
cpe-2361	68	5	bean	bean	NOUN
cpe-2361	68	6	et	et	PROPN
cpe-2361	68	7	al	al	PROPN
cpe-2361	68	8	.	.	PROPN
cpe-2361	68	9	5	5	NUM
cpe-2361	68	10	clinical	clinical	ADJ
cpe-2361	68	11	psychology	psychology	NOUN
cpe-2361	68	12	in	in	ADP
cpe-2361	68	13	europe	europe	PROPN
cpe-2361	68	14	2019	2019	NUM
cpe-2361	68	15	,	,	PUNCT
cpe-2361	68	16	vol.1(1	vol.1(1	NOUN
cpe-2361	68	17	)	)	PUNCT
cpe-2361	68	18	,	,	PUNCT
cpe-2361	68	19	article	article	NOUN
cpe-2361	68	20	e29642	e29642	VERB
cpe-2361	68	21	https://doi.org/10.32872/cpe.v1i1.29642	https://doi.org/10.32872/cpe.v1i1.29642	PROPN
cpe-2361	68	22	https://www.psychopen.eu/	https://www.psychopen.eu/	AUX
cpe-2361	68	23	a	a	DET
cpe-2361	68	24	further	further	ADJ
cpe-2361	68	25	analysis	analysis	NOUN
cpe-2361	68	26	investigated	investigate	VERB
cpe-2361	68	27	whether	whether	SCONJ
cpe-2361	68	28	the	the	DET
cpe-2361	68	29	reports	report	NOUN
cpe-2361	68	30	to	to	ADP
cpe-2361	68	31	carm	carm	VERB
cpe-2361	68	32	of	of	ADP
cpe-2361	68	33	the	the	DET
cpe-2361	68	34	specific	specific	ADJ
cpe-2361	68	35	side	side	NOUN
cpe-2361	68	36	effects	effect	NOUN
cpe-2361	68	37	mentioned	mention	VERB
cpe-2361	68	38	in	in	ADP
cpe-2361	68	39	the	the	DET
cpe-2361	68	40	february	february	PROPN
cpe-2361	68	41	new	new	PROPN
cpe-2361	68	42	zealand	zealand	PROPN
cpe-2361	68	43	herald	herald	PROPN
cpe-2361	68	44	article	article	PROPN
cpe-2361	68	45	increased	increase	VERB
cpe-2361	68	46	in	in	ADP
cpe-2361	68	47	march	march	PROPN
cpe-2361	68	48	and	and	CCONJ
cpe-2361	68	49	may	may	AUX
cpe-2361	68	50	com‐	com‐	VERB
cpe-2361	68	51	pared	pare	VERB
cpe-2361	68	52	to	to	ADP
cpe-2361	68	53	the	the	DET
cpe-2361	68	54	five	five	NUM
cpe-2361	68	55	previous	previous	ADJ
cpe-2361	68	56	months	month	NOUN
cpe-2361	68	57	.	.	PUNCT
cpe-2361	69	1	figure	figure	NOUN
cpe-2361	69	2	2	2	NUM
cpe-2361	69	3	shows	show	VERB
cpe-2361	69	4	the	the	DET
cpe-2361	69	5	rate	rate	NOUN
cpe-2361	69	6	of	of	ADP
cpe-2361	69	7	reporting	reporting	NOUN
cpe-2361	69	8	for	for	ADP
cpe-2361	69	9	the	the	DET
cpe-2361	69	10	mediamentioned	mediamentioned	ADJ
cpe-2361	69	11	side	side	NOUN
cpe-2361	69	12	effects	effect	NOUN
cpe-2361	69	13	and	and	CCONJ
cpe-2361	69	14	table	table	NOUN
cpe-2361	69	15	1	1	NUM
cpe-2361	69	16	shows	show	VERB
cpe-2361	69	17	the	the	DET
cpe-2361	69	18	interruption	interruption	NOUN
cpe-2361	69	19	effects	effect	NOUN
cpe-2361	69	20	and	and	CCONJ
cpe-2361	69	21	corresponding	correspond	VERB
cpe-2361	69	22	p	p	ADJ
cpe-2361	69	23	values	value	NOUN
cpe-2361	69	24	.	.	PUNCT
cpe-2361	70	1	figure	figure	NOUN
cpe-2361	70	2	2	2	NUM
cpe-2361	70	3	.	.	PUNCT
cpe-2361	70	4	numbers	number	NOUN
cpe-2361	70	5	before	before	ADV
cpe-2361	70	6	and	and	CCONJ
cpe-2361	70	7	after	after	ADP
cpe-2361	70	8	media	medium	NOUN
cpe-2361	70	9	reports	report	NOUN
cpe-2361	70	10	for	for	ADP
cpe-2361	70	11	the	the	DET
cpe-2361	70	12	specific	specific	ADJ
cpe-2361	70	13	side	side	NOUN
cpe-2361	70	14	effects	effect	NOUN
cpe-2361	70	15	reported	report	VERB
cpe-2361	70	16	in	in	ADP
cpe-2361	70	17	the	the	DET
cpe-2361	70	18	media	medium	NOUN
cpe-2361	70	19	and	and	CCONJ
cpe-2361	70	20	control	control	NOUN
cpe-2361	70	21	symptoms	symptom	NOUN
cpe-2361	70	22	not	not	PART
cpe-2361	70	23	in	in	ADP
cpe-2361	70	24	media	medium	NOUN
cpe-2361	70	25	reports	report	NOUN
cpe-2361	70	26	.	.	PUNCT
cpe-2361	71	1	media	medium	NOUN
cpe-2361	71	2	-	-	PUNCT
cpe-2361	71	3	induced	induce	VERB
cpe-2361	71	4	nocebo	nocebo	NOUN
cpe-2361	71	5	response	response	NOUN
cpe-2361	71	6	6	6	NUM
cpe-2361	71	7	clinical	clinical	ADJ
cpe-2361	71	8	psychology	psychology	NOUN
cpe-2361	71	9	in	in	ADP
cpe-2361	71	10	europe	europe	PROPN
cpe-2361	71	11	2019	2019	NUM
cpe-2361	71	12	,	,	PUNCT
cpe-2361	71	13	vol.1(1	vol.1(1	NOUN
cpe-2361	71	14	)	)	PUNCT
cpe-2361	71	15	,	,	PUNCT
cpe-2361	71	16	article	article	NOUN
cpe-2361	71	17	e29642	e29642	VERB
cpe-2361	71	18	https://doi.org/10.32872/cpe.v1i1.29642	https://doi.org/10.32872/cpe.v1i1.29642	PROPN
cpe-2361	71	19	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
cpe-2361	71	20	prior	prior	ADV
cpe-2361	71	21	to	to	ADP
cpe-2361	71	22	the	the	DET
cpe-2361	71	23	media	medium	NOUN
cpe-2361	71	24	coverage	coverage	NOUN
cpe-2361	71	25	,	,	PUNCT
cpe-2361	71	26	suicidal	suicidal	ADJ
cpe-2361	71	27	thoughts	thought	NOUN
cpe-2361	71	28	were	be	AUX
cpe-2361	71	29	reported	report	VERB
cpe-2361	71	30	an	an	DET
cpe-2361	71	31	average	average	NOUN
cpe-2361	71	32	of	of	ADP
cpe-2361	71	33	0.40	0.40	NUM
cpe-2361	71	34	times	time	NOUN
cpe-2361	71	35	(	(	PUNCT
cpe-2361	71	36	sd	sd	NOUN
cpe-2361	71	37	=	=	SYM
cpe-2361	71	38	0.55	0.55	NUM
cpe-2361	71	39	)	)	PUNCT
cpe-2361	71	40	per	per	ADP
cpe-2361	71	41	month	month	NOUN
cpe-2361	71	42	but	but	CCONJ
cpe-2361	71	43	following	follow	VERB
cpe-2361	71	44	the	the	DET
cpe-2361	71	45	media	medium	NOUN
cpe-2361	71	46	report	report	NOUN
cpe-2361	71	47	this	this	PRON
cpe-2361	71	48	significantly	significantly	ADV
cpe-2361	71	49	increased	increase	VERB
cpe-2361	71	50	to	to	ADP
cpe-2361	71	51	7.00	7.00	NUM
cpe-2361	71	52	(	(	PUNCT
cpe-2361	71	53	sd	sd	NOUN
cpe-2361	71	54	=	=	SYM
cpe-2361	71	55	1.41	1.41	NUM
cpe-2361	71	56	)	)	PUNCT
cpe-2361	71	57	across	across	ADP
cpe-2361	71	58	march	march	PROPN
cpe-2361	71	59	and	and	CCONJ
cpe-2361	71	60	may	may	AUX
cpe-2361	71	61	.	.	PUNCT
cpe-2361	72	1	there	there	PRON
cpe-2361	72	2	were	be	VERB
cpe-2361	72	3	no	no	DET
cpe-2361	72	4	adverse	adverse	ADJ
cpe-2361	72	5	event	event	NOUN
cpe-2361	72	6	reports	report	NOUN
cpe-2361	72	7	of	of	ADP
cpe-2361	72	8	nausea	nausea	NOUN
cpe-2361	72	9	before	before	ADP
cpe-2361	72	10	the	the	DET
cpe-2361	72	11	media	media	NOUN
cpe-2361	72	12	coverage	coverage	NOUN
cpe-2361	72	13	,	,	PUNCT
cpe-2361	72	14	but	but	CCONJ
cpe-2361	72	15	reporting	report	VERB
cpe-2361	72	16	significantly	significantly	ADV
cpe-2361	72	17	increased	increase	VERB
cpe-2361	72	18	to	to	ADP
cpe-2361	72	19	2.00	2.00	NUM
cpe-2361	72	20	(	(	PUNCT
cpe-2361	72	21	sd	sd	NOUN
cpe-2361	72	22	=	=	SYM
cpe-2361	72	23	1.41	1.41	NUM
cpe-2361	72	24	)	)	PUNCT
cpe-2361	72	25	during	during	ADP
cpe-2361	72	26	the	the	DET
cpe-2361	72	27	post	post	ADJ
cpe-2361	72	28	-	-	ADJ
cpe-2361	72	29	media	medium	NOUN
cpe-2361	72	30	months	month	NOUN
cpe-2361	72	31	.	.	PUNCT
cpe-2361	73	1	the	the	DET
cpe-2361	73	2	average	average	ADJ
cpe-2361	73	3	rate	rate	NOUN
cpe-2361	73	4	of	of	ADP
cpe-2361	73	5	reporting	reporting	NOUN
cpe-2361	73	6	per	per	ADP
cpe-2361	73	7	month	month	NOUN
cpe-2361	73	8	of	of	ADP
cpe-2361	73	9	headache	headache	NOUN
cpe-2361	73	10	was	be	AUX
cpe-2361	73	11	0.60	0.60	NUM
cpe-2361	73	12	(	(	PUNCT
cpe-2361	73	13	sd	sd	NOUN
cpe-2361	73	14	=	=	NOUN
cpe-2361	73	15	0.55	0.55	NUM
cpe-2361	73	16	)	)	PUNCT
cpe-2361	73	17	before	before	ADP
cpe-2361	73	18	the	the	DET
cpe-2361	73	19	media	medium	NOUN
cpe-2361	73	20	focus	focus	NOUN
cpe-2361	73	21	,	,	PUNCT
cpe-2361	73	22	which	which	PRON
cpe-2361	73	23	significantly	significantly	ADV
cpe-2361	73	24	increased	increase	VERB
cpe-2361	73	25	to	to	ADP
cpe-2361	73	26	4.00	4.00	NUM
cpe-2361	73	27	(	(	PUNCT
cpe-2361	73	28	sd	sd	NOUN
cpe-2361	73	29	=	=	SYM
cpe-2361	73	30	2.83	2.83	NUM
cpe-2361	73	31	)	)	PUNCT
cpe-2361	73	32	reports	report	NOUN
cpe-2361	73	33	in	in	ADP
cpe-2361	73	34	march	march	PROPN
cpe-2361	73	35	and	and	CCONJ
cpe-2361	73	36	may	may	AUX
cpe-2361	73	37	.	.	PUNCT
cpe-2361	74	1	fatigue	fatigue	NOUN
cpe-2361	74	2	was	be	AUX
cpe-2361	74	3	reported	report	VERB
cpe-2361	74	4	0.80	0.80	NUM
cpe-2361	74	5	times	time	NOUN
cpe-2361	74	6	(	(	PUNCT
cpe-2361	74	7	sd	sd	NOUN
cpe-2361	74	8	=	=	SYM
cpe-2361	74	9	1.10	1.10	NUM
cpe-2361	74	10	)	)	PUNCT
cpe-2361	74	11	over	over	ADP
cpe-2361	74	12	the	the	DET
cpe-2361	74	13	five	five	NUM
cpe-2361	74	14	pre	pre	ADJ
cpe-2361	74	15	-	-	ADJ
cpe-2361	74	16	media	medium	NOUN
cpe-2361	74	17	months	month	NOUN
cpe-2361	74	18	but	but	CCONJ
cpe-2361	74	19	this	this	PRON
cpe-2361	74	20	did	do	AUX
cpe-2361	74	21	not	not	PART
cpe-2361	74	22	change	change	VERB
cpe-2361	74	23	significantly	significantly	ADV
cpe-2361	74	24	after	after	ADP
cpe-2361	74	25	the	the	DET
cpe-2361	74	26	media	media	NOUN
cpe-2361	74	27	coverage	coverage	NOUN
cpe-2361	74	28	(	(	PUNCT
cpe-2361	74	29	m	m	NOUN
cpe-2361	74	30	=	=	NOUN
cpe-2361	74	31	4.00	4.00	NUM
cpe-2361	74	32	,	,	PUNCT
cpe-2361	74	33	sd	sd	ADP
cpe-2361	74	34	=	=	NOUN
cpe-2361	74	35	4.24	4.24	NUM
cpe-2361	74	36	)	)	PUNCT
cpe-2361	74	37	.	.	PUNCT
cpe-2361	75	1	similarly	similarly	ADV
cpe-2361	75	2	,	,	PUNCT
cpe-2361	75	3	the	the	DET
cpe-2361	75	4	reporting	reporting	NOUN
cpe-2361	75	5	of	of	ADP
cpe-2361	75	6	anxiety	anxiety	NOUN
cpe-2361	75	7	did	do	AUX
cpe-2361	75	8	not	not	PART
cpe-2361	75	9	change	change	VERB
cpe-2361	75	10	,	,	PUNCT
cpe-2361	75	11	going	go	VERB
cpe-2361	75	12	from	from	ADP
cpe-2361	75	13	an	an	DET
cpe-2361	75	14	average	average	NOUN
cpe-2361	75	15	of	of	ADP
cpe-2361	75	16	0.40	0.40	NUM
cpe-2361	75	17	(	(	PUNCT
cpe-2361	75	18	sd	sd	NOUN
cpe-2361	75	19	=	=	NOUN
cpe-2361	75	20	0.89	0.89	NUM
cpe-2361	75	21	)	)	PUNCT
cpe-2361	75	22	before	before	ADP
cpe-2361	75	23	the	the	DET
cpe-2361	75	24	media	medium	NOUN
cpe-2361	75	25	coverage	coverage	NOUN
cpe-2361	75	26	to	to	ADP
cpe-2361	75	27	1.00	1.00	NUM
cpe-2361	75	28	(	(	PUNCT
cpe-2361	75	29	sd	sd	NOUN
cpe-2361	75	30	=	=	SYM
cpe-2361	75	31	1.41	1.41	NUM
cpe-2361	75	32	)	)	PUNCT
cpe-2361	75	33	after	after	ADP
cpe-2361	75	34	the	the	DET
cpe-2361	75	35	focus	focus	NOUN
cpe-2361	75	36	.	.	PUNCT
cpe-2361	76	1	the	the	DET
cpe-2361	76	2	side	side	NOUN
cpe-2361	76	3	effects	effect	NOUN
cpe-2361	76	4	most	most	ADV
cpe-2361	76	5	frequently	frequently	ADV
cpe-2361	76	6	reported	report	VERB
cpe-2361	76	7	to	to	PART
cpe-2361	76	8	carm	carm	PROPN
cpe-2361	76	9	that	that	PRON
cpe-2361	76	10	were	be	AUX
cpe-2361	76	11	not	not	PART
cpe-2361	76	12	mentioned	mention	VERB
cpe-2361	76	13	in	in	ADP
cpe-2361	76	14	the	the	DET
cpe-2361	76	15	newspaper	newspaper	NOUN
cpe-2361	76	16	article	article	NOUN
cpe-2361	76	17	were	be	AUX
cpe-2361	76	18	investigated	investigate	VERB
cpe-2361	76	19	to	to	PART
cpe-2361	76	20	determine	determine	VERB
cpe-2361	76	21	the	the	DET
cpe-2361	76	22	effect	effect	NOUN
cpe-2361	76	23	on	on	ADP
cpe-2361	76	24	other	other	ADJ
cpe-2361	76	25	adverse	adverse	ADJ
cpe-2361	76	26	events	event	NOUN
cpe-2361	76	27	.	.	PUNCT
cpe-2361	77	1	diz‐	diz‐	PROPN
cpe-2361	77	2	ziness	ziness	PROPN
cpe-2361	77	3	,	,	PUNCT
cpe-2361	77	4	sleep	sleep	NOUN
cpe-2361	77	5	disturbance	disturbance	NOUN
cpe-2361	77	6	,	,	PUNCT
cpe-2361	77	7	irritability	irritability	NOUN
cpe-2361	77	8	and	and	CCONJ
cpe-2361	77	9	fuzzy	fuzzy	ADJ
cpe-2361	77	10	head	head	NOUN
cpe-2361	77	11	were	be	AUX
cpe-2361	77	12	all	all	PRON
cpe-2361	77	13	reported	report	VERB
cpe-2361	77	14	an	an	DET
cpe-2361	77	15	average	average	NOUN
cpe-2361	77	16	of	of	ADP
cpe-2361	77	17	0.20	0.20	NUM
cpe-2361	77	18	times	time	NOUN
cpe-2361	77	19	(	(	PUNCT
cpe-2361	77	20	sd	sd	NOUN
cpe-2361	77	21	=	=	NOUN
cpe-2361	77	22	0.45	0.45	NUM
cpe-2361	77	23	)	)	PUNCT
cpe-2361	77	24	per	per	ADP
cpe-2361	77	25	month	month	NOUN
cpe-2361	77	26	before	before	ADP
cpe-2361	77	27	the	the	DET
cpe-2361	77	28	media	medium	NOUN
cpe-2361	77	29	focus	focus	NOUN
cpe-2361	77	30	.	.	PUNCT
cpe-2361	78	1	following	follow	VERB
cpe-2361	78	2	the	the	DET
cpe-2361	78	3	coverage	coverage	NOUN
cpe-2361	78	4	,	,	PUNCT
cpe-2361	78	5	there	there	PRON
cpe-2361	78	6	was	be	VERB
cpe-2361	78	7	a	a	DET
cpe-2361	78	8	significant	significant	ADJ
cpe-2361	78	9	increase	increase	NOUN
cpe-2361	78	10	in	in	ADP
cpe-2361	78	11	the	the	DET
cpe-2361	78	12	reporting	reporting	NOUN
cpe-2361	78	13	of	of	ADP
cpe-2361	78	14	dizziness	dizziness	NOUN
cpe-2361	78	15	(	(	PUNCT
cpe-2361	78	16	m	m	NOUN
cpe-2361	78	17	=	=	NOUN
cpe-2361	78	18	3.00	3.00	NUM
cpe-2361	78	19	,	,	PUNCT
cpe-2361	78	20	sd	sd	ADP
cpe-2361	78	21	=	=	SYM
cpe-2361	78	22	1.41	1.41	NUM
cpe-2361	78	23	)	)	PUNCT
cpe-2361	78	24	and	and	CCONJ
cpe-2361	78	25	sleep	sleep	NOUN
cpe-2361	78	26	disturb‐	disturb‐	X
cpe-2361	78	27	ance	ance	NOUN
cpe-2361	78	28	(	(	PUNCT
cpe-2361	78	29	m	m	NOUN
cpe-2361	78	30	=	=	NOUN
cpe-2361	78	31	1.00	1.00	NUM
cpe-2361	78	32	,	,	PUNCT
cpe-2361	78	33	sd	sd	ADP
cpe-2361	78	34	=	=	NOUN
cpe-2361	78	35	1.41	1.41	NUM
cpe-2361	78	36	)	)	PUNCT
cpe-2361	78	37	.	.	PUNCT
cpe-2361	79	1	there	there	PRON
cpe-2361	79	2	was	be	VERB
cpe-2361	79	3	no	no	DET
cpe-2361	79	4	change	change	NOUN
cpe-2361	79	5	in	in	ADP
cpe-2361	79	6	the	the	DET
cpe-2361	79	7	post	post	ADJ
cpe-2361	79	8	-	-	ADJ
cpe-2361	79	9	media	media	ADJ
cpe-2361	79	10	rate	rate	NOUN
cpe-2361	79	11	of	of	ADP
cpe-2361	79	12	reporting	report	VERB
cpe-2361	79	13	for	for	ADP
cpe-2361	79	14	irritability	irritability	NOUN
cpe-2361	79	15	and	and	CCONJ
cpe-2361	79	16	fuzzy	fuzzy	ADJ
cpe-2361	79	17	head	head	NOUN
cpe-2361	79	18	(	(	PUNCT
cpe-2361	79	19	both	both	PRON
cpe-2361	79	20	m	m	NOUN
cpe-2361	79	21	=	=	NOUN
cpe-2361	79	22	1.00	1.00	NUM
cpe-2361	79	23	,	,	PUNCT
cpe-2361	79	24	sd	sd	ADP
cpe-2361	79	25	=	=	NOUN
cpe-2361	79	26	1.41	1.41	NUM
cpe-2361	79	27	)	)	PUNCT
cpe-2361	79	28	.	.	PUNCT
cpe-2361	80	1	before	before	ADP
cpe-2361	80	2	the	the	DET
cpe-2361	80	3	media	medium	NOUN
cpe-2361	80	4	articles	article	NOUN
cpe-2361	80	5	,	,	PUNCT
cpe-2361	80	6	drug	drug	NOUN
cpe-2361	80	7	withdrawal	withdrawal	NOUN
cpe-2361	80	8	syndrome	syndrome	NOUN
cpe-2361	80	9	was	be	AUX
cpe-2361	80	10	reported	report	VERB
cpe-2361	80	11	an	an	DET
cpe-2361	80	12	average	average	NOUN
cpe-2361	80	13	of	of	ADP
cpe-2361	80	14	0.40	0.40	NUM
cpe-2361	80	15	times	time	NOUN
cpe-2361	80	16	(	(	PUNCT
cpe-2361	80	17	sd	sd	NOUN
cpe-2361	80	18	=	=	SYM
cpe-2361	80	19	0.55	0.55	NUM
cpe-2361	80	20	)	)	PUNCT
cpe-2361	80	21	a	a	DET
cpe-2361	80	22	month	month	NOUN
cpe-2361	80	23	,	,	PUNCT
cpe-2361	80	24	which	which	PRON
cpe-2361	80	25	did	do	AUX
cpe-2361	80	26	not	not	PART
cpe-2361	80	27	change	change	VERB
cpe-2361	80	28	after	after	ADP
cpe-2361	80	29	the	the	DET
cpe-2361	80	30	media	media	NOUN
cpe-2361	80	31	coverage	coverage	NOUN
cpe-2361	80	32	(	(	PUNCT
cpe-2361	80	33	m	m	NOUN
cpe-2361	80	34	=	=	NOUN
cpe-2361	80	35	2.00	2.00	NUM
cpe-2361	80	36	,	,	PUNCT
cpe-2361	80	37	sd	sd	ADP
cpe-2361	80	38	=	=	NOUN
cpe-2361	80	39	0	0	NUM
cpe-2361	80	40	)	)	PUNCT
cpe-2361	80	41	.	.	PUNCT
cpe-2361	81	1	table	table	NOUN
cpe-2361	81	2	1	1	NUM
cpe-2361	81	3	estimated	estimate	VERB
cpe-2361	81	4	interruption	interruption	NOUN
cpe-2361	81	5	effects	effect	NOUN
cpe-2361	81	6	of	of	ADP
cpe-2361	81	7	the	the	DET
cpe-2361	81	8	newspaper	newspaper	NOUN
cpe-2361	81	9	articles	article	NOUN
cpe-2361	81	10	on	on	ADP
cpe-2361	81	11	carm	carm	PROPN
cpe-2361	81	12	reports	report	NOUN
cpe-2361	81	13	for	for	ADP
cpe-2361	81	14	specifically	specifically	ADV
cpe-2361	81	15	mentioned	mention	VERB
cpe-2361	81	16	side	side	NOUN
cpe-2361	81	17	effects	effect	NOUN
cpe-2361	81	18	and	and	CCONJ
cpe-2361	81	19	control	control	NOUN
cpe-2361	81	20	side	side	NOUN
cpe-2361	81	21	effects	effect	NOUN
cpe-2361	81	22	variable	variable	ADJ
cpe-2361	81	23	interruption	interruption	NOUN
cpe-2361	81	24	effect	effect	NOUN
cpe-2361	81	25	95	95	NUM
cpe-2361	81	26	%	%	NOUN
cpe-2361	81	27	ci	ci	NOUN
cpe-2361	81	28	p	p	ADJ
cpe-2361	81	29	side	side	NOUN
cpe-2361	81	30	effects	effect	NOUN
cpe-2361	81	31	mentioned	mention	VERB
cpe-2361	81	32	in	in	ADP
cpe-2361	81	33	article	article	NOUN
cpe-2361	81	34	suicidal	suicidal	ADJ
cpe-2361	81	35	thoughts	thought	NOUN
cpe-2361	81	36	6.64	6.64	NUM
cpe-2361	82	1	[	[	X
cpe-2361	82	2	4.60	4.60	NUM
cpe-2361	82	3	,	,	PUNCT
cpe-2361	82	4	8.68	8.68	NUM
cpe-2361	82	5	]	]	PUNCT
cpe-2361	82	6	<	<	X
cpe-2361	82	7	.001	.001	NUM
cpe-2361	82	8	nausea	nausea	NOUN
cpe-2361	82	9	1.95	1.95	NUM
cpe-2361	82	10	[	[	X
cpe-2361	82	11	0.62	0.62	NUM
cpe-2361	82	12	,	,	PUNCT
cpe-2361	82	13	3.28	3.28	NUM
cpe-2361	82	14	]	]	PUNCT
cpe-2361	82	15	.029	.029	NUM
cpe-2361	82	16	fatigue	fatigue	NOUN
cpe-2361	82	17	1.63	1.63	NUM
cpe-2361	83	1	[	[	X
cpe-2361	83	2	-1.45	-1.45	X
cpe-2361	83	3	,	,	PUNCT
cpe-2361	83	4	4.71	4.71	NUM
cpe-2361	83	5	]	]	PUNCT
cpe-2361	83	6	.339	.339	NUM
cpe-2361	83	7	headache	headache	NOUN
cpe-2361	83	8	3.62	3.62	NUM
cpe-2361	83	9	[	[	X
cpe-2361	83	10	1.05	1.05	NUM
cpe-2361	83	11	,	,	PUNCT
cpe-2361	83	12	6.19	6.19	NUM
cpe-2361	83	13	]	]	PUNCT
cpe-2361	83	14	.034	.034	NUM
cpe-2361	83	15	anxiety	anxiety	NOUN
cpe-2361	83	16	0.39	0.39	NUM
cpe-2361	83	17	[	[	X
cpe-2361	83	18	-2.34	-2.34	NUM
cpe-2361	83	19	,	,	PUNCT
cpe-2361	83	20	3.11	3.11	NUM
cpe-2361	83	21	]	]	PUNCT
cpe-2361	83	22	.791	.791	NUM
cpe-2361	83	23	side	side	NOUN
cpe-2361	83	24	effects	effect	NOUN
cpe-2361	83	25	not	not	PART
cpe-2361	83	26	mentioned	mention	VERB
cpe-2361	83	27	in	in	ADP
cpe-2361	83	28	article	article	NOUN
cpe-2361	83	29	dizziness	dizziness	VERB
cpe-2361	83	30	2.70	2.70	NUM
cpe-2361	83	31	[	[	X
cpe-2361	83	32	1.72	1.72	NUM
cpe-2361	83	33	,	,	PUNCT
cpe-2361	83	34	4.60	4.60	NUM
cpe-2361	83	35	]	]	PUNCT
cpe-2361	83	36	.002	.002	NUM
cpe-2361	83	37	drug	drug	NOUN
cpe-2361	83	38	withdrawal	withdrawal	NOUN
cpe-2361	83	39	syndrome	syndrome	NOUN
cpe-2361	83	40	2.96	2.96	NUM
cpe-2361	84	1	[	[	X
cpe-2361	84	2	0.53	0.53	NUM
cpe-2361	84	3	,	,	PUNCT
cpe-2361	84	4	5.39	5.39	NUM
cpe-2361	84	5	]	]	PUNCT
cpe-2361	84	6	.055	.055	NUM
cpe-2361	84	7	sleep	sleep	NOUN
cpe-2361	84	8	disturbance	disturbance	NOUN
cpe-2361	84	9	0.75	0.75	NUM
cpe-2361	85	1	[	[	X
cpe-2361	85	2	0.20	0.20	NUM
cpe-2361	85	3	,	,	PUNCT
cpe-2361	85	4	1.30	1.30	NUM
cpe-2361	85	5	]	]	PUNCT
cpe-2361	85	6	.036	.036	NUM
cpe-2361	85	7	irritability	irritability	NOUN
cpe-2361	85	8	0.50	0.50	NUM
cpe-2361	86	1	[	[	X
cpe-2361	86	2	-0.91	-0.91	INTJ
cpe-2361	86	3	,	,	PUNCT
cpe-2361	86	4	1.91	1.91	NUM
cpe-2361	86	5	]	]	PUNCT
cpe-2361	86	6	.507	.507	NUM
cpe-2361	86	7	fuzzy	fuzzy	ADJ
cpe-2361	86	8	head	head	NOUN
cpe-2361	86	9	0.88	0.88	NUM
cpe-2361	86	10	[	[	X
cpe-2361	86	11	-0.30	-0.30	ADJ
cpe-2361	86	12	,	,	PUNCT
cpe-2361	86	13	2.06	2.06	NUM
cpe-2361	86	14	]	]	PUNCT
cpe-2361	86	15	.190	.190	NUM
cpe-2361	86	16	mackrill	mackrill	NOUN
cpe-2361	86	17	,	,	PUNCT
cpe-2361	86	18	gamble	gamble	NOUN
cpe-2361	86	19	,	,	PUNCT
cpe-2361	86	20	bean	bean	NOUN
cpe-2361	86	21	et	et	PROPN
cpe-2361	86	22	al	al	PROPN
cpe-2361	86	23	.	.	PROPN
cpe-2361	86	24	7	7	NUM
cpe-2361	86	25	clinical	clinical	ADJ
cpe-2361	86	26	psychology	psychology	NOUN
cpe-2361	86	27	in	in	ADP
cpe-2361	86	28	europe	europe	PROPN
cpe-2361	86	29	2019	2019	NUM
cpe-2361	86	30	,	,	PUNCT
cpe-2361	86	31	vol.1(1	vol.1(1	NOUN
cpe-2361	86	32	)	)	PUNCT
cpe-2361	86	33	,	,	PUNCT
cpe-2361	86	34	article	article	NOUN
cpe-2361	86	35	e29642	e29642	VERB
cpe-2361	86	36	https://doi.org/10.32872/cpe.v1i1.29642	https://doi.org/10.32872/cpe.v1i1.29642	PROPN
cpe-2361	86	37	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
cpe-2361	86	38	discussion	discussion	NOUN
cpe-2361	86	39	main	main	ADJ
cpe-2361	86	40	findings	finding	NOUN
cpe-2361	86	41	this	this	DET
cpe-2361	86	42	study	study	NOUN
cpe-2361	86	43	found	find	VERB
cpe-2361	86	44	that	that	SCONJ
cpe-2361	86	45	reports	report	NOUN
cpe-2361	86	46	by	by	ADP
cpe-2361	86	47	the	the	DET
cpe-2361	86	48	two	two	NUM
cpe-2361	86	49	largest	large	ADJ
cpe-2361	86	50	new	new	ADJ
cpe-2361	86	51	zealand	zealand	PROPN
cpe-2361	86	52	media	medium	NOUN
cpe-2361	86	53	outlets	outlet	NOUN
cpe-2361	86	54	highlighting	highlight	VERB
cpe-2361	86	55	the	the	DET
cpe-2361	86	56	side	side	NOUN
cpe-2361	86	57	effects	effect	NOUN
cpe-2361	86	58	and	and	CCONJ
cpe-2361	86	59	lack	lack	NOUN
cpe-2361	86	60	of	of	ADP
cpe-2361	86	61	efficacy	efficacy	NOUN
cpe-2361	86	62	of	of	ADP
cpe-2361	86	63	a	a	DET
cpe-2361	86	64	new	new	ADJ
cpe-2361	86	65	generic	generic	ADJ
cpe-2361	86	66	antidepressant	antidepressant	NOUN
cpe-2361	86	67	were	be	AUX
cpe-2361	86	68	followed	follow	VERB
cpe-2361	86	69	by	by	ADP
cpe-2361	86	70	a	a	DET
cpe-2361	86	71	significant	significant	ADJ
cpe-2361	86	72	increase	increase	NOUN
cpe-2361	86	73	in	in	ADP
cpe-2361	86	74	reports	report	NOUN
cpe-2361	86	75	to	to	ADP
cpe-2361	86	76	carm	carm	VERB
cpe-2361	86	77	of	of	ADP
cpe-2361	86	78	similar	similar	ADJ
cpe-2361	86	79	side	side	NOUN
cpe-2361	86	80	effects	effect	NOUN
cpe-2361	86	81	.	.	PUNCT
cpe-2361	87	1	the	the	DET
cpe-2361	87	2	increase	increase	NOUN
cpe-2361	87	3	in	in	ADP
cpe-2361	87	4	reported	report	VERB
cpe-2361	87	5	adverse	adverse	ADJ
cpe-2361	87	6	events	event	NOUN
cpe-2361	87	7	was	be	AUX
cpe-2361	87	8	largely	largely	ADV
cpe-2361	87	9	limited	limit	VERB
cpe-2361	87	10	to	to	ADP
cpe-2361	87	11	those	those	PRON
cpe-2361	87	12	mentioned	mention	VERB
cpe-2361	87	13	in	in	ADP
cpe-2361	87	14	the	the	DET
cpe-2361	87	15	media	medium	NOUN
cpe-2361	87	16	reports	report	NOUN
cpe-2361	87	17	.	.	PUNCT
cpe-2361	88	1	while	while	SCONJ
cpe-2361	88	2	two	two	NUM
cpe-2361	88	3	of	of	ADP
cpe-2361	88	4	the	the	DET
cpe-2361	88	5	control	control	NOUN
cpe-2361	88	6	symptoms	symptom	NOUN
cpe-2361	88	7	,	,	PUNCT
cpe-2361	88	8	dizziness	dizziness	NOUN
cpe-2361	88	9	and	and	CCONJ
cpe-2361	88	10	sleep	sleep	NOUN
cpe-2361	88	11	disturbance	disturbance	NOUN
cpe-2361	88	12	,	,	PUNCT
cpe-2361	88	13	did	do	AUX
cpe-2361	88	14	also	also	ADV
cpe-2361	88	15	increase	increase	VERB
cpe-2361	88	16	,	,	PUNCT
cpe-2361	88	17	this	this	PRON
cpe-2361	88	18	was	be	AUX
cpe-2361	88	19	at	at	ADP
cpe-2361	88	20	a	a	DET
cpe-2361	88	21	lower	low	ADJ
cpe-2361	88	22	rate	rate	NOUN
cpe-2361	88	23	than	than	ADP
cpe-2361	88	24	the	the	DET
cpe-2361	88	25	symptoms	symptom	NOUN
cpe-2361	88	26	mentioned	mention	VERB
cpe-2361	88	27	in	in	ADP
cpe-2361	88	28	the	the	DET
cpe-2361	88	29	media	medium	NOUN
cpe-2361	88	30	stories	story	NOUN
cpe-2361	88	31	.	.	PUNCT
cpe-2361	89	1	the	the	DET
cpe-2361	89	2	results	result	NOUN
cpe-2361	89	3	are	be	AUX
cpe-2361	89	4	consistent	consistent	ADJ
cpe-2361	89	5	with	with	ADP
cpe-2361	89	6	a	a	DET
cpe-2361	89	7	nocebo	nocebo	NOUN
cpe-2361	89	8	response	response	NOUN
cpe-2361	89	9	driven	drive	VERB
cpe-2361	89	10	by	by	ADP
cpe-2361	89	11	the	the	DET
cpe-2361	89	12	media	medium	NOUN
cpe-2361	89	13	coverage	coverage	NOUN
cpe-2361	89	14	,	,	PUNCT
cpe-2361	89	15	whereby	whereby	SCONJ
cpe-2361	89	16	patients	patient	NOUN
cpe-2361	89	17	’	'	PUNCT
cpe-2361	89	18	expectations	expectation	NOUN
cpe-2361	89	19	of	of	ADP
cpe-2361	89	20	particular	particular	ADJ
cpe-2361	89	21	side	side	NOUN
cpe-2361	89	22	effects	effect	NOUN
cpe-2361	89	23	result	result	VERB
cpe-2361	89	24	in	in	ADP
cpe-2361	89	25	an	an	DET
cpe-2361	89	26	increase	increase	NOUN
cpe-2361	89	27	in	in	ADP
cpe-2361	89	28	those	those	DET
cpe-2361	89	29	specific	specific	ADJ
cpe-2361	89	30	symptoms	symptom	NOUN
cpe-2361	89	31	.	.	PUNCT
cpe-2361	90	1	a	a	DET
cpe-2361	90	2	pharmacologi‐	pharmacologi‐	NOUN
cpe-2361	90	3	cal	cal	NOUN
cpe-2361	90	4	explanation	explanation	NOUN
cpe-2361	90	5	for	for	ADP
cpe-2361	90	6	this	this	DET
cpe-2361	90	7	effect	effect	NOUN
cpe-2361	90	8	is	be	AUX
cpe-2361	90	9	very	very	ADV
cpe-2361	90	10	unlikely	unlikely	ADJ
cpe-2361	90	11	as	as	SCONJ
cpe-2361	90	12	the	the	DET
cpe-2361	90	13	side	side	NOUN
cpe-2361	90	14	effects	effect	NOUN
cpe-2361	90	15	highlighted	highlight	VERB
cpe-2361	90	16	in	in	ADP
cpe-2361	90	17	the	the	DET
cpe-2361	90	18	media	medium	NOUN
cpe-2361	90	19	stories	story	NOUN
cpe-2361	90	20	and	and	CCONJ
cpe-2361	90	21	the	the	DET
cpe-2361	90	22	control	control	NOUN
cpe-2361	90	23	side	side	NOUN
cpe-2361	90	24	effects	effect	NOUN
cpe-2361	90	25	were	be	AUX
cpe-2361	90	26	mentioned	mention	VERB
cpe-2361	90	27	at	at	ADP
cpe-2361	90	28	a	a	DET
cpe-2361	90	29	similar	similar	ADJ
cpe-2361	90	30	rate	rate	NOUN
cpe-2361	90	31	prior	prior	ADV
cpe-2361	90	32	to	to	ADP
cpe-2361	90	33	the	the	DET
cpe-2361	90	34	media	medium	NOUN
cpe-2361	90	35	coverage	coverage	NOUN
cpe-2361	90	36	.	.	PUNCT
cpe-2361	91	1	following	follow	VERB
cpe-2361	91	2	the	the	DET
cpe-2361	91	3	media	medium	NOUN
cpe-2361	91	4	coverage	coverage	NOUN
cpe-2361	91	5	,	,	PUNCT
cpe-2361	91	6	it	it	PRON
cpe-2361	91	7	was	be	AUX
cpe-2361	91	8	those	those	DET
cpe-2361	91	9	symptoms	symptom	NOUN
cpe-2361	91	10	mentioned	mention	VERB
cpe-2361	91	11	in	in	ADP
cpe-2361	91	12	the	the	DET
cpe-2361	91	13	media	medium	NOUN
cpe-2361	91	14	stories	story	NOUN
cpe-2361	91	15	that	that	PRON
cpe-2361	91	16	were	be	AUX
cpe-2361	91	17	mostly	mostly	ADV
cpe-2361	91	18	affected	affect	VERB
cpe-2361	91	19	.	.	PUNCT
cpe-2361	92	1	a	a	DET
cpe-2361	92	2	particular	particular	ADJ
cpe-2361	92	3	concern	concern	NOUN
cpe-2361	92	4	in	in	ADP
cpe-2361	92	5	the	the	DET
cpe-2361	92	6	findings	finding	NOUN
cpe-2361	92	7	is	be	AUX
cpe-2361	92	8	the	the	DET
cpe-2361	92	9	mirroring	mirroring	NOUN
cpe-2361	92	10	of	of	ADP
cpe-2361	92	11	reports	report	NOUN
cpe-2361	92	12	of	of	ADP
cpe-2361	92	13	decreased	decrease	VERB
cpe-2361	92	14	therapeu‐	therapeu‐	PROPN
cpe-2361	92	15	tic	tic	PROPN
cpe-2361	92	16	efficacy	efficacy	NOUN
cpe-2361	92	17	,	,	PUNCT
cpe-2361	92	18	which	which	PRON
cpe-2361	92	19	could	could	AUX
cpe-2361	92	20	potentially	potentially	ADV
cpe-2361	92	21	drive	drive	VERB
cpe-2361	92	22	non	non	ADJ
cpe-2361	92	23	-	-	NOUN
cpe-2361	92	24	persistence	persistence	NOUN
cpe-2361	92	25	with	with	ADP
cpe-2361	92	26	antidepressant	antidepressant	ADJ
cpe-2361	92	27	therapy	therapy	NOUN
cpe-2361	92	28	.	.	PUNCT
cpe-2361	93	1	also	also	ADV
cpe-2361	93	2	of	of	ADP
cpe-2361	93	3	public	public	ADJ
cpe-2361	93	4	health	health	NOUN
cpe-2361	93	5	relevance	relevance	NOUN
cpe-2361	93	6	is	be	AUX
cpe-2361	93	7	the	the	DET
cpe-2361	93	8	increase	increase	NOUN
cpe-2361	93	9	in	in	ADP
cpe-2361	93	10	reports	report	NOUN
cpe-2361	93	11	of	of	ADP
cpe-2361	93	12	suicidal	suicidal	ADJ
cpe-2361	93	13	ideation	ideation	NOUN
cpe-2361	93	14	which	which	PRON
cpe-2361	93	15	is	be	AUX
cpe-2361	93	16	likely	likely	ADJ
cpe-2361	93	17	due	due	ADP
cpe-2361	93	18	to	to	ADP
cpe-2361	93	19	the	the	DET
cpe-2361	93	20	highlighting	highlighting	NOUN
cpe-2361	93	21	of	of	ADP
cpe-2361	93	22	suicidal	suicidal	ADJ
cpe-2361	93	23	thoughts	thought	NOUN
cpe-2361	93	24	and	and	CCONJ
cpe-2361	93	25	behaviour	behaviour	NOUN
cpe-2361	93	26	by	by	ADP
cpe-2361	93	27	patients	patient	NOUN
cpe-2361	93	28	discussed	discuss	VERB
cpe-2361	93	29	in	in	ADP
cpe-2361	93	30	the	the	DET
cpe-2361	93	31	media	medium	NOUN
cpe-2361	93	32	stories	story	NOUN
cpe-2361	93	33	in	in	ADP
cpe-2361	93	34	february	february	PROPN
cpe-2361	93	35	and	and	CCONJ
cpe-2361	93	36	again	again	ADV
cpe-2361	93	37	in	in	ADP
cpe-2361	93	38	april	april	PROPN
cpe-2361	93	39	.	.	PUNCT
cpe-2361	94	1	comparison	comparison	NOUN
cpe-2361	94	2	with	with	ADP
cpe-2361	94	3	other	other	ADJ
cpe-2361	94	4	studies	study	NOUN
cpe-2361	94	5	previous	previous	ADJ
cpe-2361	94	6	studies	study	NOUN
cpe-2361	94	7	have	have	AUX
cpe-2361	94	8	shown	show	VERB
cpe-2361	94	9	that	that	SCONJ
cpe-2361	94	10	information	information	NOUN
cpe-2361	94	11	about	about	ADP
cpe-2361	94	12	likely	likely	ADJ
cpe-2361	94	13	side	side	NOUN
cpe-2361	94	14	effects	effect	NOUN
cpe-2361	94	15	from	from	ADP
cpe-2361	94	16	medication	medication	NOUN
cpe-2361	94	17	can	can	AUX
cpe-2361	94	18	result	result	VERB
cpe-2361	94	19	in	in	ADP
cpe-2361	94	20	a	a	DET
cpe-2361	94	21	significant	significant	ADJ
cpe-2361	94	22	increase	increase	NOUN
cpe-2361	94	23	in	in	ADP
cpe-2361	94	24	reports	report	NOUN
cpe-2361	94	25	of	of	ADP
cpe-2361	94	26	those	those	DET
cpe-2361	94	27	specific	specific	ADJ
cpe-2361	94	28	effects	effect	NOUN
cpe-2361	94	29	.	.	PUNCT
cpe-2361	95	1	patients	patient	NOUN
cpe-2361	95	2	who	who	PRON
cpe-2361	95	3	were	be	AUX
cpe-2361	95	4	told	tell	VERB
cpe-2361	95	5	about	about	ADP
cpe-2361	95	6	sexual	sexual	ADJ
cpe-2361	95	7	side	side	NOUN
cpe-2361	95	8	effects	effect	NOUN
cpe-2361	95	9	when	when	SCONJ
cpe-2361	95	10	starting	start	VERB
cpe-2361	95	11	finasteride	finasteride	ADJ
cpe-2361	95	12	or	or	CCONJ
cpe-2361	95	13	beta	beta	NOUN
cpe-2361	95	14	-	-	PUNCT
cpe-2361	95	15	blocker	blocker	NOUN
cpe-2361	95	16	medication	medication	NOUN
cpe-2361	95	17	were	be	AUX
cpe-2361	95	18	significantly	significantly	ADV
cpe-2361	95	19	more	more	ADV
cpe-2361	95	20	likely	likely	ADJ
cpe-2361	95	21	to	to	PART
cpe-2361	95	22	report	report	VERB
cpe-2361	95	23	these	these	DET
cpe-2361	95	24	symptoms	symptom	NOUN
cpe-2361	95	25	than	than	ADP
cpe-2361	95	26	patients	patient	NOUN
cpe-2361	95	27	who	who	PRON
cpe-2361	95	28	were	be	AUX
cpe-2361	95	29	not	not	PART
cpe-2361	95	30	told	tell	VERB
cpe-2361	95	31	of	of	ADP
cpe-2361	95	32	these	these	DET
cpe-2361	95	33	side	side	NOUN
cpe-2361	95	34	effects	effect	NOUN
cpe-2361	95	35	(	(	PUNCT
cpe-2361	95	36	cocco	cocco	PROPN
cpe-2361	95	37	,	,	PUNCT
cpe-2361	95	38	2009	2009	NUM
cpe-2361	95	39	;	;	PUNCT
cpe-2361	95	40	mondaini	mondaini	PROPN
cpe-2361	95	41	et	et	PROPN
cpe-2361	95	42	al	al	PROPN
cpe-2361	95	43	.	.	PROPN
cpe-2361	95	44	,	,	PUNCT
cpe-2361	95	45	2007	2007	NUM
cpe-2361	95	46	)	)	PUNCT
cpe-2361	95	47	.	.	PUNCT
cpe-2361	96	1	similarly	similarly	ADV
cpe-2361	96	2	,	,	PUNCT
cpe-2361	96	3	in	in	ADP
cpe-2361	96	4	the	the	DET
cpe-2361	96	5	context	context	NOUN
cpe-2361	96	6	of	of	ADP
cpe-2361	96	7	a	a	DET
cpe-2361	96	8	clini‐	clini‐	NOUN
cpe-2361	96	9	cal	cal	NOUN
cpe-2361	96	10	trial	trial	NOUN
cpe-2361	96	11	,	,	PUNCT
cpe-2361	96	12	those	those	DET
cpe-2361	96	13	patients	patient	NOUN
cpe-2361	96	14	warned	warn	VERB
cpe-2361	96	15	of	of	ADP
cpe-2361	96	16	gastrointestinal	gastrointestinal	ADJ
cpe-2361	96	17	side	side	NOUN
cpe-2361	96	18	effects	effect	NOUN
cpe-2361	96	19	in	in	ADP
cpe-2361	96	20	one	one	NUM
cpe-2361	96	21	research	research	NOUN
cpe-2361	96	22	site	site	NOUN
cpe-2361	96	23	were	be	AUX
cpe-2361	96	24	more	more	ADV
cpe-2361	96	25	likely	likely	ADJ
cpe-2361	96	26	to	to	PART
cpe-2361	96	27	complain	complain	VERB
cpe-2361	96	28	of	of	ADP
cpe-2361	96	29	this	this	PRON
cpe-2361	96	30	as	as	ADP
cpe-2361	96	31	a	a	DET
cpe-2361	96	32	side	side	NOUN
cpe-2361	96	33	effect	effect	NOUN
cpe-2361	96	34	and	and	CCONJ
cpe-2361	96	35	withdraw	withdraw	VERB
cpe-2361	96	36	from	from	ADP
cpe-2361	96	37	the	the	DET
cpe-2361	96	38	study	study	NOUN
cpe-2361	96	39	due	due	ADP
cpe-2361	96	40	to	to	ADP
cpe-2361	96	41	these	these	DET
cpe-2361	96	42	complaints	complaint	NOUN
cpe-2361	96	43	(	(	PUNCT
cpe-2361	96	44	myers	myers	PROPN
cpe-2361	96	45	,	,	PUNCT
cpe-2361	96	46	cairns	cairns	PROPN
cpe-2361	96	47	,	,	PUNCT
cpe-2361	96	48	&	&	CCONJ
cpe-2361	96	49	singer	singer	NOUN
cpe-2361	96	50	,	,	PUNCT
cpe-2361	96	51	1987	1987	NUM
cpe-2361	96	52	)	)	PUNCT
cpe-2361	96	53	.	.	PUNCT
cpe-2361	97	1	seeing	see	VERB
cpe-2361	97	2	another	another	DET
cpe-2361	97	3	person	person	NOUN
cpe-2361	97	4	in	in	ADP
cpe-2361	97	5	a	a	DET
cpe-2361	97	6	media	medium	NOUN
cpe-2361	97	7	story	story	NOUN
cpe-2361	97	8	report	report	NOUN
cpe-2361	97	9	side	side	NOUN
cpe-2361	97	10	effects	effect	NOUN
cpe-2361	97	11	from	from	ADP
cpe-2361	97	12	a	a	DET
cpe-2361	97	13	medication	medication	NOUN
cpe-2361	97	14	can	can	AUX
cpe-2361	97	15	also	also	ADV
cpe-2361	97	16	increase	increase	VERB
cpe-2361	97	17	the	the	DET
cpe-2361	97	18	expectations	expectation	NOUN
cpe-2361	97	19	of	of	ADP
cpe-2361	97	20	a	a	DET
cpe-2361	97	21	similar	similar	ADJ
cpe-2361	97	22	response	response	NOUN
cpe-2361	97	23	(	(	PUNCT
cpe-2361	97	24	faasse	faasse	NOUN
cpe-2361	97	25	&	&	CCONJ
cpe-2361	97	26	petrie	petrie	NOUN
cpe-2361	97	27	,	,	PUNCT
cpe-2361	97	28	2016	2016	NUM
cpe-2361	97	29	)	)	PUNCT
cpe-2361	97	30	.	.	PUNCT
cpe-2361	98	1	in	in	ADP
cpe-2361	98	2	an	an	DET
cpe-2361	98	3	earlier	early	ADJ
cpe-2361	98	4	study	study	NOUN
cpe-2361	98	5	by	by	ADP
cpe-2361	98	6	our	our	PRON
cpe-2361	98	7	group	group	NOUN
cpe-2361	98	8	,	,	PUNCT
cpe-2361	98	9	media	medium	NOUN
cpe-2361	98	10	reporting	reporting	NOUN
cpe-2361	98	11	on	on	ADP
cpe-2361	98	12	a	a	DET
cpe-2361	98	13	change	change	NOUN
cpe-2361	98	14	in	in	ADP
cpe-2361	98	15	the	the	DET
cpe-2361	98	16	formulation	formulation	NOUN
cpe-2361	98	17	and	and	CCONJ
cpe-2361	98	18	appearance	appearance	NOUN
cpe-2361	98	19	of	of	ADP
cpe-2361	98	20	thyro‐	thyro‐	PROPN
cpe-2361	98	21	xine	xine	PROPN
cpe-2361	98	22	replacement	replacement	NOUN
cpe-2361	98	23	therapy	therapy	NOUN
cpe-2361	98	24	that	that	PRON
cpe-2361	98	25	led	lead	VERB
cpe-2361	98	26	to	to	ADP
cpe-2361	98	27	a	a	DET
cpe-2361	98	28	dramatic	dramatic	ADJ
cpe-2361	98	29	increase	increase	NOUN
cpe-2361	98	30	in	in	ADP
cpe-2361	98	31	adverse	adverse	ADJ
cpe-2361	98	32	reaction	reaction	NOUN
cpe-2361	98	33	reports	report	NOUN
cpe-2361	98	34	(	(	PUNCT
cpe-2361	98	35	faasse	faasse	ADJ
cpe-2361	98	36	,	,	PUNCT
cpe-2361	98	37	cundy	cundy	NOUN
cpe-2361	98	38	,	,	PUNCT
cpe-2361	98	39	&	&	CCONJ
cpe-2361	98	40	petrie	petrie	NOUN
cpe-2361	98	41	,	,	PUNCT
cpe-2361	98	42	2009	2009	NUM
cpe-2361	98	43	)	)	PUNCT
cpe-2361	98	44	,	,	PUNCT
cpe-2361	98	45	found	find	VERB
cpe-2361	98	46	side	side	ADJ
cpe-2361	98	47	effect	effect	NOUN
cpe-2361	98	48	complaints	complaint	NOUN
cpe-2361	98	49	increased	increase	VERB
cpe-2361	98	50	significantly	significantly	ADV
cpe-2361	98	51	after	after	ADP
cpe-2361	98	52	television	television	NOUN
cpe-2361	98	53	news	news	NOUN
cpe-2361	98	54	stories	story	NOUN
cpe-2361	98	55	.	.	PUNCT
cpe-2361	99	1	the	the	DET
cpe-2361	99	2	largest	large	ADJ
cpe-2361	99	3	increases	increase	NOUN
cpe-2361	99	4	concerned	concerned	ADJ
cpe-2361	99	5	symptoms	symptom	NOUN
cpe-2361	99	6	mentioned	mention	VERB
cpe-2361	99	7	in	in	ADP
cpe-2361	99	8	the	the	DET
cpe-2361	99	9	me‐	me‐	PROPN
cpe-2361	99	10	dia	dia	PROPN
cpe-2361	99	11	reports	report	VERB
cpe-2361	99	12	.	.	PUNCT
cpe-2361	100	1	this	this	PRON
cpe-2361	100	2	was	be	AUX
cpe-2361	100	3	strongest	strong	ADJ
cpe-2361	100	4	for	for	ADP
cpe-2361	100	5	the	the	DET
cpe-2361	100	6	initial	initial	ADJ
cpe-2361	100	7	coverage	coverage	NOUN
cpe-2361	100	8	and	and	CCONJ
cpe-2361	100	9	weakened	weaken	VERB
cpe-2361	100	10	with	with	ADP
cpe-2361	100	11	successive	successive	ADJ
cpe-2361	100	12	sto‐	sto‐	PROPN
cpe-2361	100	13	ries	rie	NOUN
cpe-2361	100	14	(	(	PUNCT
cpe-2361	100	15	faasse	faasse	ADJ
cpe-2361	100	16	,	,	PUNCT
cpe-2361	100	17	gamble	gamble	NOUN
cpe-2361	100	18	,	,	PUNCT
cpe-2361	100	19	cundy	cundy	NOUN
cpe-2361	100	20	,	,	PUNCT
cpe-2361	100	21	&	&	CCONJ
cpe-2361	100	22	petrie	petrie	NOUN
cpe-2361	100	23	,	,	PUNCT
cpe-2361	100	24	2012	2012	NUM
cpe-2361	100	25	)	)	PUNCT
cpe-2361	100	26	.	.	PUNCT
cpe-2361	101	1	this	this	PRON
cpe-2361	101	2	occurred	occur	VERB
cpe-2361	101	3	in	in	ADP
cpe-2361	101	4	the	the	DET
cpe-2361	101	5	current	current	ADJ
cpe-2361	101	6	study	study	NOUN
cpe-2361	101	7	,	,	PUNCT
cpe-2361	101	8	as	as	SCONJ
cpe-2361	101	9	the	the	DET
cpe-2361	101	10	may	may	AUX
cpe-2361	101	11	adverse	adverse	ADJ
cpe-2361	101	12	event	event	NOUN
cpe-2361	101	13	reporting	reporting	NOUN
cpe-2361	101	14	was	be	AUX
cpe-2361	101	15	not	not	PART
cpe-2361	101	16	as	as	ADV
cpe-2361	101	17	large	large	ADJ
cpe-2361	101	18	as	as	ADP
cpe-2361	101	19	in	in	ADP
cpe-2361	101	20	march	march	PROPN
cpe-2361	101	21	.	.	PUNCT
cpe-2361	102	1	research	research	NOUN
cpe-2361	102	2	on	on	ADP
cpe-2361	102	3	side	side	NOUN
cpe-2361	102	4	effects	effect	NOUN
cpe-2361	102	5	from	from	ADP
cpe-2361	102	6	media	medium	NOUN
cpe-2361	102	7	-	-	PUNCT
cpe-2361	102	8	induced	induce	VERB
cpe-2361	102	9	nocebo	nocebo	NOUN
cpe-2361	102	10	response	response	NOUN
cpe-2361	102	11	8	8	NUM
cpe-2361	102	12	clinical	clinical	ADJ
cpe-2361	102	13	psychology	psychology	NOUN
cpe-2361	102	14	in	in	ADP
cpe-2361	102	15	europe	europe	PROPN
cpe-2361	102	16	2019	2019	NUM
cpe-2361	102	17	,	,	PUNCT
cpe-2361	102	18	vol.1(1	vol.1(1	NOUN
cpe-2361	102	19	)	)	PUNCT
cpe-2361	102	20	,	,	PUNCT
cpe-2361	102	21	article	article	NOUN
cpe-2361	102	22	e29642	e29642	VERB
cpe-2361	102	23	https://doi.org/10.32872/cpe.v1i1.29642	https://doi.org/10.32872/cpe.v1i1.29642	PROPN
cpe-2361	102	24	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
cpe-2361	102	25	electromagnetic	electromagnetic	ADJ
cpe-2361	102	26	fields	field	NOUN
cpe-2361	102	27	has	have	AUX
cpe-2361	102	28	also	also	ADV
cpe-2361	102	29	shown	show	VERB
cpe-2361	102	30	that	that	SCONJ
cpe-2361	102	31	alarmist	alarmist	ADJ
cpe-2361	102	32	media	medium	NOUN
cpe-2361	102	33	reports	report	NOUN
cpe-2361	102	34	,	,	PUNCT
cpe-2361	102	35	which	which	PRON
cpe-2361	102	36	emphasise	emphasise	VERB
cpe-2361	102	37	ad‐	ad‐	ADJ
cpe-2361	102	38	verse	verse	NOUN
cpe-2361	102	39	effects	effect	NOUN
cpe-2361	102	40	,	,	PUNCT
cpe-2361	102	41	exacerbate	exacerbate	VERB
cpe-2361	102	42	the	the	DET
cpe-2361	102	43	nocebo	nocebo	NOUN
cpe-2361	102	44	effect	effect	NOUN
cpe-2361	102	45	and	and	CCONJ
cpe-2361	102	46	lead	lead	VERB
cpe-2361	102	47	to	to	ADP
cpe-2361	102	48	greater	great	ADJ
cpe-2361	102	49	symptom	symptom	NOUN
cpe-2361	102	50	reporting	reporting	NOUN
cpe-2361	102	51	and	and	CCONJ
cpe-2361	102	52	a	a	DET
cpe-2361	102	53	perceived	perceive	VERB
cpe-2361	102	54	sensitivity	sensitivity	NOUN
cpe-2361	102	55	to	to	ADP
cpe-2361	102	56	the	the	DET
cpe-2361	102	57	supposedly	supposedly	ADV
cpe-2361	102	58	harmful	harmful	ADJ
cpe-2361	102	59	substance	substance	NOUN
cpe-2361	102	60	(	(	PUNCT
cpe-2361	102	61	verrender	verrender	NOUN
cpe-2361	102	62	,	,	PUNCT
cpe-2361	102	63	loughran	loughran	NOUN
cpe-2361	102	64	,	,	PUNCT
cpe-2361	102	65	dalecki	dalecki	PROPN
cpe-2361	102	66	,	,	PUNCT
cpe-2361	102	67	freudenstein	freudenstein	ADJ
cpe-2361	102	68	,	,	PUNCT
cpe-2361	102	69	&	&	CCONJ
cpe-2361	102	70	croft	croft	PROPN
cpe-2361	102	71	,	,	PUNCT
cpe-2361	102	72	2018	2018	NUM
cpe-2361	102	73	;	;	PUNCT
cpe-2361	102	74	witthöft	witthöft	PROPN
cpe-2361	102	75	&	&	CCONJ
cpe-2361	102	76	rubin	rubin	PROPN
cpe-2361	102	77	,	,	PUNCT
cpe-2361	102	78	2013	2013	NUM
cpe-2361	102	79	)	)	PUNCT
cpe-2361	102	80	.	.	PUNCT
cpe-2361	103	1	switches	switch	NOUN
cpe-2361	103	2	to	to	ADP
cpe-2361	103	3	generic	generic	ADJ
cpe-2361	103	4	medicine	medicine	NOUN
cpe-2361	103	5	provide	provide	VERB
cpe-2361	103	6	potential	potential	NOUN
cpe-2361	103	7	for	for	ADP
cpe-2361	103	8	a	a	DET
cpe-2361	103	9	nocebo	nocebo	NOUN
cpe-2361	103	10	response	response	NOUN
cpe-2361	103	11	to	to	PART
cpe-2361	103	12	be	be	AUX
cpe-2361	103	13	strongly	strongly	ADV
cpe-2361	103	14	influenced	influence	VERB
cpe-2361	103	15	by	by	ADP
cpe-2361	103	16	negative	negative	ADJ
cpe-2361	103	17	media	medium	NOUN
cpe-2361	103	18	coverage	coverage	NOUN
cpe-2361	103	19	as	as	ADP
cpe-2361	103	20	non	non	ADJ
cpe-2361	103	21	-	-	NOUN
cpe-2361	103	22	adherence	adherence	ADJ
cpe-2361	103	23	,	,	PUNCT
cpe-2361	103	24	patient	patient	ADJ
cpe-2361	103	25	reports	report	NOUN
cpe-2361	103	26	of	of	ADP
cpe-2361	103	27	decreased	decrease	VERB
cpe-2361	103	28	ef‐	ef‐	NOUN
cpe-2361	103	29	ficacy	ficacy	NOUN
cpe-2361	103	30	and	and	CCONJ
cpe-2361	103	31	increased	increase	VERB
cpe-2361	103	32	side	side	NOUN
cpe-2361	103	33	effects	effect	NOUN
cpe-2361	103	34	are	be	AUX
cpe-2361	103	35	more	more	ADV
cpe-2361	103	36	common	common	ADJ
cpe-2361	103	37	following	follow	VERB
cpe-2361	103	38	switches	switch	NOUN
cpe-2361	103	39	(	(	PUNCT
cpe-2361	103	40	boone	boone	PROPN
cpe-2361	103	41	et	et	PROPN
cpe-2361	103	42	al	al	PROPN
cpe-2361	103	43	.	.	PROPN
cpe-2361	103	44	,	,	PUNCT
cpe-2361	103	45	2018	2018	NUM
cpe-2361	103	46	;	;	PUNCT
cpe-2361	103	47	weissenfeld	weissenfeld	VERB
cpe-2361	103	48	,	,	PUNCT
cpe-2361	103	49	stock	stock	NOUN
cpe-2361	103	50	,	,	PUNCT
cpe-2361	103	51	lüngen	lüngen	X
cpe-2361	103	52	,	,	PUNCT
cpe-2361	103	53	&	&	CCONJ
cpe-2361	103	54	gerber	gerber	PROPN
cpe-2361	103	55	,	,	PUNCT
cpe-2361	103	56	2010	2010	NUM
cpe-2361	103	57	)	)	PUNCT
cpe-2361	103	58	.	.	PUNCT
cpe-2361	104	1	a	a	DET
cpe-2361	104	2	nocebo	nocebo	NOUN
cpe-2361	104	3	response	response	NOUN
cpe-2361	104	4	induced	induce	VERB
cpe-2361	104	5	through	through	ADP
cpe-2361	104	6	media	medium	NOUN
cpe-2361	104	7	reports	report	NOUN
cpe-2361	104	8	can	can	AUX
cpe-2361	104	9	have	have	VERB
cpe-2361	104	10	a	a	DET
cpe-2361	104	11	detrimental	detrimental	ADJ
cpe-2361	104	12	effect	effect	NOUN
cpe-2361	104	13	.	.	PUNCT
cpe-2361	105	1	recent	recent	ADJ
cpe-2361	105	2	work	work	NOUN
cpe-2361	105	3	has	have	AUX
cpe-2361	105	4	shown	show	VERB
cpe-2361	105	5	that	that	SCONJ
cpe-2361	105	6	negative	negative	ADJ
cpe-2361	105	7	stories	story	NOUN
cpe-2361	105	8	in	in	ADP
cpe-2361	105	9	the	the	DET
cpe-2361	105	10	media	medium	NOUN
cpe-2361	105	11	about	about	ADP
cpe-2361	105	12	statins	statin	NOUN
cpe-2361	105	13	have	have	AUX
cpe-2361	105	14	led	lead	VERB
cpe-2361	105	15	to	to	ADP
cpe-2361	105	16	an	an	DET
cpe-2361	105	17	increase	increase	NOUN
cpe-2361	105	18	in	in	ADP
cpe-2361	105	19	the	the	DET
cpe-2361	105	20	rate	rate	NOUN
cpe-2361	105	21	of	of	ADP
cpe-2361	105	22	patients	patient	NOUN
cpe-2361	105	23	discontinuing	discontinue	VERB
cpe-2361	105	24	statins	statin	NOUN
cpe-2361	105	25	in	in	ADP
cpe-2361	105	26	the	the	DET
cpe-2361	105	27	united	united	ADJ
cpe-2361	105	28	kingdom	kingdom	PROPN
cpe-2361	105	29	(	(	PUNCT
cpe-2361	105	30	matthews	matthews	PROPN
cpe-2361	105	31	et	et	PROPN
cpe-2361	105	32	al	al	PROPN
cpe-2361	105	33	.	.	PROPN
cpe-2361	105	34	,	,	PUNCT
cpe-2361	105	35	2016	2016	NUM
cpe-2361	105	36	)	)	PUNCT
cpe-2361	105	37	and	and	CCONJ
cpe-2361	105	38	this	this	DET
cpe-2361	105	39	early	early	ADJ
cpe-2361	105	40	discontinuation	discontinuation	NOUN
cpe-2361	105	41	has	have	AUX
cpe-2361	105	42	been	be	AUX
cpe-2361	105	43	linked	link	VERB
cpe-2361	105	44	to	to	ADP
cpe-2361	105	45	an	an	DET
cpe-2361	105	46	increase	increase	NOUN
cpe-2361	105	47	in	in	ADP
cpe-2361	105	48	myocardial	myocardial	ADJ
cpe-2361	105	49	infarction	infarction	NOUN
cpe-2361	105	50	and	and	CCONJ
cpe-2361	105	51	death	death	NOUN
cpe-2361	105	52	from	from	ADP
cpe-2361	105	53	cardiovascular	cardiovascular	ADJ
cpe-2361	105	54	disease	disease	NOUN
cpe-2361	105	55	in	in	ADP
cpe-2361	105	56	denmark	denmark	PROPN
cpe-2361	105	57	(	(	PUNCT
cpe-2361	105	58	nielsen	nielsen	PROPN
cpe-2361	105	59	&	&	CCONJ
cpe-2361	105	60	nordestgaard	nordestgaard	PROPN
cpe-2361	105	61	,	,	PUNCT
cpe-2361	105	62	2016	2016	NUM
cpe-2361	105	63	)	)	PUNCT
cpe-2361	105	64	.	.	PUNCT
cpe-2361	106	1	the	the	DET
cpe-2361	106	2	likely	likely	ADJ
cpe-2361	106	3	mechanisms	mechanism	NOUN
cpe-2361	106	4	of	of	ADP
cpe-2361	106	5	the	the	DET
cpe-2361	106	6	nocebo	nocebo	NOUN
cpe-2361	106	7	response	response	NOUN
cpe-2361	106	8	found	find	VERB
cpe-2361	106	9	in	in	ADP
cpe-2361	106	10	this	this	DET
cpe-2361	106	11	study	study	NOUN
cpe-2361	106	12	are	be	AUX
cpe-2361	106	13	social	social	ADJ
cpe-2361	106	14	trans‐	trans‐	X
cpe-2361	106	15	mission	mission	NOUN
cpe-2361	106	16	and	and	CCONJ
cpe-2361	106	17	the	the	DET
cpe-2361	106	18	misattribution	misattribution	NOUN
cpe-2361	106	19	of	of	ADP
cpe-2361	106	20	common	common	ADJ
cpe-2361	106	21	symptoms	symptom	NOUN
cpe-2361	106	22	to	to	ADP
cpe-2361	106	23	the	the	DET
cpe-2361	106	24	effects	effect	NOUN
cpe-2361	106	25	of	of	ADP
cpe-2361	106	26	the	the	DET
cpe-2361	106	27	new	new	ADJ
cpe-2361	106	28	medica‐	medica‐	PROPN
cpe-2361	106	29	tion	tion	NOUN
cpe-2361	106	30	(	(	PUNCT
cpe-2361	106	31	petrie	petrie	NOUN
cpe-2361	106	32	&	&	CCONJ
cpe-2361	106	33	rief	rief	NOUN
cpe-2361	106	34	,	,	PUNCT
cpe-2361	106	35	2019	2019	NUM
cpe-2361	106	36	)	)	PUNCT
cpe-2361	106	37	.	.	PUNCT
cpe-2361	107	1	previous	previous	ADJ
cpe-2361	107	2	research	research	NOUN
cpe-2361	107	3	has	have	AUX
cpe-2361	107	4	found	find	VERB
cpe-2361	107	5	that	that	SCONJ
cpe-2361	107	6	seeing	see	VERB
cpe-2361	107	7	another	another	DET
cpe-2361	107	8	person	person	NOUN
cpe-2361	107	9	report	report	VERB
cpe-2361	107	10	side	side	NOUN
cpe-2361	107	11	effects	effect	NOUN
cpe-2361	107	12	after	after	ADP
cpe-2361	107	13	receiving	receive	VERB
cpe-2361	107	14	a	a	DET
cpe-2361	107	15	treatment	treatment	NOUN
cpe-2361	107	16	increases	increase	VERB
cpe-2361	107	17	the	the	DET
cpe-2361	107	18	likelihood	likelihood	NOUN
cpe-2361	107	19	of	of	ADP
cpe-2361	107	20	side	side	NOUN
cpe-2361	107	21	effects	effect	NOUN
cpe-2361	107	22	’	'	PUNCT
cpe-2361	107	23	complaints	complaint	NOUN
cpe-2361	107	24	after	after	ADP
cpe-2361	107	25	receiving	receive	VERB
cpe-2361	107	26	the	the	DET
cpe-2361	107	27	same	same	ADJ
cpe-2361	107	28	treatment	treatment	NOUN
cpe-2361	107	29	,	,	PUNCT
cpe-2361	107	30	especially	especially	ADV
cpe-2361	107	31	if	if	SCONJ
cpe-2361	107	32	the	the	DET
cpe-2361	107	33	observer	observer	NOUN
cpe-2361	107	34	can	can	AUX
cpe-2361	107	35	empathise	empathise	VERB
cpe-2361	107	36	with	with	ADP
cpe-2361	107	37	the	the	DET
cpe-2361	107	38	per‐	per‐	PUNCT
cpe-2361	107	39	son	son	NOUN
cpe-2361	107	40	reporting	report	VERB
cpe-2361	107	41	the	the	DET
cpe-2361	107	42	side	side	NOUN
cpe-2361	107	43	effects	effect	NOUN
cpe-2361	107	44	(	(	PUNCT
cpe-2361	107	45	faasse	faasse	X
cpe-2361	107	46	,	,	PUNCT
cpe-2361	107	47	parkes	parkes	PROPN
cpe-2361	107	48	,	,	PUNCT
cpe-2361	107	49	kearney	kearney	PROPN
cpe-2361	107	50	,	,	PUNCT
cpe-2361	107	51	&	&	CCONJ
cpe-2361	107	52	petrie	petrie	NOUN
cpe-2361	107	53	,	,	PUNCT
cpe-2361	107	54	2018	2018	NUM
cpe-2361	107	55	)	)	PUNCT
cpe-2361	107	56	.	.	PUNCT
cpe-2361	108	1	studies	study	NOUN
cpe-2361	108	2	have	have	AUX
cpe-2361	108	3	also	also	ADV
cpe-2361	108	4	found	find	VERB
cpe-2361	108	5	that	that	SCONJ
cpe-2361	108	6	individuals	individual	NOUN
cpe-2361	108	7	with	with	ADP
cpe-2361	108	8	higher	high	ADJ
cpe-2361	108	9	levels	level	NOUN
cpe-2361	108	10	of	of	ADP
cpe-2361	108	11	psychological	psychological	ADJ
cpe-2361	108	12	distress	distress	NOUN
cpe-2361	108	13	also	also	ADV
cpe-2361	108	14	report	report	VERB
cpe-2361	108	15	a	a	DET
cpe-2361	108	16	greater	great	ADJ
cpe-2361	108	17	number	number	NOUN
cpe-2361	108	18	of	of	ADP
cpe-2361	108	19	physical	physical	ADJ
cpe-2361	108	20	symptoms	symptom	NOUN
cpe-2361	108	21	(	(	PUNCT
cpe-2361	108	22	watson	watson	PROPN
cpe-2361	108	23	&	&	CCONJ
cpe-2361	108	24	pennebaker	pennebaker	PROPN
cpe-2361	108	25	,	,	PUNCT
cpe-2361	108	26	1989	1989	NUM
cpe-2361	108	27	)	)	PUNCT
cpe-2361	108	28	.	.	PUNCT
cpe-2361	109	1	this	this	PRON
cpe-2361	109	2	is	be	AUX
cpe-2361	109	3	likely	likely	ADJ
cpe-2361	109	4	to	to	PART
cpe-2361	109	5	be	be	AUX
cpe-2361	109	6	of	of	ADP
cpe-2361	109	7	more	more	ADJ
cpe-2361	109	8	relevance	relevance	NOUN
cpe-2361	109	9	in	in	ADP
cpe-2361	109	10	this	this	DET
cpe-2361	109	11	group	group	NOUN
cpe-2361	109	12	of	of	ADP
cpe-2361	109	13	patients	patient	NOUN
cpe-2361	109	14	taking	take	VERB
cpe-2361	109	15	an	an	DET
cpe-2361	109	16	antidepressant	antidepressant	NOUN
cpe-2361	109	17	and	and	CCONJ
cpe-2361	109	18	thus	thus	ADV
cpe-2361	109	19	allowing	allow	VERB
cpe-2361	109	20	more	more	ADJ
cpe-2361	109	21	symptoms	symptom	NOUN
cpe-2361	109	22	to	to	PART
cpe-2361	109	23	be	be	AUX
cpe-2361	109	24	misattributed	misattribute	VERB
cpe-2361	109	25	to	to	ADP
cpe-2361	109	26	the	the	DET
cpe-2361	109	27	effects	effect	NOUN
cpe-2361	109	28	of	of	ADP
cpe-2361	109	29	the	the	DET
cpe-2361	109	30	new	new	ADJ
cpe-2361	109	31	generic	generic	ADJ
cpe-2361	109	32	medicine	medicine	NOUN
cpe-2361	109	33	.	.	PUNCT
cpe-2361	110	1	while	while	SCONJ
cpe-2361	110	2	generic	generic	ADJ
cpe-2361	110	3	switches	switch	NOUN
cpe-2361	110	4	are	be	AUX
cpe-2361	110	5	now	now	ADV
cpe-2361	110	6	commonplace	commonplace	ADJ
cpe-2361	110	7	in	in	ADP
cpe-2361	110	8	new	new	PROPN
cpe-2361	110	9	zealand	zealand	PROPN
cpe-2361	110	10	,	,	PUNCT
cpe-2361	110	11	a	a	DET
cpe-2361	110	12	recent	recent	ADJ
cpe-2361	110	13	general	general	ADJ
cpe-2361	110	14	population	population	NOUN
cpe-2361	110	15	survey	survey	NOUN
cpe-2361	110	16	found	find	VERB
cpe-2361	110	17	38	38	NUM
cpe-2361	110	18	%	%	NOUN
cpe-2361	110	19	still	still	ADV
cpe-2361	110	20	preferred	prefer	VERB
cpe-2361	110	21	taking	take	VERB
cpe-2361	110	22	branded	brand	VERB
cpe-2361	110	23	medication	medication	NOUN
cpe-2361	110	24	compared	compare	VERB
cpe-2361	110	25	to	to	ADP
cpe-2361	110	26	a	a	DET
cpe-2361	110	27	generic	generic	ADJ
cpe-2361	110	28	or	or	CCONJ
cpe-2361	110	29	no	no	PRON
cpe-2361	110	30	prefer‐	prefer‐	NOUN
cpe-2361	110	31	ence	ence	NOUN
cpe-2361	110	32	(	(	PUNCT
cpe-2361	110	33	kleinstäuber	kleinstäuber	PROPN
cpe-2361	110	34	,	,	PUNCT
cpe-2361	110	35	mackrill	mackrill	NOUN
cpe-2361	110	36	,	,	PUNCT
cpe-2361	110	37	&	&	CCONJ
cpe-2361	110	38	petrie	petrie	NOUN
cpe-2361	110	39	,	,	PUNCT
cpe-2361	110	40	2018	2018	NUM
cpe-2361	110	41	)	)	PUNCT
cpe-2361	110	42	.	.	PUNCT
cpe-2361	111	1	following	follow	VERB
cpe-2361	111	2	a	a	DET
cpe-2361	111	3	switch	switch	NOUN
cpe-2361	111	4	to	to	ADP
cpe-2361	111	5	a	a	DET
cpe-2361	111	6	generic	generic	ADJ
cpe-2361	111	7	medicine	medicine	NOUN
cpe-2361	111	8	more	more	ADJ
cpe-2361	111	9	side	side	NOUN
cpe-2361	111	10	effects	effect	NOUN
cpe-2361	111	11	are	be	AUX
cpe-2361	111	12	reported	report	VERB
cpe-2361	111	13	by	by	ADP
cpe-2361	111	14	patients	patient	NOUN
cpe-2361	111	15	who	who	PRON
cpe-2361	111	16	are	be	AUX
cpe-2361	111	17	older	old	ADJ
cpe-2361	111	18	,	,	PUNCT
cpe-2361	111	19	female	female	ADJ
cpe-2361	111	20	and	and	CCONJ
cpe-2361	111	21	by	by	ADP
cpe-2361	111	22	those	those	PRON
cpe-2361	111	23	who	who	PRON
cpe-2361	111	24	have	have	AUX
cpe-2361	111	25	been	be	AUX
cpe-2361	111	26	on	on	ADP
cpe-2361	111	27	their	their	PRON
cpe-2361	111	28	previous	previous	ADJ
cpe-2361	111	29	branded	brand	VERB
cpe-2361	111	30	medicine	medicine	NOUN
cpe-2361	111	31	longer	long	ADV
cpe-2361	111	32	(	(	PUNCT
cpe-2361	111	33	mackrill	mackrill	NOUN
cpe-2361	111	34	&	&	CCONJ
cpe-2361	111	35	petrie	petrie	PROPN
cpe-2361	111	36	,	,	PUNCT
cpe-2361	111	37	2018	2018	NUM
cpe-2361	111	38	)	)	PUNCT
cpe-2361	111	39	.	.	PUNCT
cpe-2361	112	1	strengths	strength	NOUN
cpe-2361	112	2	and	and	CCONJ
cpe-2361	112	3	limitations	limitation	NOUN
cpe-2361	112	4	while	while	SCONJ
cpe-2361	112	5	this	this	DET
cpe-2361	112	6	study	study	NOUN
cpe-2361	112	7	drew	draw	VERB
cpe-2361	112	8	on	on	ADP
cpe-2361	112	9	adverse	adverse	ADJ
cpe-2361	112	10	reports	report	NOUN
cpe-2361	112	11	to	to	ADP
cpe-2361	112	12	a	a	DET
cpe-2361	112	13	national	national	ADJ
cpe-2361	112	14	database	database	NOUN
cpe-2361	112	15	,	,	PUNCT
cpe-2361	112	16	it	it	PRON
cpe-2361	112	17	is	be	AUX
cpe-2361	112	18	likely	likely	ADJ
cpe-2361	112	19	that	that	SCONJ
cpe-2361	112	20	the	the	DET
cpe-2361	112	21	rates	rate	NOUN
cpe-2361	112	22	are	be	AUX
cpe-2361	112	23	a	a	DET
cpe-2361	112	24	substantively	substantively	ADV
cpe-2361	112	25	low	low	ADJ
cpe-2361	112	26	estimate	estimate	NOUN
cpe-2361	112	27	of	of	ADP
cpe-2361	112	28	the	the	DET
cpe-2361	112	29	true	true	ADJ
cpe-2361	112	30	effect	effect	NOUN
cpe-2361	112	31	of	of	ADP
cpe-2361	112	32	the	the	DET
cpe-2361	112	33	nocebo	nocebo	NOUN
cpe-2361	112	34	effect	effect	NOUN
cpe-2361	112	35	caused	cause	VERB
cpe-2361	112	36	by	by	ADP
cpe-2361	112	37	the	the	DET
cpe-2361	112	38	me‐	me‐	PROPN
cpe-2361	112	39	dia	dia	PROPN
cpe-2361	112	40	coverage	coverage	PROPN
cpe-2361	112	41	.	.	PUNCT
cpe-2361	113	1	studies	study	NOUN
cpe-2361	113	2	estimate	estimate	VERB
cpe-2361	113	3	that	that	SCONJ
cpe-2361	113	4	reports	report	VERB
cpe-2361	113	5	to	to	ADP
cpe-2361	113	6	a	a	DET
cpe-2361	113	7	national	national	ADJ
cpe-2361	113	8	adverse	adverse	ADJ
cpe-2361	113	9	database	database	NOUN
cpe-2361	113	10	represent	represent	VERB
cpe-2361	113	11	less	less	ADJ
cpe-2361	113	12	than	than	ADP
cpe-2361	113	13	10	10	NUM
cpe-2361	113	14	%	%	NOUN
cpe-2361	113	15	of	of	ADP
cpe-2361	113	16	detected	detect	VERB
cpe-2361	113	17	adverse	adverse	ADJ
cpe-2361	113	18	drug	drug	NOUN
cpe-2361	113	19	reactions	reaction	NOUN
cpe-2361	113	20	(	(	PUNCT
cpe-2361	113	21	mcgettigan	mcgettigan	PROPN
cpe-2361	113	22	,	,	PUNCT
cpe-2361	113	23	golden	golden	ADJ
cpe-2361	113	24	,	,	PUNCT
cpe-2361	113	25	conroy	conroy	PROPN
cpe-2361	113	26	,	,	PUNCT
cpe-2361	113	27	arthur	arthur	PROPN
cpe-2361	113	28	,	,	PUNCT
cpe-2361	113	29	&	&	CCONJ
cpe-2361	113	30	feely	feely	ADV
cpe-2361	113	31	,	,	PUNCT
cpe-2361	113	32	1997	1997	NUM
cpe-2361	113	33	;	;	PUNCT
cpe-2361	113	34	smith	smith	PROPN
cpe-2361	113	35	et	et	PROPN
cpe-2361	113	36	al	al	PROPN
cpe-2361	113	37	.	.	PROPN
cpe-2361	113	38	,	,	PUNCT
cpe-2361	113	39	1996	1996	NUM
cpe-2361	113	40	)	)	PUNCT
cpe-2361	113	41	.	.	PUNCT
cpe-2361	114	1	it	it	PRON
cpe-2361	114	2	is	be	AUX
cpe-2361	114	3	further	far	ADV
cpe-2361	114	4	likely	likely	ADJ
cpe-2361	114	5	that	that	SCONJ
cpe-2361	114	6	many	many	ADJ
cpe-2361	114	7	patients	patient	NOUN
cpe-2361	114	8	would	would	AUX
cpe-2361	114	9	not	not	PART
cpe-2361	114	10	have	have	AUX
cpe-2361	114	11	sought	seek	VERB
cpe-2361	114	12	medical	medical	ADJ
cpe-2361	114	13	assistance	assistance	NOUN
cpe-2361	114	14	for	for	ADP
cpe-2361	114	15	symptoms	symptom	NOUN
cpe-2361	114	16	due	due	ADP
cpe-2361	114	17	to	to	ADP
cpe-2361	114	18	the	the	DET
cpe-2361	114	19	perception	perception	NOUN
cpe-2361	114	20	that	that	SCONJ
cpe-2361	114	21	there	there	PRON
cpe-2361	114	22	was	be	VERB
cpe-2361	114	23	little	little	ADJ
cpe-2361	114	24	that	that	PRON
cpe-2361	114	25	could	could	AUX
cpe-2361	114	26	be	be	AUX
cpe-2361	114	27	done	do	VERB
cpe-2361	114	28	by	by	ADP
cpe-2361	114	29	their	their	PRON
cpe-2361	114	30	gp	gp	NOUN
cpe-2361	114	31	.	.	PUNCT
cpe-2361	115	1	the	the	DET
cpe-2361	115	2	study	study	NOUN
cpe-2361	115	3	is	be	AUX
cpe-2361	115	4	limited	limit	VERB
cpe-2361	115	5	by	by	ADP
cpe-2361	115	6	the	the	DET
cpe-2361	115	7	non	non	ADJ
cpe-2361	115	8	-	-	ADJ
cpe-2361	115	9	experimental	experimental	ADJ
cpe-2361	115	10	design	design	NOUN
cpe-2361	115	11	and	and	CCONJ
cpe-2361	115	12	restricted	restrict	VERB
cpe-2361	115	13	in	in	ADP
cpe-2361	115	14	outcomes	outcome	NOUN
cpe-2361	115	15	to	to	ADP
cpe-2361	115	16	the	the	DET
cpe-2361	115	17	specific	specific	ADJ
cpe-2361	115	18	side	side	NOUN
cpe-2361	115	19	effect	effect	NOUN
cpe-2361	115	20	categories	category	NOUN
cpe-2361	115	21	recorded	record	VERB
cpe-2361	115	22	by	by	ADP
cpe-2361	115	23	carm	carm	PROPN
cpe-2361	115	24	.	.	PUNCT
cpe-2361	116	1	as	as	ADP
cpe-2361	116	2	such	such	ADJ
cpe-2361	116	3	,	,	PUNCT
cpe-2361	116	4	it	it	PRON
cpe-2361	116	5	is	be	AUX
cpe-2361	116	6	possible	possible	ADJ
cpe-2361	116	7	that	that	SCONJ
cpe-2361	116	8	patients	patient	NOUN
cpe-2361	116	9	may	may	AUX
cpe-2361	116	10	have	have	AUX
cpe-2361	116	11	experienced	experience	VERB
cpe-2361	116	12	other	other	ADJ
cpe-2361	116	13	side	side	NOUN
cpe-2361	116	14	effects	effect	NOUN
cpe-2361	116	15	that	that	SCONJ
cpe-2361	116	16	the	the	DET
cpe-2361	116	17	carm	carm	NOUN
cpe-2361	116	18	database	database	NOUN
cpe-2361	116	19	does	do	AUX
cpe-2361	116	20	not	not	PART
cpe-2361	116	21	measure	measure	VERB
cpe-2361	116	22	.	.	PUNCT
cpe-2361	117	1	although	although	SCONJ
cpe-2361	117	2	mackrill	mackrill	NOUN
cpe-2361	117	3	,	,	PUNCT
cpe-2361	117	4	gamble	gamble	NOUN
cpe-2361	117	5	,	,	PUNCT
cpe-2361	117	6	bean	bean	NOUN
cpe-2361	117	7	et	et	PROPN
cpe-2361	117	8	al	al	PROPN
cpe-2361	117	9	.	.	PROPN
cpe-2361	117	10	9	9	NUM
cpe-2361	117	11	clinical	clinical	ADJ
cpe-2361	117	12	psychology	psychology	NOUN
cpe-2361	117	13	in	in	ADP
cpe-2361	117	14	europe	europe	PROPN
cpe-2361	117	15	2019	2019	NUM
cpe-2361	117	16	,	,	PUNCT
cpe-2361	117	17	vol.1(1	vol.1(1	NOUN
cpe-2361	117	18	)	)	PUNCT
cpe-2361	117	19	,	,	PUNCT
cpe-2361	117	20	article	article	NOUN
cpe-2361	117	21	e29642	e29642	VERB
cpe-2361	117	22	https://doi.org/10.32872/cpe.v1i1.29642	https://doi.org/10.32872/cpe.v1i1.29642	PROPN
cpe-2361	117	23	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
cpe-2361	117	24	patients	patient	NOUN
cpe-2361	117	25	can	can	AUX
cpe-2361	117	26	make	make	VERB
cpe-2361	117	27	direct	direct	ADJ
cpe-2361	117	28	reports	report	NOUN
cpe-2361	117	29	using	use	VERB
cpe-2361	117	30	online	online	ADJ
cpe-2361	117	31	forms	form	NOUN
cpe-2361	117	32	this	this	PRON
cpe-2361	117	33	makes	make	VERB
cpe-2361	117	34	up	up	ADP
cpe-2361	117	35	only	only	ADV
cpe-2361	117	36	a	a	DET
cpe-2361	117	37	small	small	ADJ
cpe-2361	117	38	percent‐	percent‐	NOUN
cpe-2361	117	39	age	age	NOUN
cpe-2361	117	40	of	of	ADP
cpe-2361	117	41	carm	carm	PROPN
cpe-2361	117	42	reports	report	NOUN
cpe-2361	117	43	.	.	PUNCT
cpe-2361	118	1	the	the	DET
cpe-2361	118	2	behavioural	behavioural	ADJ
cpe-2361	118	3	outcomes	outcome	NOUN
cpe-2361	118	4	of	of	ADP
cpe-2361	118	5	the	the	DET
cpe-2361	118	6	adverse	adverse	ADJ
cpe-2361	118	7	event	event	NOUN
cpe-2361	118	8	reporting	reporting	NOUN
cpe-2361	118	9	are	be	AUX
cpe-2361	118	10	also	also	ADV
cpe-2361	118	11	unknown	unknown	ADJ
cpe-2361	118	12	.	.	PUNCT
cpe-2361	119	1	it	it	PRON
cpe-2361	119	2	is	be	AUX
cpe-2361	119	3	not	not	PART
cpe-2361	119	4	known	know	VERB
cpe-2361	119	5	whether	whether	SCONJ
cpe-2361	119	6	there	there	PRON
cpe-2361	119	7	was	be	VERB
cpe-2361	119	8	an	an	DET
cpe-2361	119	9	increase	increase	NOUN
cpe-2361	119	10	in	in	ADP
cpe-2361	119	11	suicidal	suicidal	ADJ
cpe-2361	119	12	behaviour	behaviour	NOUN
cpe-2361	119	13	following	follow	VERB
cpe-2361	119	14	the	the	DET
cpe-2361	119	15	stories	story	NOUN
cpe-2361	119	16	or	or	CCONJ
cpe-2361	119	17	whether	whether	SCONJ
cpe-2361	119	18	patients	patient	NOUN
cpe-2361	119	19	stopped	stop	VERB
cpe-2361	119	20	venlafaxine	venlafaxine	NOUN
cpe-2361	119	21	or	or	CCONJ
cpe-2361	119	22	changed	change	VERB
cpe-2361	119	23	to	to	ADP
cpe-2361	119	24	another	another	DET
cpe-2361	119	25	medication	medication	NOUN
cpe-2361	119	26	.	.	PUNCT
cpe-2361	120	1	in	in	ADP
cpe-2361	120	2	conclusion	conclusion	NOUN
cpe-2361	120	3	,	,	PUNCT
cpe-2361	120	4	we	we	PRON
cpe-2361	120	5	found	find	VERB
cpe-2361	120	6	media	medium	NOUN
cpe-2361	120	7	coverage	coverage	NOUN
cpe-2361	120	8	of	of	ADP
cpe-2361	120	9	reports	report	NOUN
cpe-2361	120	10	of	of	ADP
cpe-2361	120	11	a	a	DET
cpe-2361	120	12	lack	lack	NOUN
cpe-2361	120	13	of	of	ADP
cpe-2361	120	14	efficacy	efficacy	NOUN
cpe-2361	120	15	and	and	CCONJ
cpe-2361	120	16	side	side	NOUN
cpe-2361	120	17	ef‐	ef‐	NOUN
cpe-2361	120	18	fects	fect	NOUN
cpe-2361	120	19	following	follow	VERB
cpe-2361	120	20	a	a	DET
cpe-2361	120	21	switch	switch	NOUN
cpe-2361	120	22	to	to	ADP
cpe-2361	120	23	a	a	DET
cpe-2361	120	24	generic	generic	ADJ
cpe-2361	120	25	version	version	NOUN
cpe-2361	120	26	of	of	ADP
cpe-2361	120	27	venlafaxine	venlafaxine	NOUN
cpe-2361	120	28	were	be	AUX
cpe-2361	120	29	likely	likely	ADV
cpe-2361	120	30	responsible	responsible	ADJ
cpe-2361	120	31	for	for	ADP
cpe-2361	120	32	an	an	DET
cpe-2361	120	33	increase	increase	NOUN
cpe-2361	120	34	in	in	ADP
cpe-2361	120	35	similar	similar	ADJ
cpe-2361	120	36	reports	report	NOUN
cpe-2361	120	37	to	to	ADP
cpe-2361	120	38	a	a	DET
cpe-2361	120	39	national	national	ADJ
cpe-2361	120	40	centre	centre	NOUN
cpe-2361	120	41	for	for	ADP
cpe-2361	120	42	adverse	adverse	ADJ
cpe-2361	120	43	drug	drug	NOUN
cpe-2361	120	44	reactions	reaction	NOUN
cpe-2361	120	45	.	.	PUNCT
cpe-2361	121	1	of	of	ADP
cpe-2361	121	2	particular	particular	ADJ
cpe-2361	121	3	concern	concern	NOUN
cpe-2361	121	4	is	be	AUX
cpe-2361	121	5	how	how	SCONJ
cpe-2361	121	6	media	medium	NOUN
cpe-2361	121	7	reports	report	NOUN
cpe-2361	121	8	of	of	ADP
cpe-2361	121	9	increases	increase	NOUN
cpe-2361	121	10	in	in	ADP
cpe-2361	121	11	suicidal	suicidal	ADJ
cpe-2361	121	12	thoughts	thought	NOUN
cpe-2361	121	13	and	and	CCONJ
cpe-2361	121	14	loss	loss	NOUN
cpe-2361	121	15	of	of	ADP
cpe-2361	121	16	drug	drug	NOUN
cpe-2361	121	17	efficacy	efficacy	NOUN
cpe-2361	121	18	following	follow	VERB
cpe-2361	121	19	a	a	DET
cpe-2361	121	20	drug	drug	NOUN
cpe-2361	121	21	switch	switch	NOUN
cpe-2361	121	22	can	can	AUX
cpe-2361	121	23	be	be	AUX
cpe-2361	121	24	readily	readily	ADV
cpe-2361	121	25	converted	convert	VERB
cpe-2361	121	26	in	in	ADP
cpe-2361	121	27	similar	similar	ADJ
cpe-2361	121	28	complaints	complaint	NOUN
cpe-2361	121	29	across	across	ADP
cpe-2361	121	30	the	the	DET
cpe-2361	121	31	wider	wide	ADJ
cpe-2361	121	32	community	community	NOUN
cpe-2361	121	33	.	.	PUNCT
cpe-2361	122	1	more	more	ADJ
cpe-2361	122	2	research	research	NOUN
cpe-2361	122	3	is	be	AUX
cpe-2361	122	4	also	also	ADV
cpe-2361	122	5	required	require	VERB
cpe-2361	122	6	on	on	ADP
cpe-2361	122	7	how	how	SCONJ
cpe-2361	122	8	such	such	ADJ
cpe-2361	122	9	media	medium	NOUN
cpe-2361	122	10	reports	report	NOUN
cpe-2361	122	11	are	be	AUX
cpe-2361	122	12	associated	associate	VERB
cpe-2361	122	13	with	with	ADP
cpe-2361	122	14	increases	increase	NOUN
cpe-2361	122	15	in	in	ADP
cpe-2361	122	16	non	non	ADJ
cpe-2361	122	17	-	-	NOUN
cpe-2361	122	18	adherence	adherence	ADJ
cpe-2361	122	19	and	and	CCONJ
cpe-2361	122	20	non	non	ADJ
cpe-2361	122	21	-	-	NOUN
cpe-2361	122	22	persistence	persistence	NOUN
cpe-2361	122	23	with	with	ADP
cpe-2361	122	24	medication	medication	NOUN
cpe-2361	122	25	,	,	PUNCT
cpe-2361	122	26	as	as	ADV
cpe-2361	122	27	well	well	ADV
cpe-2361	122	28	as	as	ADP
cpe-2361	122	29	possible	possible	ADJ
cpe-2361	122	30	increases	increase	NOUN
cpe-2361	122	31	in	in	ADP
cpe-2361	122	32	suicidal	suicidal	ADJ
cpe-2361	122	33	behaviour	behaviour	NOUN
cpe-2361	122	34	.	.	PUNCT
cpe-2361	123	1	future	future	ADJ
cpe-2361	123	2	work	work	NOUN
cpe-2361	123	3	may	may	AUX
cpe-2361	123	4	also	also	ADV
cpe-2361	123	5	be	be	AUX
cpe-2361	123	6	needed	need	VERB
cpe-2361	123	7	to	to	PART
cpe-2361	123	8	develop	develop	VERB
cpe-2361	123	9	guidelines	guideline	NOUN
cpe-2361	123	10	for	for	ADP
cpe-2361	123	11	media	medium	NOUN
cpe-2361	123	12	reporting	reporting	NOUN
cpe-2361	123	13	on	on	ADP
cpe-2361	123	14	generic	generic	ADJ
cpe-2361	123	15	switches	switch	NOUN
cpe-2361	123	16	with	with	ADP
cpe-2361	123	17	a	a	DET
cpe-2361	123	18	view	view	NOUN
cpe-2361	123	19	to	to	ADP
cpe-2361	123	20	avoiding	avoid	VERB
cpe-2361	123	21	these	these	DET
cpe-2361	123	22	adverse	adverse	ADJ
cpe-2361	123	23	outcomes	outcome	NOUN
cpe-2361	123	24	.	.	PUNCT
cpe-2361	124	1	funding	funding	NOUN
cpe-2361	124	2	:	:	PUNCT
cpe-2361	124	3	the	the	DET
cpe-2361	124	4	authors	author	NOUN
cpe-2361	124	5	have	have	VERB
cpe-2361	124	6	no	no	DET
cpe-2361	124	7	funding	funding	NOUN
cpe-2361	124	8	to	to	PART
cpe-2361	124	9	report	report	VERB
cpe-2361	124	10	.	.	PUNCT
cpe-2361	125	1	competing	compete	VERB
cpe-2361	125	2	interests	interest	NOUN
cpe-2361	125	3	:	:	PUNCT
cpe-2361	125	4	km	km	PROPN
cpe-2361	125	5	,	,	PUNCT
cpe-2361	125	6	gg	gg	PROPN
cpe-2361	125	7	,	,	PUNCT
cpe-2361	125	8	db	db	PROPN
cpe-2361	125	9	,	,	PUNCT
cpe-2361	125	10	tc	tc	PRON
cpe-2361	125	11	declare	declare	VERB
cpe-2361	125	12	no	no	DET
cpe-2361	125	13	conflicts	conflict	NOUN
cpe-2361	125	14	of	of	ADP
cpe-2361	125	15	interest	interest	NOUN
cpe-2361	125	16	.	.	PUNCT
cpe-2361	126	1	kp	kp	PROPN
cpe-2361	126	2	has	have	AUX
cpe-2361	126	3	received	receive	VERB
cpe-2361	126	4	research	research	NOUN
cpe-2361	126	5	grants	grant	NOUN
cpe-2361	126	6	in	in	ADP
cpe-2361	126	7	the	the	DET
cpe-2361	126	8	past	past	NOUN
cpe-2361	126	9	from	from	ADP
cpe-2361	126	10	pharmac	pharmac	NOUN
cpe-2361	126	11	,	,	PUNCT
cpe-2361	126	12	the	the	DET
cpe-2361	126	13	new	new	PROPN
cpe-2361	126	14	zealand	zealand	PROPN
cpe-2361	126	15	government	government	NOUN
cpe-2361	126	16	’s	’s	PART
cpe-2361	126	17	pharmaceutical	pharmaceutical	PROPN
cpe-2361	126	18	management	management	NOUN
cpe-2361	126	19	agency	agency	NOUN
cpe-2361	126	20	.	.	PUNCT
cpe-2361	127	1	acknowledgments	acknowledgment	NOUN
cpe-2361	127	2	:	:	PUNCT
cpe-2361	127	3	the	the	DET
cpe-2361	127	4	authors	author	NOUN
cpe-2361	127	5	have	have	VERB
cpe-2361	127	6	no	no	DET
cpe-2361	127	7	support	support	NOUN
cpe-2361	127	8	to	to	PART
cpe-2361	127	9	report	report	VERB
cpe-2361	127	10	.	.	PUNCT
cpe-2361	128	1	references	reference	NOUN
cpe-2361	128	2	boone	boone	PROPN
cpe-2361	128	3	,	,	PUNCT
cpe-2361	128	4	n.	n.	PROPN
cpe-2361	128	5	w.	w.	PROPN
cpe-2361	128	6	,	,	PUNCT
cpe-2361	128	7	liu	liu	PROPN
cpe-2361	128	8	,	,	PUNCT
cpe-2361	128	9	l.	l.	PROPN
cpe-2361	128	10	,	,	PUNCT
cpe-2361	128	11	romberg	romberg	PROPN
cpe-2361	128	12	-	-	PUNCT
cpe-2361	128	13	camps	camp	NOUN
cpe-2361	128	14	,	,	PUNCT
cpe-2361	128	15	m.	m.	NOUN
cpe-2361	128	16	j.	j.	PROPN
cpe-2361	128	17	,	,	PUNCT
cpe-2361	128	18	duijsens	duijsens	PROPN
cpe-2361	128	19	,	,	PUNCT
cpe-2361	128	20	l.	l.	PROPN
cpe-2361	128	21	,	,	PUNCT
cpe-2361	128	22	houwen	houwen	PROPN
cpe-2361	128	23	,	,	PUNCT
cpe-2361	128	24	c.	c.	PROPN
cpe-2361	128	25	,	,	PUNCT
cpe-2361	128	26	van	van	PROPN
cpe-2361	128	27	der	der	PROPN
cpe-2361	128	28	kuy	kuy	PROPN
cpe-2361	128	29	,	,	PUNCT
cpe-2361	128	30	p.	p.	PROPN
cpe-2361	128	31	h.	h.	PROPN
cpe-2361	128	32	m.	m.	PROPN
cpe-2361	128	33	,	,	PUNCT
cpe-2361	128	34	.	.	PUNCT
cpe-2361	128	35	.	.	PUNCT
cpe-2361	128	36	.	.	PUNCT
cpe-2361	129	1	van	van	PROPN
cpe-2361	129	2	bodegraven	bodegraven	PROPN
cpe-2361	129	3	,	,	PUNCT
cpe-2361	129	4	a.	a.	NOUN
cpe-2361	129	5	a.	a.	NOUN
cpe-2361	129	6	(	(	PUNCT
cpe-2361	129	7	2018	2018	NUM
cpe-2361	129	8	)	)	PUNCT
cpe-2361	129	9	.	.	PUNCT
cpe-2361	130	1	the	the	DET
cpe-2361	130	2	nocebo	nocebo	NOUN
cpe-2361	130	3	effect	effect	NOUN
cpe-2361	130	4	challenges	challenge	VERB
cpe-2361	130	5	the	the	DET
cpe-2361	130	6	non	non	ADJ
cpe-2361	130	7	-	-	ADJ
cpe-2361	130	8	medical	medical	ADJ
cpe-2361	130	9	infliximab	infliximab	NOUN
cpe-2361	130	10	switch	switch	NOUN
cpe-2361	130	11	in	in	ADP
cpe-2361	130	12	practice	practice	NOUN
cpe-2361	130	13	.	.	PUNCT
cpe-2361	131	1	european	european	ADJ
cpe-2361	131	2	journal	journal	PROPN
cpe-2361	131	3	of	of	ADP
cpe-2361	131	4	clinical	clinical	ADJ
cpe-2361	131	5	pharmacology	pharmacology	NOUN
cpe-2361	131	6	,	,	PUNCT
cpe-2361	131	7	74(5	74(5	NOUN
cpe-2361	131	8	)	)	PUNCT
cpe-2361	131	9	,	,	PUNCT
cpe-2361	131	10	655	655	NUM
cpe-2361	131	11	-	-	SYM
cpe-2361	131	12	661	661	NUM
cpe-2361	131	13	.	.	PUNCT
cpe-2361	132	1	https://doi.org/10.1007/s00228-018-2418-4	https://doi.org/10.1007/s00228-018-2418-4	NUM
cpe-2361	132	2	cocco	cocco	PROPN
cpe-2361	132	3	,	,	PUNCT
cpe-2361	132	4	g.	g.	PROPN
cpe-2361	132	5	(	(	PUNCT
cpe-2361	132	6	2009	2009	NUM
cpe-2361	132	7	)	)	PUNCT
cpe-2361	132	8	.	.	PUNCT
cpe-2361	133	1	erectile	erectile	ADJ
cpe-2361	133	2	dysfunction	dysfunction	NOUN
cpe-2361	133	3	after	after	ADP
cpe-2361	133	4	therapy	therapy	NOUN
cpe-2361	133	5	with	with	ADP
cpe-2361	133	6	metoprolol	metoprolol	PROPN
cpe-2361	133	7	:	:	PUNCT
cpe-2361	133	8	the	the	DET
cpe-2361	133	9	hawthorne	hawthorne	ADJ
cpe-2361	133	10	effect	effect	NOUN
cpe-2361	133	11	.	.	PUNCT
cpe-2361	134	1	cardiology	cardiology	NOUN
cpe-2361	134	2	,	,	PUNCT
cpe-2361	134	3	112(3	112(3	NUM
cpe-2361	134	4	)	)	PUNCT
cpe-2361	134	5	,	,	PUNCT
cpe-2361	134	6	174	174	NUM
cpe-2361	134	7	-	-	SYM
cpe-2361	134	8	177	177	NUM
cpe-2361	134	9	.	.	PUNCT
cpe-2361	135	1	https://doi.org/10.1159/000147951	https://doi.org/10.1159/000147951	PROPN
cpe-2361	135	2	colgan	colgan	PROPN
cpe-2361	135	3	,	,	PUNCT
cpe-2361	135	4	s.	s.	PROPN
cpe-2361	135	5	,	,	PUNCT
cpe-2361	135	6	faasse	faasse	NOUN
cpe-2361	135	7	,	,	PUNCT
cpe-2361	135	8	k.	k.	PROPN
cpe-2361	135	9	,	,	PUNCT
cpe-2361	135	10	martin	martin	PROPN
cpe-2361	135	11	,	,	PUNCT
cpe-2361	135	12	l.	l.	PROPN
cpe-2361	135	13	r.	r.	PROPN
cpe-2361	135	14	,	,	PUNCT
cpe-2361	135	15	stephens	stephens	PROPN
cpe-2361	135	16	,	,	PUNCT
cpe-2361	135	17	m.	m.	PROPN
cpe-2361	135	18	h.	h.	PROPN
cpe-2361	135	19	,	,	PUNCT
cpe-2361	135	20	grey	grey	PROPN
cpe-2361	135	21	,	,	PUNCT
cpe-2361	135	22	a.	a.	NOUN
cpe-2361	135	23	,	,	PUNCT
cpe-2361	135	24	&	&	CCONJ
cpe-2361	135	25	petrie	petrie	PROPN
cpe-2361	135	26	,	,	PUNCT
cpe-2361	135	27	k.	k.	PROPN
cpe-2361	135	28	j.	j.	PROPN
cpe-2361	135	29	(	(	PUNCT
cpe-2361	135	30	2015	2015	NUM
cpe-2361	135	31	)	)	PUNCT
cpe-2361	135	32	.	.	PUNCT
cpe-2361	136	1	perceptions	perception	NOUN
cpe-2361	136	2	of	of	ADP
cpe-2361	136	3	generic	generic	ADJ
cpe-2361	136	4	medication	medication	NOUN
cpe-2361	136	5	in	in	ADP
cpe-2361	136	6	the	the	DET
cpe-2361	136	7	general	general	ADJ
cpe-2361	136	8	population	population	NOUN
cpe-2361	136	9	,	,	PUNCT
cpe-2361	136	10	doctors	doctor	NOUN
cpe-2361	136	11	and	and	CCONJ
cpe-2361	136	12	pharmacists	pharmacist	NOUN
cpe-2361	136	13	:	:	PUNCT
cpe-2361	136	14	a	a	DET
cpe-2361	136	15	systematic	systematic	ADJ
cpe-2361	136	16	review	review	NOUN
cpe-2361	136	17	.	.	PUNCT
cpe-2361	137	1	bmj	bmj	PROPN
cpe-2361	137	2	open	open	ADJ
cpe-2361	137	3	,	,	PUNCT
cpe-2361	137	4	5(12	5(12	NUM
cpe-2361	137	5	)	)	PUNCT
cpe-2361	137	6	,	,	PUNCT
cpe-2361	137	7	article	article	NOUN
cpe-2361	137	8	e008915	e008915	NOUN
cpe-2361	137	9	.	.	PUNCT
cpe-2361	138	1	https://doi.org/10.1136/bmjopen-2015-008915	https://doi.org/10.1136/bmjopen-2015-008915	NOUN
cpe-2361	138	2	desmarais	desmarais	PROPN
cpe-2361	138	3	,	,	PUNCT
cpe-2361	138	4	j.	j.	PROPN
cpe-2361	138	5	e.	e.	PROPN
cpe-2361	138	6	,	,	PUNCT
cpe-2361	138	7	beauclair	beauclair	PROPN
cpe-2361	138	8	,	,	PUNCT
cpe-2361	138	9	l.	l.	PROPN
cpe-2361	138	10	,	,	PUNCT
cpe-2361	138	11	&	&	CCONJ
cpe-2361	138	12	margolese	margolese	PROPN
cpe-2361	138	13	,	,	PUNCT
cpe-2361	138	14	h.	h.	PROPN
cpe-2361	138	15	c.	c.	PROPN
cpe-2361	138	16	(	(	PUNCT
cpe-2361	138	17	2011	2011	NUM
cpe-2361	138	18	)	)	PUNCT
cpe-2361	138	19	.	.	PUNCT
cpe-2361	139	1	switching	switch	VERB
cpe-2361	139	2	from	from	ADP
cpe-2361	139	3	brand‐name	brand‐name	NOUN
cpe-2361	139	4	to	to	ADP
cpe-2361	139	5	generic	generic	ADJ
cpe-2361	139	6	psychotropic	psychotropic	ADJ
cpe-2361	139	7	medications	medication	NOUN
cpe-2361	139	8	:	:	PUNCT
cpe-2361	139	9	a	a	DET
cpe-2361	139	10	literature	literature	NOUN
cpe-2361	139	11	review	review	NOUN
cpe-2361	139	12	.	.	PUNCT
cpe-2361	140	1	cns	cns	PROPN
cpe-2361	140	2	neuroscience	neuroscience	PROPN
cpe-2361	140	3	&	&	CCONJ
cpe-2361	140	4	therapeutics	therapeutic	NOUN
cpe-2361	140	5	,	,	PUNCT
cpe-2361	140	6	17(6	17(6	NUM
cpe-2361	140	7	)	)	PUNCT
cpe-2361	140	8	,	,	PUNCT
cpe-2361	140	9	750	750	NUM
cpe-2361	140	10	-	-	SYM
cpe-2361	140	11	760	760	NUM
cpe-2361	140	12	.	.	PUNCT
cpe-2361	140	13	https://doi.org/10.1111/j.1755-5949.2010.00210.x	https://doi.org/10.1111/j.1755-5949.2010.00210.x	ADJ
cpe-2361	140	14	faasse	faasse	NOUN
cpe-2361	140	15	,	,	PUNCT
cpe-2361	140	16	k.	k.	PROPN
cpe-2361	140	17	,	,	PUNCT
cpe-2361	140	18	cundy	cundy	PROPN
cpe-2361	140	19	,	,	PUNCT
cpe-2361	140	20	t.	t.	PROPN
cpe-2361	140	21	,	,	PUNCT
cpe-2361	140	22	gamble	gamble	NOUN
cpe-2361	140	23	,	,	PUNCT
cpe-2361	140	24	g.	g.	PROPN
cpe-2361	140	25	,	,	PUNCT
cpe-2361	140	26	&	&	CCONJ
cpe-2361	140	27	petrie	petrie	PROPN
cpe-2361	140	28	,	,	PUNCT
cpe-2361	140	29	k.	k.	PROPN
cpe-2361	140	30	j.	j.	PROPN
cpe-2361	140	31	(	(	PUNCT
cpe-2361	140	32	2013	2013	NUM
cpe-2361	140	33	)	)	PUNCT
cpe-2361	140	34	.	.	PUNCT
cpe-2361	141	1	the	the	DET
cpe-2361	141	2	effect	effect	NOUN
cpe-2361	141	3	of	of	ADP
cpe-2361	141	4	an	an	DET
cpe-2361	141	5	apparent	apparent	ADJ
cpe-2361	141	6	change	change	NOUN
cpe-2361	141	7	to	to	ADP
cpe-2361	141	8	a	a	DET
cpe-2361	141	9	branded	brand	VERB
cpe-2361	141	10	or	or	CCONJ
cpe-2361	141	11	generic	generic	ADJ
cpe-2361	141	12	medication	medication	NOUN
cpe-2361	141	13	on	on	ADP
cpe-2361	141	14	drug	drug	NOUN
cpe-2361	141	15	effectiveness	effectiveness	NOUN
cpe-2361	141	16	and	and	CCONJ
cpe-2361	141	17	side	side	NOUN
cpe-2361	141	18	effects	effect	NOUN
cpe-2361	141	19	.	.	PUNCT
cpe-2361	142	1	psychosomatic	psychosomatic	ADJ
cpe-2361	142	2	medicine	medicine	NOUN
cpe-2361	142	3	,	,	PUNCT
cpe-2361	142	4	75(1	75(1	NOUN
cpe-2361	142	5	)	)	PUNCT
cpe-2361	142	6	,	,	PUNCT
cpe-2361	142	7	90	90	NUM
cpe-2361	142	8	-	-	SYM
cpe-2361	142	9	96	96	NUM
cpe-2361	142	10	.	.	PUNCT
cpe-2361	143	1	https://doi.org/10.1097/psy.0b013e3182738826	https://doi.org/10.1097/psy.0b013e3182738826	PROPN
cpe-2361	143	2	faasse	faasse	NOUN
cpe-2361	143	3	,	,	PUNCT
cpe-2361	143	4	k.	k.	PROPN
cpe-2361	143	5	,	,	PUNCT
cpe-2361	143	6	cundy	cundy	PROPN
cpe-2361	143	7	,	,	PUNCT
cpe-2361	143	8	t.	t.	PROPN
cpe-2361	143	9	,	,	PUNCT
cpe-2361	143	10	&	&	CCONJ
cpe-2361	143	11	petrie	petrie	PROPN
cpe-2361	143	12	,	,	PUNCT
cpe-2361	143	13	k.	k.	PROPN
cpe-2361	143	14	j.	j.	PROPN
cpe-2361	143	15	(	(	PUNCT
cpe-2361	143	16	2009	2009	NUM
cpe-2361	143	17	)	)	PUNCT
cpe-2361	143	18	.	.	PUNCT
cpe-2361	144	1	thyroxine	thyroxine	NOUN
cpe-2361	144	2	:	:	PUNCT
cpe-2361	144	3	anatomy	anatomy	NOUN
cpe-2361	144	4	of	of	ADP
cpe-2361	144	5	a	a	DET
cpe-2361	144	6	health	health	NOUN
cpe-2361	144	7	scare	scare	NOUN
cpe-2361	144	8	.	.	PUNCT
cpe-2361	145	1	bmj	bmj	PROPN
cpe-2361	145	2	:	:	PUNCT
cpe-2361	145	3	clinical	clinical	ADJ
cpe-2361	145	4	research	research	NOUN
cpe-2361	145	5	edition	edition	NOUN
cpe-2361	145	6	,	,	PUNCT
cpe-2361	145	7	339	339	NUM
cpe-2361	145	8	,	,	PUNCT
cpe-2361	145	9	article	article	NOUN
cpe-2361	145	10	b5613	b5613	PROPN
cpe-2361	145	11	.	.	PUNCT
cpe-2361	146	1	https://doi.org/10.1136/bmj.b5613	https://doi.org/10.1136/bmj.b5613	X
cpe-2361	146	2	media	medium	NOUN
cpe-2361	146	3	-	-	PUNCT
cpe-2361	146	4	induced	induce	VERB
cpe-2361	146	5	nocebo	nocebo	NOUN
cpe-2361	146	6	response	response	NOUN
cpe-2361	146	7	10	10	NUM
cpe-2361	146	8	clinical	clinical	ADJ
cpe-2361	146	9	psychology	psychology	NOUN
cpe-2361	146	10	in	in	ADP
cpe-2361	146	11	europe	europe	PROPN
cpe-2361	146	12	2019	2019	NUM
cpe-2361	146	13	,	,	PUNCT
cpe-2361	146	14	vol.1(1	vol.1(1	NOUN
cpe-2361	146	15	)	)	PUNCT
cpe-2361	146	16	,	,	PUNCT
cpe-2361	146	17	article	article	NOUN
cpe-2361	146	18	e29642	e29642	VERB
cpe-2361	146	19	https://doi.org/10.32872/cpe.v1i1.29642	https://doi.org/10.32872/cpe.v1i1.29642	PROPN
cpe-2361	146	20	https://doi.org/10.1007/s00228-018-2418-4	https://doi.org/10.1007/s00228-018-2418-4	NUM
cpe-2361	146	21	https://doi.org/10.1159/000147951	https://doi.org/10.1159/000147951	PROPN
cpe-2361	146	22	https://doi.org/10.1136/bmjopen-2015-008915	https://doi.org/10.1136/bmjopen-2015-008915	PROPN
cpe-2361	146	23	https://doi.org/10.1111/j.1755-5949.2010.00210.x	https://doi.org/10.1111/j.1755-5949.2010.00210.x	ADJ
cpe-2361	146	24	https://doi.org/10.1097/psy.0b013e3182738826	https://doi.org/10.1097/psy.0b013e3182738826	PROPN
cpe-2361	146	25	https://doi.org/10.1136/bmj.b5613	https://doi.org/10.1136/bmj.b5613	X
cpe-2361	147	1	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
cpe-2361	147	2	faasse	faasse	NOUN
cpe-2361	147	3	,	,	PUNCT
cpe-2361	147	4	k.	k.	NOUN
cpe-2361	147	5	,	,	PUNCT
cpe-2361	147	6	gamble	gamble	NOUN
cpe-2361	147	7	,	,	PUNCT
cpe-2361	147	8	g.	g.	NOUN
cpe-2361	147	9	,	,	PUNCT
cpe-2361	147	10	cundy	cundy	NOUN
cpe-2361	147	11	,	,	PUNCT
cpe-2361	147	12	t.	t.	PROPN
cpe-2361	147	13	,	,	PUNCT
cpe-2361	147	14	&	&	CCONJ
cpe-2361	147	15	petrie	petrie	PROPN
cpe-2361	147	16	,	,	PUNCT
cpe-2361	147	17	k.	k.	PROPN
cpe-2361	147	18	j.	j.	PROPN
cpe-2361	148	1	(	(	PUNCT
cpe-2361	148	2	2012	2012	NUM
cpe-2361	148	3	)	)	PUNCT
cpe-2361	148	4	.	.	PUNCT
cpe-2361	149	1	impact	impact	NOUN
cpe-2361	149	2	of	of	ADP
cpe-2361	149	3	television	television	NOUN
cpe-2361	149	4	coverage	coverage	NOUN
cpe-2361	149	5	on	on	ADP
cpe-2361	149	6	the	the	DET
cpe-2361	149	7	number	number	NOUN
cpe-2361	149	8	and	and	CCONJ
cpe-2361	149	9	type	type	NOUN
cpe-2361	149	10	of	of	ADP
cpe-2361	149	11	symptoms	symptom	NOUN
cpe-2361	149	12	reported	report	VERB
cpe-2361	149	13	during	during	ADP
cpe-2361	149	14	a	a	DET
cpe-2361	149	15	health	health	NOUN
cpe-2361	149	16	scare	scare	NOUN
cpe-2361	149	17	:	:	PUNCT
cpe-2361	149	18	a	a	DET
cpe-2361	149	19	retrospective	retrospective	ADJ
cpe-2361	149	20	pre	pre	ADJ
cpe-2361	149	21	–	–	PUNCT
cpe-2361	149	22	post	post	ADJ
cpe-2361	149	23	observational	observational	ADJ
cpe-2361	149	24	study	study	NOUN
cpe-2361	149	25	.	.	PUNCT
cpe-2361	150	1	bmj	bmj	PROPN
cpe-2361	150	2	open	open	ADJ
cpe-2361	150	3	,	,	PUNCT
cpe-2361	150	4	2(4	2(4	NUM
cpe-2361	150	5	)	)	PUNCT
cpe-2361	150	6	,	,	PUNCT
cpe-2361	150	7	article	article	NOUN
cpe-2361	150	8	e001607	e001607	PROPN
cpe-2361	150	9	.	.	PUNCT
cpe-2361	151	1	https://doi.org/10.1136/bmjopen-2012-001607	https://doi.org/10.1136/bmjopen-2012-001607	PROPN
cpe-2361	151	2	faasse	faasse	NOUN
cpe-2361	151	3	,	,	PUNCT
cpe-2361	151	4	k.	k.	PROPN
cpe-2361	151	5	,	,	PUNCT
cpe-2361	151	6	martin	martin	PROPN
cpe-2361	151	7	,	,	PUNCT
cpe-2361	151	8	l.	l.	PROPN
cpe-2361	151	9	r.	r.	PROPN
cpe-2361	151	10	,	,	PUNCT
cpe-2361	151	11	grey	grey	PROPN
cpe-2361	151	12	,	,	PUNCT
cpe-2361	151	13	a.	a.	NOUN
cpe-2361	151	14	,	,	PUNCT
cpe-2361	151	15	gamble	gamble	NOUN
cpe-2361	151	16	,	,	PUNCT
cpe-2361	151	17	g.	g.	PROPN
cpe-2361	151	18	,	,	PUNCT
cpe-2361	151	19	&	&	CCONJ
cpe-2361	151	20	petrie	petrie	PROPN
cpe-2361	151	21	,	,	PUNCT
cpe-2361	151	22	k.	k.	PROPN
cpe-2361	151	23	j.	j.	PROPN
cpe-2361	151	24	(	(	PUNCT
cpe-2361	151	25	2016	2016	NUM
cpe-2361	151	26	)	)	PUNCT
cpe-2361	151	27	.	.	PUNCT
cpe-2361	152	1	impact	impact	NOUN
cpe-2361	152	2	of	of	ADP
cpe-2361	152	3	brand	brand	NOUN
cpe-2361	152	4	or	or	CCONJ
cpe-2361	152	5	generic	generic	ADJ
cpe-2361	152	6	labeling	labeling	NOUN
cpe-2361	152	7	on	on	ADP
cpe-2361	152	8	medication	medication	NOUN
cpe-2361	152	9	effectiveness	effectiveness	NOUN
cpe-2361	152	10	and	and	CCONJ
cpe-2361	152	11	side	side	NOUN
cpe-2361	152	12	effects	effect	NOUN
cpe-2361	152	13	.	.	PUNCT
cpe-2361	153	1	health	health	NOUN
cpe-2361	153	2	psychology	psychology	NOUN
cpe-2361	153	3	,	,	PUNCT
cpe-2361	153	4	35(2	35(2	NUM
cpe-2361	153	5	)	)	PUNCT
cpe-2361	153	6	,	,	PUNCT
cpe-2361	153	7	187	187	NUM
cpe-2361	153	8	-	-	SYM
cpe-2361	153	9	190	190	NUM
cpe-2361	153	10	.	.	PUNCT
cpe-2361	154	1	https://doi.org/10.1037/hea0000282	https://doi.org/10.1037/hea0000282	NUM
cpe-2361	154	2	faasse	faasse	NOUN
cpe-2361	154	3	,	,	PUNCT
cpe-2361	154	4	k.	k.	PROPN
cpe-2361	154	5	,	,	PUNCT
cpe-2361	154	6	parkes	parkes	PROPN
cpe-2361	154	7	,	,	PUNCT
cpe-2361	154	8	b.	b.	PROPN
cpe-2361	154	9	,	,	PUNCT
cpe-2361	154	10	kearney	kearney	PROPN
cpe-2361	154	11	,	,	PUNCT
cpe-2361	154	12	j.	j.	PROPN
cpe-2361	154	13	,	,	PUNCT
cpe-2361	154	14	&	&	CCONJ
cpe-2361	154	15	petrie	petrie	PROPN
cpe-2361	154	16	,	,	PUNCT
cpe-2361	154	17	k.	k.	PROPN
cpe-2361	154	18	j.	j.	PROPN
cpe-2361	154	19	(	(	PUNCT
cpe-2361	154	20	2018	2018	NUM
cpe-2361	154	21	)	)	PUNCT
cpe-2361	154	22	.	.	PUNCT
cpe-2361	155	1	the	the	DET
cpe-2361	155	2	influence	influence	NOUN
cpe-2361	155	3	of	of	ADP
cpe-2361	155	4	social	social	ADJ
cpe-2361	155	5	modeling	modeling	NOUN
cpe-2361	155	6	,	,	PUNCT
cpe-2361	155	7	gender	gender	NOUN
cpe-2361	155	8	and	and	CCONJ
cpe-2361	155	9	empathy	empathy	NOUN
cpe-2361	155	10	on	on	ADP
cpe-2361	155	11	side	side	ADJ
cpe-2361	155	12	effects	effect	NOUN
cpe-2361	155	13	.	.	PUNCT
cpe-2361	156	1	annals	annal	NOUN
cpe-2361	156	2	of	of	ADP
cpe-2361	156	3	behavioral	behavioral	ADJ
cpe-2361	156	4	medicine	medicine	NOUN
cpe-2361	156	5	,	,	PUNCT
cpe-2361	156	6	52(7	52(7	NUM
cpe-2361	156	7	)	)	PUNCT
cpe-2361	156	8	,	,	PUNCT
cpe-2361	156	9	560	560	NUM
cpe-2361	156	10	-	-	SYM
cpe-2361	156	11	570	570	NUM
cpe-2361	156	12	.	.	PUNCT
cpe-2361	157	1	https://doi.org/10.1093/abm/kax025	https://doi.org/10.1093/abm/kax025	PROPN
cpe-2361	157	2	faasse	faasse	NOUN
cpe-2361	157	3	,	,	PUNCT
cpe-2361	157	4	k.	k.	PROPN
cpe-2361	157	5	,	,	PUNCT
cpe-2361	157	6	&	&	CCONJ
cpe-2361	157	7	petrie	petrie	PROPN
cpe-2361	157	8	,	,	PUNCT
cpe-2361	157	9	k.	k.	PROPN
cpe-2361	157	10	j.	j.	PROPN
cpe-2361	157	11	(	(	PUNCT
cpe-2361	157	12	2013	2013	NUM
cpe-2361	157	13	)	)	PUNCT
cpe-2361	157	14	.	.	PUNCT
cpe-2361	158	1	the	the	DET
cpe-2361	158	2	nocebo	nocebo	NOUN
cpe-2361	158	3	effect	effect	NOUN
cpe-2361	158	4	:	:	PUNCT
cpe-2361	158	5	patient	patient	ADJ
cpe-2361	158	6	expectations	expectation	NOUN
cpe-2361	158	7	and	and	CCONJ
cpe-2361	158	8	medication	medication	NOUN
cpe-2361	158	9	side	side	NOUN
cpe-2361	158	10	effects	effect	NOUN
cpe-2361	158	11	.	.	PUNCT
cpe-2361	159	1	postgraduate	postgraduate	PROPN
cpe-2361	159	2	medical	medical	ADJ
cpe-2361	159	3	journal	journal	NOUN
cpe-2361	159	4	,	,	PUNCT
cpe-2361	159	5	89(1055	89(1055	NUM
cpe-2361	159	6	)	)	PUNCT
cpe-2361	159	7	,	,	PUNCT
cpe-2361	159	8	540	540	NUM
cpe-2361	159	9	-	-	SYM
cpe-2361	159	10	546	546	NUM
cpe-2361	159	11	.	.	PUNCT
cpe-2361	160	1	https://doi.org/10.1136/postgradmedj-2012-131730	https://doi.org/10.1136/postgradmedj-2012-131730	NOUN
cpe-2361	160	2	faasse	faasse	NOUN
cpe-2361	160	3	,	,	PUNCT
cpe-2361	160	4	k.	k.	PROPN
cpe-2361	160	5	,	,	PUNCT
cpe-2361	160	6	&	&	CCONJ
cpe-2361	160	7	petrie	petrie	PROPN
cpe-2361	160	8	,	,	PUNCT
cpe-2361	160	9	k.	k.	PROPN
cpe-2361	160	10	j.	j.	PROPN
cpe-2361	160	11	(	(	PUNCT
cpe-2361	160	12	2016	2016	NUM
cpe-2361	160	13	)	)	PUNCT
cpe-2361	160	14	.	.	PUNCT
cpe-2361	161	1	from	from	ADP
cpe-2361	161	2	me	i	PRON
cpe-2361	161	3	to	to	ADP
cpe-2361	161	4	you	you	PRON
cpe-2361	161	5	:	:	PUNCT
cpe-2361	161	6	the	the	DET
cpe-2361	161	7	effect	effect	NOUN
cpe-2361	161	8	of	of	ADP
cpe-2361	161	9	social	social	ADJ
cpe-2361	161	10	modeling	modeling	NOUN
cpe-2361	161	11	on	on	ADP
cpe-2361	161	12	treatment	treatment	NOUN
cpe-2361	161	13	outcomes	outcome	NOUN
cpe-2361	161	14	.	.	PUNCT
cpe-2361	162	1	current	current	ADJ
cpe-2361	162	2	directions	direction	NOUN
cpe-2361	162	3	in	in	ADP
cpe-2361	162	4	psychological	psychological	ADJ
cpe-2361	162	5	science	science	NOUN
cpe-2361	162	6	,	,	PUNCT
cpe-2361	162	7	25(6	25(6	NOUN
cpe-2361	162	8	)	)	PUNCT
cpe-2361	162	9	,	,	PUNCT
cpe-2361	162	10	438	438	NUM
cpe-2361	162	11	-	-	SYM
cpe-2361	162	12	443	443	NUM
cpe-2361	162	13	.	.	PUNCT
cpe-2361	163	1	https://doi.org/10.1177/0963721416657316	https://doi.org/10.1177/0963721416657316	PROPN
cpe-2361	163	2	henry	henry	PROPN
cpe-2361	163	3	,	,	PUNCT
cpe-2361	163	4	d.	d.	PROPN
cpe-2361	163	5	(	(	PUNCT
cpe-2361	163	6	2018	2018	NUM
cpe-2361	163	7	,	,	PUNCT
cpe-2361	163	8	february	february	PROPN
cpe-2361	163	9	28	28	NUM
cpe-2361	163	10	)	)	PUNCT
cpe-2361	163	11	.	.	PUNCT
cpe-2361	164	1	patients	patient	NOUN
cpe-2361	164	2	say	say	VERB
cpe-2361	164	3	generic	generic	ADJ
cpe-2361	164	4	pharmac	pharmac	NOUN
cpe-2361	164	5	-	-	PUNCT
cpe-2361	164	6	funded	fund	VERB
cpe-2361	164	7	version	version	NOUN
cpe-2361	164	8	of	of	ADP
cpe-2361	164	9	antidepressant	antidepressant	ADJ
cpe-2361	164	10	venlafaxine	venlafaxine	NOUN
cpe-2361	164	11	left	leave	VERB
cpe-2361	164	12	them	they	PRON
cpe-2361	164	13	depressed	depressed	ADJ
cpe-2361	164	14	,	,	PUNCT
cpe-2361	164	15	anxious	anxious	ADJ
cpe-2361	164	16	.	.	PUNCT
cpe-2361	165	1	the	the	DET
cpe-2361	165	2	new	new	PROPN
cpe-2361	165	3	zealand	zealand	PROPN
cpe-2361	165	4	herald	herald	PROPN
cpe-2361	165	5	.	.	PUNCT
cpe-2361	165	6	retrieved	retrieve	VERB
cpe-2361	165	7	from	from	ADP
cpe-2361	165	8	http://www.nzherald.co.nz	http://www.nzherald.co.nz	PROPN
cpe-2361	165	9	kleinstäuber	kleinstäuber	PROPN
cpe-2361	165	10	,	,	PUNCT
cpe-2361	165	11	m.	m.	NOUN
cpe-2361	165	12	,	,	PUNCT
cpe-2361	165	13	mackrill	mackrill	NOUN
cpe-2361	165	14	,	,	PUNCT
cpe-2361	165	15	k.	k.	PROPN
cpe-2361	165	16	,	,	PUNCT
cpe-2361	165	17	&	&	CCONJ
cpe-2361	165	18	petrie	petrie	PROPN
cpe-2361	165	19	,	,	PUNCT
cpe-2361	165	20	k.	k.	PROPN
cpe-2361	165	21	j.	j.	PROPN
cpe-2361	165	22	(	(	PUNCT
cpe-2361	165	23	2018	2018	NUM
cpe-2361	165	24	)	)	PUNCT
cpe-2361	165	25	.	.	PUNCT
cpe-2361	166	1	characteristics	characteristic	NOUN
cpe-2361	166	2	of	of	ADP
cpe-2361	166	3	individuals	individual	NOUN
cpe-2361	166	4	who	who	PRON
cpe-2361	166	5	prefer	prefer	VERB
cpe-2361	166	6	branded	brand	VERB
cpe-2361	166	7	innovator	innovator	NOUN
cpe-2361	166	8	over	over	ADP
cpe-2361	166	9	generic	generic	ADJ
cpe-2361	166	10	medicines	medicine	NOUN
cpe-2361	166	11	:	:	PUNCT
cpe-2361	166	12	a	a	DET
cpe-2361	166	13	new	new	PROPN
cpe-2361	166	14	zealand	zealand	PROPN
cpe-2361	166	15	general	general	ADJ
cpe-2361	166	16	population	population	NOUN
cpe-2361	166	17	survey	survey	NOUN
cpe-2361	166	18	.	.	PUNCT
cpe-2361	167	1	drugs	drug	NOUN
cpe-2361	167	2	&	&	CCONJ
cpe-2361	167	3	therapy	therapy	NOUN
cpe-2361	167	4	perspectives	perspective	NOUN
cpe-2361	167	5	,	,	PUNCT
cpe-2361	167	6	34(10	34(10	NUM
cpe-2361	167	7	)	)	PUNCT
cpe-2361	167	8	,	,	PUNCT
cpe-2361	167	9	478	478	NUM
cpe-2361	167	10	-	-	SYM
cpe-2361	167	11	483	483	NUM
cpe-2361	167	12	.	.	PUNCT
cpe-2361	168	1	https://doi.org/10.1007/s40267-018-0541-z	https://doi.org/10.1007/s40267-018-0541-z	PROPN
cpe-2361	168	2	leclerc	leclerc	PROPN
cpe-2361	168	3	,	,	PUNCT
cpe-2361	168	4	j.	j.	PROPN
cpe-2361	168	5	,	,	PUNCT
cpe-2361	168	6	blais	blais	PROPN
cpe-2361	168	7	,	,	PUNCT
cpe-2361	168	8	c.	c.	PROPN
cpe-2361	168	9	,	,	PUNCT
cpe-2361	168	10	rochette	rochette	NOUN
cpe-2361	168	11	,	,	PUNCT
cpe-2361	168	12	l.	l.	PROPN
cpe-2361	168	13	,	,	PUNCT
cpe-2361	168	14	hamel	hamel	PROPN
cpe-2361	168	15	,	,	PUNCT
cpe-2361	168	16	d.	d.	PROPN
cpe-2361	168	17	,	,	PUNCT
cpe-2361	168	18	guénette	guénette	NOUN
cpe-2361	168	19	,	,	PUNCT
cpe-2361	168	20	l.	l.	PROPN
cpe-2361	168	21	,	,	PUNCT
cpe-2361	168	22	&	&	CCONJ
cpe-2361	168	23	poirier	poirier	PROPN
cpe-2361	168	24	,	,	PUNCT
cpe-2361	168	25	p.	p.	NOUN
cpe-2361	168	26	(	(	PUNCT
cpe-2361	168	27	2017	2017	NUM
cpe-2361	168	28	)	)	PUNCT
cpe-2361	168	29	.	.	PUNCT
cpe-2361	169	1	impact	impact	NOUN
cpe-2361	169	2	of	of	ADP
cpe-2361	169	3	the	the	DET
cpe-2361	169	4	commercialization	commercialization	NOUN
cpe-2361	169	5	of	of	ADP
cpe-2361	169	6	three	three	NUM
cpe-2361	169	7	generic	generic	ADJ
cpe-2361	169	8	angiotensin	angiotensin	NOUN
cpe-2361	169	9	ii	ii	PROPN
cpe-2361	169	10	receptor	receptor	NOUN
cpe-2361	169	11	blockers	blocker	NOUN
cpe-2361	169	12	on	on	ADP
cpe-2361	169	13	adverse	adverse	ADJ
cpe-2361	169	14	events	event	NOUN
cpe-2361	169	15	in	in	ADP
cpe-2361	169	16	quebec	quebec	PROPN
cpe-2361	169	17	,	,	PUNCT
cpe-2361	169	18	canada	canada	PROPN
cpe-2361	169	19	:	:	PUNCT
cpe-2361	169	20	a	a	DET
cpe-2361	169	21	population	population	NOUN
cpe-2361	169	22	-	-	PUNCT
cpe-2361	169	23	based	base	VERB
cpe-2361	169	24	time	time	NOUN
cpe-2361	169	25	series	series	PROPN
cpe-2361	169	26	analysis	analysis	NOUN
cpe-2361	169	27	.	.	PUNCT
cpe-2361	170	1	circulation	circulation	NOUN
cpe-2361	170	2	:	:	PUNCT
cpe-2361	170	3	cardiovascular	cardiovascular	ADJ
cpe-2361	170	4	quality	quality	NOUN
cpe-2361	170	5	and	and	CCONJ
cpe-2361	170	6	outcomes	outcome	NOUN
cpe-2361	170	7	,	,	PUNCT
cpe-2361	170	8	10(10	10(10	NUM
cpe-2361	170	9	)	)	PUNCT
cpe-2361	170	10	,	,	PUNCT
cpe-2361	170	11	article	article	NOUN
cpe-2361	170	12	e003891	e003891	PROPN
cpe-2361	170	13	.	.	PUNCT
cpe-2361	171	1	https://doi.org/10.1161/circoutcomes.117.003891	https://doi.org/10.1161/circoutcomes.117.003891	PROPN
cpe-2361	171	2	mackrill	mackrill	X
cpe-2361	171	3	,	,	PUNCT
cpe-2361	171	4	k.	k.	PROPN
cpe-2361	171	5	,	,	PUNCT
cpe-2361	171	6	&	&	CCONJ
cpe-2361	171	7	petrie	petrie	PROPN
cpe-2361	171	8	,	,	PUNCT
cpe-2361	171	9	k.	k.	PROPN
cpe-2361	171	10	j.	j.	PROPN
cpe-2361	171	11	(	(	PUNCT
cpe-2361	171	12	2018	2018	NUM
cpe-2361	171	13	)	)	PUNCT
cpe-2361	171	14	.	.	PUNCT
cpe-2361	172	1	what	what	PRON
cpe-2361	172	2	is	be	AUX
cpe-2361	172	3	associated	associate	VERB
cpe-2361	172	4	with	with	ADP
cpe-2361	172	5	increased	increase	VERB
cpe-2361	172	6	side	side	NOUN
cpe-2361	172	7	effects	effect	NOUN
cpe-2361	172	8	and	and	CCONJ
cpe-2361	172	9	lower	low	ADJ
cpe-2361	172	10	perceived	perceive	VERB
cpe-2361	172	11	efficacy	efficacy	NOUN
cpe-2361	172	12	following	follow	VERB
cpe-2361	172	13	switching	switch	VERB
cpe-2361	172	14	to	to	ADP
cpe-2361	172	15	a	a	DET
cpe-2361	172	16	generic	generic	ADJ
cpe-2361	172	17	medicine	medicine	NOUN
cpe-2361	172	18	?	?	PUNCT
cpe-2361	173	1	a	a	DET
cpe-2361	173	2	new	new	PROPN
cpe-2361	173	3	zealand	zealand	PROPN
cpe-2361	173	4	cross	cross	ADJ
cpe-2361	173	5	-	-	ADJ
cpe-2361	173	6	sectional	sectional	ADJ
cpe-2361	173	7	patient	patient	ADJ
cpe-2361	173	8	survey	survey	NOUN
cpe-2361	173	9	.	.	PUNCT
cpe-2361	174	1	bmj	bmj	PROPN
cpe-2361	174	2	open	open	ADJ
cpe-2361	174	3	,	,	PUNCT
cpe-2361	174	4	8(10	8(10	NUM
cpe-2361	174	5	)	)	PUNCT
cpe-2361	174	6	,	,	PUNCT
cpe-2361	174	7	article	article	NOUN
cpe-2361	174	8	e023667	e023667	PROPN
cpe-2361	174	9	.	.	PUNCT
cpe-2361	175	1	https://doi.org/10.1136/bmjopen-2018-023667	https://doi.org/10.1136/bmjopen-2018-023667	PROPN
cpe-2361	175	2	matthews	matthews	PROPN
cpe-2361	175	3	,	,	PUNCT
cpe-2361	175	4	a.	a.	NOUN
cpe-2361	175	5	,	,	PUNCT
cpe-2361	175	6	herrett	herrett	PROPN
cpe-2361	175	7	,	,	PUNCT
cpe-2361	175	8	e.	e.	PROPN
cpe-2361	175	9	,	,	PUNCT
cpe-2361	175	10	gasparrini	gasparrini	PROPN
cpe-2361	175	11	,	,	PUNCT
cpe-2361	175	12	a.	a.	PROPN
cpe-2361	175	13	,	,	PUNCT
cpe-2361	175	14	van	van	PROPN
cpe-2361	175	15	staa	staa	ADV
cpe-2361	175	16	,	,	PUNCT
cpe-2361	175	17	t.	t.	PROPN
cpe-2361	175	18	,	,	PUNCT
cpe-2361	175	19	goldacre	goldacre	PROPN
cpe-2361	175	20	,	,	PUNCT
cpe-2361	175	21	b.	b.	PROPN
cpe-2361	175	22	,	,	PUNCT
cpe-2361	175	23	smeeth	smeeth	PROPN
cpe-2361	175	24	,	,	PUNCT
cpe-2361	175	25	l.	l.	PROPN
cpe-2361	175	26	,	,	PUNCT
cpe-2361	175	27	&	&	CCONJ
cpe-2361	175	28	bhaskaran	bhaskaran	PROPN
cpe-2361	175	29	,	,	PUNCT
cpe-2361	175	30	k.	k.	PROPN
cpe-2361	175	31	(	(	PUNCT
cpe-2361	175	32	2016	2016	NUM
cpe-2361	175	33	)	)	PUNCT
cpe-2361	175	34	.	.	PUNCT
cpe-2361	176	1	impact	impact	NOUN
cpe-2361	176	2	of	of	ADP
cpe-2361	176	3	statin	statin	ADJ
cpe-2361	176	4	related	related	ADJ
cpe-2361	176	5	media	medium	NOUN
cpe-2361	176	6	coverage	coverage	NOUN
cpe-2361	176	7	on	on	ADP
cpe-2361	176	8	use	use	NOUN
cpe-2361	176	9	of	of	ADP
cpe-2361	176	10	statins	statin	NOUN
cpe-2361	176	11	:	:	PUNCT
cpe-2361	176	12	interrupted	interrupt	VERB
cpe-2361	176	13	time	time	NOUN
cpe-2361	176	14	series	series	PROPN
cpe-2361	176	15	analysis	analysis	NOUN
cpe-2361	176	16	with	with	ADP
cpe-2361	176	17	uk	uk	PROPN
cpe-2361	176	18	primary	primary	ADJ
cpe-2361	176	19	care	care	NOUN
cpe-2361	176	20	data	data	PROPN
cpe-2361	176	21	.	.	PUNCT
cpe-2361	177	1	bmj	bmj	PROPN
cpe-2361	177	2	:	:	PUNCT
cpe-2361	177	3	clinical	clinical	ADJ
cpe-2361	177	4	research	research	NOUN
cpe-2361	177	5	edition	edition	NOUN
cpe-2361	177	6	,	,	PUNCT
cpe-2361	177	7	353	353	NUM
cpe-2361	177	8	,	,	PUNCT
cpe-2361	177	9	article	article	NOUN
cpe-2361	177	10	i3283	i3283	PROPN
cpe-2361	177	11	.	.	PUNCT
cpe-2361	178	1	https://doi.org/10.1136/bmj.i3283	https://doi.org/10.1136/bmj.i3283	NUM
cpe-2361	178	2	maude	maude	NOUN
cpe-2361	178	3	,	,	PUNCT
cpe-2361	178	4	s.	s.	PROPN
cpe-2361	178	5	(	(	PUNCT
cpe-2361	178	6	2018	2018	NUM
cpe-2361	178	7	,	,	PUNCT
cpe-2361	178	8	february	february	PROPN
cpe-2361	178	9	28	28	NUM
cpe-2361	178	10	)	)	PUNCT
cpe-2361	178	11	.	.	PUNCT
cpe-2361	179	1	anti	anti	ADJ
cpe-2361	179	2	-	-	ADJ
cpe-2361	179	3	depressant	depressant	ADJ
cpe-2361	179	4	swap	swap	NOUN
cpe-2361	179	5	:	:	PUNCT
cpe-2361	179	6	sufferers	sufferer	NOUN
cpe-2361	179	7	claim	claim	VERB
cpe-2361	179	8	generic	generic	ADJ
cpe-2361	179	9	drug	drug	NOUN
cpe-2361	179	10	is	be	AUX
cpe-2361	179	11	harming	harm	VERB
cpe-2361	179	12	their	their	PRON
cpe-2361	179	13	condition	condition	NOUN
cpe-2361	179	14	.	.	PUNCT
cpe-2361	180	1	stuff	stuff	NOUN
cpe-2361	180	2	.	.	PUNCT
cpe-2361	181	1	retrieved	retrieve	VERB
cpe-2361	181	2	from	from	ADP
cpe-2361	181	3	https://www.stuff.co.nz	https://www.stuff.co.nz	PROPN
cpe-2361	181	4	mcgettigan	mcgettigan	NOUN
cpe-2361	181	5	,	,	PUNCT
cpe-2361	181	6	p.	p.	NOUN
cpe-2361	181	7	,	,	PUNCT
cpe-2361	181	8	golden	golden	PROPN
cpe-2361	181	9	,	,	PUNCT
cpe-2361	181	10	j.	j.	PROPN
cpe-2361	181	11	,	,	PUNCT
cpe-2361	181	12	conroy	conroy	PROPN
cpe-2361	181	13	,	,	PUNCT
cpe-2361	181	14	r.	r.	PROPN
cpe-2361	181	15	m.	m.	PROPN
cpe-2361	181	16	,	,	PUNCT
cpe-2361	181	17	arthur	arthur	PROPN
cpe-2361	181	18	,	,	PUNCT
cpe-2361	181	19	n.	n.	PROPN
cpe-2361	181	20	,	,	PUNCT
cpe-2361	181	21	&	&	CCONJ
cpe-2361	181	22	feely	feely	ADV
cpe-2361	181	23	,	,	PUNCT
cpe-2361	181	24	j.	j.	PROPN
cpe-2361	181	25	(	(	PUNCT
cpe-2361	181	26	1997	1997	NUM
cpe-2361	181	27	)	)	PUNCT
cpe-2361	181	28	.	.	PUNCT
cpe-2361	182	1	reporting	reporting	NOUN
cpe-2361	182	2	of	of	ADP
cpe-2361	182	3	adverse	adverse	ADJ
cpe-2361	182	4	drug	drug	NOUN
cpe-2361	182	5	reactions	reaction	NOUN
cpe-2361	182	6	by	by	ADP
cpe-2361	182	7	hospital	hospital	NOUN
cpe-2361	182	8	doctors	doctor	NOUN
cpe-2361	182	9	and	and	CCONJ
cpe-2361	182	10	the	the	DET
cpe-2361	182	11	response	response	NOUN
cpe-2361	182	12	to	to	ADP
cpe-2361	182	13	intervention	intervention	NOUN
cpe-2361	182	14	.	.	PUNCT
cpe-2361	183	1	british	british	ADJ
cpe-2361	183	2	journal	journal	PROPN
cpe-2361	183	3	of	of	ADP
cpe-2361	183	4	clinical	clinical	ADJ
cpe-2361	183	5	pharmacology	pharmacology	NOUN
cpe-2361	183	6	,	,	PUNCT
cpe-2361	183	7	44(1	44(1	PROPN
cpe-2361	183	8	)	)	PUNCT
cpe-2361	183	9	,	,	PUNCT
cpe-2361	183	10	98	98	NUM
cpe-2361	183	11	-	-	SYM
cpe-2361	183	12	100	100	NUM
cpe-2361	183	13	.	.	PUNCT
cpe-2361	184	1	https://doi.org/10.1046/j.1365-2125.1997.00616.x	https://doi.org/10.1046/j.1365-2125.1997.00616.x	PROPN
cpe-2361	184	2	mondaini	mondaini	NOUN
cpe-2361	184	3	,	,	PUNCT
cpe-2361	184	4	n.	n.	NOUN
cpe-2361	184	5	,	,	PUNCT
cpe-2361	184	6	gontero	gontero	NOUN
cpe-2361	184	7	,	,	PUNCT
cpe-2361	184	8	p.	p.	PROPN
cpe-2361	184	9	,	,	PUNCT
cpe-2361	184	10	giubilei	giubilei	PROPN
cpe-2361	184	11	,	,	PUNCT
cpe-2361	184	12	g.	g.	PROPN
cpe-2361	184	13	,	,	PUNCT
cpe-2361	184	14	lombardi	lombardi	PROPN
cpe-2361	184	15	,	,	PUNCT
cpe-2361	184	16	g.	g.	PROPN
cpe-2361	184	17	,	,	PUNCT
cpe-2361	184	18	cai	cai	PROPN
cpe-2361	184	19	,	,	PUNCT
cpe-2361	184	20	t.	t.	PROPN
cpe-2361	184	21	,	,	PUNCT
cpe-2361	184	22	gavazzi	gavazzi	NOUN
cpe-2361	184	23	,	,	PUNCT
cpe-2361	184	24	a.	a.	NOUN
cpe-2361	184	25	,	,	PUNCT
cpe-2361	184	26	&	&	CCONJ
cpe-2361	184	27	bartoletti	bartoletti	PROPN
cpe-2361	184	28	,	,	PUNCT
cpe-2361	184	29	r.	r.	PROPN
cpe-2361	184	30	(	(	PUNCT
cpe-2361	184	31	2007	2007	NUM
cpe-2361	184	32	)	)	PUNCT
cpe-2361	184	33	.	.	PUNCT
cpe-2361	185	1	finasteride	finasteride	ADJ
cpe-2361	185	2	5	5	NUM
cpe-2361	185	3	mg	mg	NOUN
cpe-2361	185	4	and	and	CCONJ
cpe-2361	185	5	sexual	sexual	ADJ
cpe-2361	185	6	side	side	NOUN
cpe-2361	185	7	effects	effect	NOUN
cpe-2361	185	8	:	:	PUNCT
cpe-2361	185	9	how	how	SCONJ
cpe-2361	185	10	many	many	ADJ
cpe-2361	185	11	of	of	ADP
cpe-2361	185	12	these	these	PRON
cpe-2361	185	13	are	be	AUX
cpe-2361	185	14	related	relate	VERB
cpe-2361	185	15	to	to	ADP
cpe-2361	185	16	a	a	DET
cpe-2361	185	17	nocebo	nocebo	NOUN
cpe-2361	185	18	mackrill	mackrill	NOUN
cpe-2361	185	19	,	,	PUNCT
cpe-2361	185	20	gamble	gamble	ADJ
cpe-2361	185	21	,	,	PUNCT
cpe-2361	185	22	bean	bean	NOUN
cpe-2361	185	23	et	et	PROPN
cpe-2361	185	24	al	al	PROPN
cpe-2361	185	25	.	.	PROPN
cpe-2361	185	26	11	11	NUM
cpe-2361	185	27	clinical	clinical	ADJ
cpe-2361	185	28	psychology	psychology	NOUN
cpe-2361	185	29	in	in	ADP
cpe-2361	185	30	europe	europe	PROPN
cpe-2361	185	31	2019	2019	NUM
cpe-2361	185	32	,	,	PUNCT
cpe-2361	185	33	vol.1(1	vol.1(1	NOUN
cpe-2361	185	34	)	)	PUNCT
cpe-2361	185	35	,	,	PUNCT
cpe-2361	185	36	article	article	NOUN
cpe-2361	185	37	e29642	e29642	VERB
cpe-2361	185	38	https://doi.org/10.32872/cpe.v1i1.29642	https://doi.org/10.32872/cpe.v1i1.29642	PROPN
cpe-2361	185	39	https://doi.org/10.1136/bmjopen-2012-001607	https://doi.org/10.1136/bmjopen-2012-001607	PROPN
cpe-2361	185	40	https://doi.org/10.1037/hea0000282	https://doi.org/10.1037/hea0000282	VERB
cpe-2361	185	41	https://doi.org/10.1093/abm/kax025	https://doi.org/10.1093/abm/kax025	PROPN
cpe-2361	185	42	https://doi.org/10.1136/postgradmedj-2012-131730	https://doi.org/10.1136/postgradmedj-2012-131730	ADV
cpe-2361	186	1	https://doi.org/10.1177/0963721416657316	https://doi.org/10.1177/0963721416657316	ADJ
cpe-2361	186	2	http://www.nzherald.co.nz	http://www.nzherald.co.nz	NOUN
cpe-2361	186	3	https://doi.org/10.1007/s40267-018-0541-z	https://doi.org/10.1007/s40267-018-0541-z	PROPN
cpe-2361	186	4	https://doi.org/10.1161/circoutcomes.117.003891	https://doi.org/10.1161/circoutcomes.117.003891	PROPN
cpe-2361	186	5	https://doi.org/10.1136/bmjopen-2018-023667	https://doi.org/10.1136/bmjopen-2018-023667	PROPN
cpe-2361	186	6	https://doi.org/10.1136/bmj.i3283	https://doi.org/10.1136/bmj.i3283	NUM
cpe-2361	186	7	https://www.stuff.co.nz	https://www.stuff.co.nz	PROPN
cpe-2361	186	8	https://doi.org/10.1046/j.1365-2125.1997.00616.x	https://doi.org/10.1046/j.1365-2125.1997.00616.x	VERB
cpe-2361	186	9	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
cpe-2361	186	10	phenomenon	phenomenon	NOUN
cpe-2361	186	11	?	?	PUNCT
cpe-2361	187	1	journal	journal	NOUN
cpe-2361	187	2	of	of	ADP
cpe-2361	187	3	sexual	sexual	ADJ
cpe-2361	187	4	medicine	medicine	NOUN
cpe-2361	187	5	,	,	PUNCT
cpe-2361	187	6	4(6	4(6	NUM
cpe-2361	187	7	)	)	PUNCT
cpe-2361	187	8	,	,	PUNCT
cpe-2361	187	9	1708	1708	NUM
cpe-2361	187	10	-	-	SYM
cpe-2361	187	11	1712	1712	NUM
cpe-2361	187	12	.	.	PUNCT
cpe-2361	188	1	https://doi.org/10.1111/j.1743-6109.2007.00563.x	https://doi.org/10.1111/j.1743-6109.2007.00563.x	AUX
cpe-2361	188	2	myers	myers	PROPN
cpe-2361	188	3	,	,	PUNCT
cpe-2361	188	4	m.	m.	NOUN
cpe-2361	188	5	g.	g.	PROPN
cpe-2361	188	6	,	,	PUNCT
cpe-2361	188	7	cairns	cairns	PROPN
cpe-2361	188	8	,	,	PUNCT
cpe-2361	188	9	j.	j.	PROPN
cpe-2361	188	10	a.	a.	PROPN
cpe-2361	188	11	,	,	PUNCT
cpe-2361	188	12	&	&	CCONJ
cpe-2361	188	13	singer	singer	PROPN
cpe-2361	188	14	,	,	PUNCT
cpe-2361	188	15	j.	j.	PROPN
cpe-2361	188	16	(	(	PUNCT
cpe-2361	188	17	1987	1987	NUM
cpe-2361	188	18	)	)	PUNCT
cpe-2361	188	19	.	.	PUNCT
cpe-2361	189	1	the	the	DET
cpe-2361	189	2	consent	consent	NOUN
cpe-2361	189	3	form	form	NOUN
cpe-2361	189	4	as	as	ADP
cpe-2361	189	5	a	a	DET
cpe-2361	189	6	possible	possible	ADJ
cpe-2361	189	7	cause	cause	NOUN
cpe-2361	189	8	of	of	ADP
cpe-2361	189	9	side	side	NOUN
cpe-2361	189	10	effects	effect	NOUN
cpe-2361	189	11	.	.	PUNCT
cpe-2361	190	1	clinical	clinical	ADJ
cpe-2361	190	2	pharmacology	pharmacology	NOUN
cpe-2361	190	3	and	and	CCONJ
cpe-2361	190	4	therapeutics	therapeutic	NOUN
cpe-2361	190	5	,	,	PUNCT
cpe-2361	190	6	42(3	42(3	NUM
cpe-2361	190	7	)	)	PUNCT
cpe-2361	190	8	,	,	PUNCT
cpe-2361	190	9	250	250	NUM
cpe-2361	190	10	-	-	SYM
cpe-2361	190	11	253	253	NUM
cpe-2361	190	12	.	.	PUNCT
cpe-2361	191	1	https://doi.org/10.1038/clpt.1987.142	https://doi.org/10.1038/clpt.1987.142	PROPN
cpe-2361	191	2	nielsen	nielsen	PROPN
cpe-2361	191	3	,	,	PUNCT
cpe-2361	191	4	s.	s.	PROPN
cpe-2361	191	5	f.	f.	PROPN
cpe-2361	191	6	,	,	PUNCT
cpe-2361	191	7	&	&	CCONJ
cpe-2361	191	8	nordestgaard	nordestgaard	PROPN
cpe-2361	191	9	,	,	PUNCT
cpe-2361	191	10	b.	b.	PROPN
cpe-2361	191	11	g.	g.	PROPN
cpe-2361	191	12	(	(	PUNCT
cpe-2361	191	13	2016	2016	NUM
cpe-2361	191	14	)	)	PUNCT
cpe-2361	191	15	.	.	PUNCT
cpe-2361	192	1	negative	negative	ADJ
cpe-2361	192	2	statin	statin	PROPN
cpe-2361	192	3	-	-	PUNCT
cpe-2361	192	4	related	relate	VERB
cpe-2361	192	5	news	news	NOUN
cpe-2361	192	6	stories	story	NOUN
cpe-2361	192	7	decrease	decrease	VERB
cpe-2361	192	8	statin	statin	ADJ
cpe-2361	192	9	persistence	persistence	NOUN
cpe-2361	192	10	and	and	CCONJ
cpe-2361	192	11	increase	increase	VERB
cpe-2361	192	12	myocardial	myocardial	ADJ
cpe-2361	192	13	infarction	infarction	NOUN
cpe-2361	192	14	and	and	CCONJ
cpe-2361	192	15	cardiovascular	cardiovascular	ADJ
cpe-2361	192	16	mortality	mortality	NOUN
cpe-2361	192	17	:	:	PUNCT
cpe-2361	192	18	a	a	DET
cpe-2361	192	19	nationwide	nationwide	ADJ
cpe-2361	192	20	prospective	prospective	ADJ
cpe-2361	192	21	cohort	cohort	NOUN
cpe-2361	192	22	study	study	NOUN
cpe-2361	192	23	.	.	PUNCT
cpe-2361	193	1	european	european	ADJ
cpe-2361	193	2	heart	heart	PROPN
cpe-2361	193	3	journal	journal	PROPN
cpe-2361	193	4	,	,	PUNCT
cpe-2361	193	5	37(11	37(11	NUM
cpe-2361	193	6	)	)	PUNCT
cpe-2361	193	7	,	,	PUNCT
cpe-2361	193	8	908	908	NUM
cpe-2361	193	9	-	-	SYM
cpe-2361	193	10	916	916	NUM
cpe-2361	193	11	.	.	PUNCT
cpe-2361	194	1	https://doi.org/10.1093/eurheartj/ehv641	https://doi.org/10.1093/eurheartj/ehv641	PROPN
cpe-2361	194	2	petrie	petrie	PROPN
cpe-2361	194	3	,	,	PUNCT
cpe-2361	194	4	k.	k.	PROPN
cpe-2361	194	5	j.	j.	PROPN
cpe-2361	194	6	,	,	PUNCT
cpe-2361	194	7	&	&	CCONJ
cpe-2361	194	8	rief	rief	PROPN
cpe-2361	194	9	,	,	PUNCT
cpe-2361	194	10	w.	w.	PROPN
cpe-2361	194	11	(	(	PUNCT
cpe-2361	194	12	2019	2019	NUM
cpe-2361	194	13	)	)	PUNCT
cpe-2361	194	14	.	.	PUNCT
cpe-2361	195	1	psychobiological	psychobiological	ADJ
cpe-2361	195	2	mechanisms	mechanism	NOUN
cpe-2361	195	3	of	of	ADP
cpe-2361	195	4	placebo	placebo	NOUN
cpe-2361	195	5	and	and	CCONJ
cpe-2361	195	6	nocebo	nocebo	NOUN
cpe-2361	195	7	effects	effect	NOUN
cpe-2361	195	8	:	:	PUNCT
cpe-2361	195	9	pathways	pathway	NOUN
cpe-2361	195	10	to	to	PART
cpe-2361	195	11	improve	improve	VERB
cpe-2361	195	12	treatments	treatment	NOUN
cpe-2361	195	13	and	and	CCONJ
cpe-2361	195	14	reduce	reduce	VERB
cpe-2361	195	15	side	side	NOUN
cpe-2361	195	16	effects	effect	NOUN
cpe-2361	195	17	.	.	PUNCT
cpe-2361	196	1	annual	annual	ADJ
cpe-2361	196	2	review	review	NOUN
cpe-2361	196	3	of	of	ADP
cpe-2361	196	4	psychology	psychology	NOUN
cpe-2361	196	5	,	,	PUNCT
cpe-2361	196	6	70(1	70(1	NOUN
cpe-2361	196	7	)	)	PUNCT
cpe-2361	196	8	,	,	PUNCT
cpe-2361	196	9	599	599	NUM
cpe-2361	196	10	-	-	SYM
cpe-2361	196	11	625	625	NUM
cpe-2361	196	12	.	.	PUNCT
cpe-2361	197	1	https://doi.org/10.1146/annurev-psych-010418-102907	https://doi.org/10.1146/annurev-psych-010418-102907	PROPN
cpe-2361	197	2	smith	smith	PROPN
cpe-2361	197	3	,	,	PUNCT
cpe-2361	197	4	c.	c.	PROPN
cpe-2361	197	5	c.	c.	PROPN
cpe-2361	197	6	,	,	PUNCT
cpe-2361	197	7	bennett	bennett	PROPN
cpe-2361	197	8	,	,	PUNCT
cpe-2361	197	9	p.	p.	PROPN
cpe-2361	197	10	m.	m.	NOUN
cpe-2361	197	11	,	,	PUNCT
cpe-2361	197	12	pearce	pearce	PROPN
cpe-2361	197	13	,	,	PUNCT
cpe-2361	197	14	h.	h.	PROPN
cpe-2361	197	15	m.	m.	PROPN
cpe-2361	197	16	,	,	PUNCT
cpe-2361	197	17	harrison	harrison	PROPN
cpe-2361	197	18	,	,	PUNCT
cpe-2361	197	19	p.	p.	NOUN
cpe-2361	197	20	i.	i.	PROPN
cpe-2361	197	21	,	,	PUNCT
cpe-2361	197	22	reynolds	reynolds	PROPN
cpe-2361	197	23	,	,	PUNCT
cpe-2361	197	24	d.	d.	PROPN
cpe-2361	197	25	j.	j.	PROPN
cpe-2361	197	26	m.	m.	PROPN
cpe-2361	197	27	,	,	PUNCT
cpe-2361	197	28	aronson	aronson	PROPN
cpe-2361	197	29	,	,	PUNCT
cpe-2361	197	30	j.	j.	PROPN
cpe-2361	197	31	k.	k.	PROPN
cpe-2361	197	32	,	,	PUNCT
cpe-2361	197	33	&	&	CCONJ
cpe-2361	197	34	grahame	grahame	PROPN
cpe-2361	197	35	-	-	PUNCT
cpe-2361	197	36	smith	smith	PROPN
cpe-2361	197	37	,	,	PUNCT
cpe-2361	197	38	d.	d.	PROPN
cpe-2361	197	39	g.	g.	PROPN
cpe-2361	197	40	(	(	PUNCT
cpe-2361	197	41	1996	1996	NUM
cpe-2361	197	42	)	)	PUNCT
cpe-2361	197	43	.	.	PUNCT
cpe-2361	198	1	adverse	adverse	ADJ
cpe-2361	198	2	drug	drug	NOUN
cpe-2361	198	3	reactions	reaction	NOUN
cpe-2361	198	4	in	in	ADP
cpe-2361	198	5	a	a	DET
cpe-2361	198	6	hospital	hospital	NOUN
cpe-2361	198	7	general	general	ADJ
cpe-2361	198	8	medical	medical	ADJ
cpe-2361	198	9	unit	unit	NOUN
cpe-2361	198	10	meriting	merit	VERB
cpe-2361	198	11	notification	notification	NOUN
cpe-2361	198	12	to	to	ADP
cpe-2361	198	13	the	the	DET
cpe-2361	198	14	committee	committee	NOUN
cpe-2361	198	15	on	on	ADP
cpe-2361	198	16	safety	safety	NOUN
cpe-2361	198	17	of	of	ADP
cpe-2361	198	18	medicines	medicine	NOUN
cpe-2361	198	19	.	.	PUNCT
cpe-2361	199	1	british	british	ADJ
cpe-2361	199	2	journal	journal	PROPN
cpe-2361	199	3	of	of	ADP
cpe-2361	199	4	clinical	clinical	ADJ
cpe-2361	199	5	pharmacology	pharmacology	NOUN
cpe-2361	199	6	,	,	PUNCT
cpe-2361	199	7	42(4	42(4	PROPN
cpe-2361	199	8	)	)	PUNCT
cpe-2361	199	9	,	,	PUNCT
cpe-2361	199	10	423	423	NUM
cpe-2361	199	11	-	-	SYM
cpe-2361	199	12	429	429	NUM
cpe-2361	199	13	.	.	PUNCT
cpe-2361	200	1	https://doi.org/10.1111/j.1365-2125.1996.tb00004.x	https://doi.org/10.1111/j.1365-2125.1996.tb00004.x	PROPN
cpe-2361	200	2	steele	steele	PROPN
cpe-2361	200	3	,	,	PUNCT
cpe-2361	200	4	m.	m.	NOUN
cpe-2361	200	5	(	(	PUNCT
cpe-2361	200	6	2018	2018	NUM
cpe-2361	200	7	)	)	PUNCT
cpe-2361	200	8	.	.	PUNCT
cpe-2361	201	1	fight	fight	VERB
cpe-2361	201	2	over	over	ADP
cpe-2361	201	3	pharmac	pharmac	NOUN
cpe-2361	201	4	's	's	PART
cpe-2361	201	5	switch	switch	NOUN
cpe-2361	201	6	to	to	ADP
cpe-2361	201	7	generic	generic	ADJ
cpe-2361	201	8	anti	anti	ADJ
cpe-2361	201	9	-	-	ADJ
cpe-2361	201	10	depressant	depressant	ADJ
cpe-2361	201	11	brand	brand	NOUN
cpe-2361	201	12	continues	continue	VERB
cpe-2361	201	13	.	.	PUNCT
cpe-2361	202	1	stuff	stuff	NOUN
cpe-2361	202	2	.	.	PUNCT
cpe-2361	203	1	retrieved	retrieve	VERB
cpe-2361	203	2	from	from	ADP
cpe-2361	203	3	https://www.stuff.co.nz	https://www.stuff.co.nz	PROPN
cpe-2361	203	4	verrender	verrender	NOUN
cpe-2361	203	5	,	,	PUNCT
cpe-2361	203	6	a.	a.	NOUN
cpe-2361	203	7	,	,	PUNCT
cpe-2361	203	8	loughran	loughran	NOUN
cpe-2361	203	9	,	,	PUNCT
cpe-2361	203	10	s.	s.	PROPN
cpe-2361	203	11	p.	p.	PROPN
cpe-2361	203	12	,	,	PUNCT
cpe-2361	203	13	dalecki	dalecki	PROPN
cpe-2361	203	14	,	,	PUNCT
cpe-2361	203	15	a.	a.	NOUN
cpe-2361	203	16	,	,	PUNCT
cpe-2361	203	17	freudenstein	freudenstein	PROPN
cpe-2361	203	18	,	,	PUNCT
cpe-2361	203	19	f.	f.	PROPN
cpe-2361	203	20	,	,	PUNCT
cpe-2361	203	21	&	&	CCONJ
cpe-2361	203	22	croft	croft	PROPN
cpe-2361	203	23	,	,	PUNCT
cpe-2361	203	24	r.	r.	PROPN
cpe-2361	203	25	j.	j.	PROPN
cpe-2361	203	26	(	(	PUNCT
cpe-2361	203	27	2018	2018	NUM
cpe-2361	203	28	)	)	PUNCT
cpe-2361	203	29	.	.	PUNCT
cpe-2361	204	1	can	can	AUX
cpe-2361	204	2	explicit	explicit	VERB
cpe-2361	204	3	suggestions	suggestion	NOUN
cpe-2361	204	4	about	about	ADP
cpe-2361	204	5	the	the	DET
cpe-2361	204	6	harmfulness	harmfulness	NOUN
cpe-2361	204	7	of	of	ADP
cpe-2361	204	8	emf	emf	NOUN
cpe-2361	204	9	exposure	exposure	NOUN
cpe-2361	204	10	exacerbate	exacerbate	VERB
cpe-2361	204	11	a	a	DET
cpe-2361	204	12	nocebo	nocebo	NOUN
cpe-2361	204	13	response	response	NOUN
cpe-2361	204	14	in	in	ADP
cpe-2361	204	15	healthy	healthy	ADJ
cpe-2361	204	16	controls	control	NOUN
cpe-2361	204	17	?	?	PUNCT
cpe-2361	205	1	environmental	environmental	ADJ
cpe-2361	205	2	research	research	NOUN
cpe-2361	205	3	,	,	PUNCT
cpe-2361	205	4	166	166	NUM
cpe-2361	205	5	,	,	PUNCT
cpe-2361	205	6	409	409	NUM
cpe-2361	205	7	-	-	SYM
cpe-2361	205	8	417	417	NUM
cpe-2361	205	9	.	.	PUNCT
cpe-2361	206	1	https://doi.org/10.1016/j.envres.2018.06.032	https://doi.org/10.1016/j.envres.2018.06.032	PROPN
cpe-2361	206	2	watson	watson	PROPN
cpe-2361	206	3	,	,	PUNCT
cpe-2361	206	4	d.	d.	PROPN
cpe-2361	206	5	,	,	PUNCT
cpe-2361	206	6	&	&	CCONJ
cpe-2361	206	7	pennebaker	pennebaker	PROPN
cpe-2361	206	8	,	,	PUNCT
cpe-2361	206	9	j.	j.	PROPN
cpe-2361	206	10	w.	w.	PROPN
cpe-2361	206	11	(	(	PUNCT
cpe-2361	206	12	1989	1989	NUM
cpe-2361	206	13	)	)	PUNCT
cpe-2361	206	14	.	.	PUNCT
cpe-2361	207	1	health	health	NOUN
cpe-2361	207	2	complaints	complaint	NOUN
cpe-2361	207	3	,	,	PUNCT
cpe-2361	207	4	stress	stress	NOUN
cpe-2361	207	5	and	and	CCONJ
cpe-2361	207	6	distress	distress	NOUN
cpe-2361	207	7	:	:	PUNCT
cpe-2361	207	8	exploring	explore	VERB
cpe-2361	207	9	the	the	DET
cpe-2361	207	10	central	central	ADJ
cpe-2361	207	11	role	role	NOUN
cpe-2361	207	12	of	of	ADP
cpe-2361	207	13	negative	negative	ADJ
cpe-2361	207	14	affectivity	affectivity	NOUN
cpe-2361	207	15	.	.	PUNCT
cpe-2361	208	1	psychological	psychological	ADJ
cpe-2361	208	2	review	review	NOUN
cpe-2361	208	3	,	,	PUNCT
cpe-2361	208	4	96(2	96(2	NUM
cpe-2361	208	5	)	)	PUNCT
cpe-2361	208	6	,	,	PUNCT
cpe-2361	208	7	234	234	NUM
cpe-2361	208	8	-	-	SYM
cpe-2361	208	9	254	254	NUM
cpe-2361	208	10	.	.	PUNCT
cpe-2361	209	1	https://doi.org/10.1037/0033-295x.96.2.234	https://doi.org/10.1037/0033-295x.96.2.234	ADJ
cpe-2361	209	2	weissenfeld	weissenfeld	PROPN
cpe-2361	209	3	,	,	PUNCT
cpe-2361	209	4	j.	j.	PROPN
cpe-2361	209	5	,	,	PUNCT
cpe-2361	209	6	stock	stock	NOUN
cpe-2361	209	7	,	,	PUNCT
cpe-2361	209	8	s.	s.	PROPN
cpe-2361	209	9	,	,	PUNCT
cpe-2361	209	10	lüngen	lüngen	PROPN
cpe-2361	209	11	,	,	PUNCT
cpe-2361	209	12	m.	m.	NOUN
cpe-2361	209	13	,	,	PUNCT
cpe-2361	209	14	&	&	CCONJ
cpe-2361	209	15	gerber	gerber	PROPN
cpe-2361	209	16	,	,	PUNCT
cpe-2361	209	17	a.	a.	NOUN
cpe-2361	209	18	(	(	PUNCT
cpe-2361	209	19	2010	2010	NUM
cpe-2361	209	20	)	)	PUNCT
cpe-2361	209	21	.	.	PUNCT
cpe-2361	210	1	the	the	DET
cpe-2361	210	2	nocebo	nocebo	NOUN
cpe-2361	210	3	effect	effect	NOUN
cpe-2361	210	4	:	:	PUNCT
cpe-2361	210	5	a	a	DET
cpe-2361	210	6	reason	reason	NOUN
cpe-2361	210	7	for	for	ADP
cpe-2361	210	8	patients	patient	NOUN
cpe-2361	210	9	’	'	PUNCT
cpe-2361	210	10	non	non	NOUN
cpe-2361	210	11	-	-	NOUN
cpe-2361	210	12	adherence	adherence	NOUN
cpe-2361	210	13	to	to	ADP
cpe-2361	210	14	generic	generic	ADJ
cpe-2361	210	15	substitution	substitution	NOUN
cpe-2361	210	16	?	?	PUNCT
cpe-2361	211	1	die	die	PROPN
cpe-2361	211	2	pharmazie	pharmazie	PROPN
cpe-2361	211	3	,	,	PUNCT
cpe-2361	211	4	65(7	65(7	NUM
cpe-2361	211	5	)	)	PUNCT
cpe-2361	211	6	,	,	PUNCT
cpe-2361	211	7	451	451	NUM
cpe-2361	211	8	-	-	SYM
cpe-2361	211	9	456	456	NUM
cpe-2361	211	10	.	.	PUNCT
cpe-2361	212	1	witthöft	witthöft	PROPN
cpe-2361	212	2	,	,	PUNCT
cpe-2361	212	3	m.	m.	NOUN
cpe-2361	212	4	,	,	PUNCT
cpe-2361	212	5	&	&	CCONJ
cpe-2361	212	6	rubin	rubin	PROPN
cpe-2361	212	7	,	,	PUNCT
cpe-2361	212	8	g.	g.	PROPN
cpe-2361	212	9	j.	j.	PROPN
cpe-2361	212	10	(	(	PUNCT
cpe-2361	212	11	2013	2013	NUM
cpe-2361	212	12	)	)	PUNCT
cpe-2361	212	13	.	.	PUNCT
cpe-2361	212	14	are	be	AUX
cpe-2361	212	15	media	medium	NOUN
cpe-2361	212	16	warnings	warning	NOUN
cpe-2361	212	17	about	about	ADP
cpe-2361	212	18	the	the	DET
cpe-2361	212	19	adverse	adverse	ADJ
cpe-2361	212	20	health	health	NOUN
cpe-2361	212	21	effects	effect	NOUN
cpe-2361	212	22	of	of	ADP
cpe-2361	212	23	modern	modern	ADJ
cpe-2361	212	24	life	life	NOUN
cpe-2361	212	25	self	self	NOUN
cpe-2361	212	26	-	-	PUNCT
cpe-2361	212	27	fulfilling	fulfil	VERB
cpe-2361	212	28	?	?	PUNCT
cpe-2361	213	1	an	an	DET
cpe-2361	213	2	experimental	experimental	ADJ
cpe-2361	213	3	study	study	NOUN
cpe-2361	213	4	on	on	ADP
cpe-2361	213	5	idiopathic	idiopathic	ADJ
cpe-2361	213	6	environmental	environmental	ADJ
cpe-2361	213	7	intolerance	intolerance	NOUN
cpe-2361	213	8	attributed	attribute	VERB
cpe-2361	213	9	to	to	ADP
cpe-2361	213	10	electromagnetic	electromagnetic	ADJ
cpe-2361	213	11	fields	field	NOUN
cpe-2361	213	12	(	(	PUNCT
cpe-2361	213	13	iei	iei	PROPN
cpe-2361	213	14	-	-	PUNCT
cpe-2361	213	15	emf	emf	NOUN
cpe-2361	213	16	)	)	PUNCT
cpe-2361	213	17	.	.	PUNCT
cpe-2361	214	1	journal	journal	PROPN
cpe-2361	214	2	of	of	ADP
cpe-2361	214	3	psychosomatic	psychosomatic	ADJ
cpe-2361	214	4	research	research	NOUN
cpe-2361	214	5	,	,	PUNCT
cpe-2361	214	6	74(3	74(3	NOUN
cpe-2361	214	7	)	)	PUNCT
cpe-2361	214	8	,	,	PUNCT
cpe-2361	214	9	206	206	NUM
cpe-2361	214	10	-	-	SYM
cpe-2361	214	11	212	212	NUM
cpe-2361	214	12	.	.	PUNCT
cpe-2361	215	1	https://doi.org/10.1016/j.jpsychores.2012.12.002	https://doi.org/10.1016/j.jpsychores.2012.12.002	NOUN
cpe-2361	215	2	media	medium	NOUN
cpe-2361	215	3	-	-	PUNCT
cpe-2361	215	4	induced	induce	VERB
cpe-2361	215	5	nocebo	nocebo	NOUN
cpe-2361	215	6	response	response	NOUN
cpe-2361	215	7	12	12	NUM
cpe-2361	215	8	psychopen	psychopen	ADJ
cpe-2361	215	9	gold	gold	NOUN
cpe-2361	215	10	is	be	AUX
cpe-2361	215	11	a	a	DET
cpe-2361	215	12	publishing	publishing	NOUN
cpe-2361	215	13	service	service	NOUN
cpe-2361	215	14	by	by	ADP
cpe-2361	215	15	leibniz	leibniz	PROPN
cpe-2361	215	16	institute	institute	PROPN
cpe-2361	215	17	for	for	ADP
cpe-2361	215	18	psychology	psychology	NOUN
cpe-2361	215	19	information	information	NOUN
cpe-2361	215	20	(	(	PUNCT
cpe-2361	215	21	zpid	zpid	NOUN
cpe-2361	215	22	)	)	PUNCT
cpe-2361	215	23	,	,	PUNCT
cpe-2361	215	24	germany	germany	PROPN
cpe-2361	215	25	.	.	PUNCT
cpe-2361	216	1	www.leibniz-psychology.org	www.leibniz-psychology.org	PROPN
cpe-2361	216	2	https://doi.org/10.1111/j.1743-6109.2007.00563.x	https://doi.org/10.1111/j.1743-6109.2007.00563.x	X
cpe-2361	217	1	https://doi.org/10.1038/clpt.1987.142	https://doi.org/10.1038/clpt.1987.142	PROPN
cpe-2361	217	2	https://doi.org/10.1093/eurheartj/ehv641	https://doi.org/10.1093/eurheartj/ehv641	PROPN
cpe-2361	218	1	https://doi.org/10.1146/annurev-psych-010418-102907	https://doi.org/10.1146/annurev-psych-010418-102907	PROPN
cpe-2361	218	2	https://doi.org/10.1111/j.1365-2125.1996.tb00004.x	https://doi.org/10.1111/j.1365-2125.1996.tb00004.x	PROPN
cpe-2361	219	1	https://www.stuff.co.nz	https://www.stuff.co.nz	NOUN
cpe-2361	219	2	https://doi.org/10.1016/j.envres.2018.06.032	https://doi.org/10.1016/j.envres.2018.06.032	PROPN
cpe-2361	219	3	https://doi.org/10.1037/0033-295x.96.2.234	https://doi.org/10.1037/0033-295x.96.2.234	ADJ
cpe-2361	219	4	https://doi.org/10.1016/j.jpsychores.2012.12.002	https://doi.org/10.1016/j.jpsychores.2012.12.002	NOUN
cpe-2361	219	5	https://www.leibniz-psychology.org/	https://www.leibniz-psychology.org/	PRON
cpe-2361	219	6	https://www.psychopen.eu/	https://www.psychopen.eu/	VERB
cpe-2361	219	7	media	medium	NOUN
cpe-2361	219	8	-	-	PUNCT
cpe-2361	219	9	induced	induce	VERB
cpe-2361	219	10	nocebo	nocebo	NOUN
cpe-2361	219	11	response	response	NOUN
cpe-2361	219	12	(	(	PUNCT
cpe-2361	219	13	introduction	introduction	NOUN
cpe-2361	219	14	)	)	PUNCT
cpe-2361	219	15	method	method	NOUN
cpe-2361	219	16	newspaper	newspaper	NOUN
cpe-2361	219	17	articles	article	NOUN
cpe-2361	219	18	adverse	adverse	ADJ
cpe-2361	219	19	drug	drug	NOUN
cpe-2361	219	20	reactions	reaction	NOUN
cpe-2361	219	21	measures	measure	VERB
cpe-2361	220	1	statistical	statistical	ADJ
cpe-2361	220	2	analyses	analysis	NOUN
cpe-2361	220	3	results	result	VERB
cpe-2361	220	4	discussion	discussion	VERB
cpe-2361	220	5	main	main	ADJ
cpe-2361	220	6	findings	finding	NOUN
cpe-2361	220	7	comparison	comparison	NOUN
cpe-2361	220	8	with	with	ADP
cpe-2361	220	9	other	other	ADJ
cpe-2361	220	10	studies	study	NOUN
cpe-2361	220	11	strengths	strength	NOUN
cpe-2361	220	12	and	and	CCONJ
cpe-2361	220	13	limitations	limitation	NOUN
cpe-2361	220	14	(	(	PUNCT
cpe-2361	220	15	additional	additional	ADJ
cpe-2361	220	16	information	information	NOUN
cpe-2361	220	17	)	)	PUNCT
cpe-2361	220	18	funding	fund	VERB
cpe-2361	220	19	competing	compete	VERB
cpe-2361	220	20	interests	interest	NOUN
cpe-2361	220	21	acknowledgments	acknowledgment	NOUN
cpe-2361	220	22	references	reference	NOUN